https://novapharmanews.com/eu/news/eu-secures-emergency-favipiravir-deliveries-hantavirus-response 2026-06-10T05:13:11.980Z weekly 0.7 https://novapharmanews.com/eu/news/eye-drugs-list-sodium-hyaluronate-tafluprost-tobramycin-uses 2026-06-10T08:13:33.142Z weekly 0.7 https://novapharmanews.com/apac/news/areas-with-risk-of-dengue-cdc-map-criteria-global-reach 2026-06-10T05:16:26.552Z weekly 0.7 https://novapharmanews.com/us/news/breast-cancer-statistics-worldwide-what-the-data-shows 2026-06-10T04:58:15.689Z weekly 0.7 https://novapharmanews.com/us/news/manufacturing-pipeline-approvals-evidence-confirms 2026-06-10T05:16:28.547Z weekly 0.7 https://novapharmanews.com/us/news/glp-1-usage-statistics-data-shows 2026-06-10T04:58:34.881Z weekly 0.7 https://novapharmanews.com/us/news/novo-nordisk-supply-wegovy-stabilizes-new-manufacturing-capacity 2026-06-10T07:24:59.131Z weekly 0.7 https://novapharmanews.com/us/news/biontech-first-patient-phase-1-pancreatic-cancer-mrna-vaccine-trial 2026-06-10T04:58:42.897Z weekly 0.7 https://novapharmanews.com/us/news/maritide-phase-2-obesity-data-20-percent-weight-loss-one-year 2026-06-10T05:16:36.518Z weekly 0.7 https://novapharmanews.com/us/news/gsk-blenrep-returns-us-market-fda-approves-resubmission 2026-06-10T06:31:51.291Z weekly 0.7 https://novapharmanews.com/us/news/moderna-mrna-1083-phase-3-flu-covid-immune-response 2026-06-10T05:11:08.258Z weekly 0.7 https://novapharmanews.com/us/news/danuglipron-phase-3-pfizer-phase-2b-obesity-trial 2026-06-10T05:01:00.637Z weekly 0.7 https://novapharmanews.com/us/news/biogen-eisai-expand-leqembi-access-subcutaneous-maintenance-dosing 2026-06-10T08:07:29.663Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-vyloy-her2-negative-gastric-gej-cancer 2026-06-10T05:16:38.571Z weekly 0.7 https://novapharmanews.com/us/news/novo-nordisk-supply-of-wegovy-stabilizes-as-fda-shortage-ends 2026-06-10T06:24:20.701Z weekly 0.7 https://novapharmanews.com/us/news/jj-reports-positive-phase-3-tremfya-data-ulcerative-colitis 2026-06-10T05:16:42.557Z weekly 0.7 https://novapharmanews.com/us/news/sanofi-completes-inhibrx-acquisition-for-1-7b 2026-06-10T05:16:44.559Z weekly 0.7 https://novapharmanews.com/us/news/mari-tide-phase-2-amgen-reports-up-to-20-percent-weight-loss-at-one-year 2026-06-10T04:58:54.899Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-dupixent-for-copd-eosinophilic-phenotype 2026-06-10T05:16:46.560Z weekly 0.7 https://novapharmanews.com/us/news/gsk-blenrep-fda-approval-relapsed-multiple-myeloma 2026-06-10T07:54:34.805Z weekly 0.7 https://novapharmanews.com/us/news/modernas-mrna-1083-phase-3-stronger-flu-covid-immune-responses 2026-06-10T07:09:36.226Z weekly 0.7 https://novapharmanews.com/us/news/merck-harpoon-therapeutics-acquisition-oncology-pipeline 2026-06-10T07:27:49.556Z weekly 0.7 https://novapharmanews.com/us/news/pfizer-danuglipron-phase-2b-obesity-endpoint 2026-06-10T08:47:15.937Z weekly 0.7 https://novapharmanews.com/us/news/roche-positive-phase-3-trontinemab-alzheimers-disease 2026-06-10T05:16:54.569Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-keytruda-adjuvant-nsclc-merck 2026-06-10T07:21:40.371Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-mercks-keytruda-adjuvant-nsclc-treatment 2026-06-10T07:18:26.726Z weekly 0.7 https://novapharmanews.com/us/news/eli-lilly-donanemab-wins-fda-approval-early-alzheimers-disease 2026-06-10T04:58:38.891Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-keytruda-adjuvant-nsclc-merck-catalyst 2026-06-10T05:11:09.383Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-keytruda-adjuvant-nsclc-early-stage-lung-cancer 2026-06-10T05:45:32.840Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-keytruda-adjuvant-nsclc-merck-investor-watch 2026-06-10T05:24:54.381Z weekly 0.7 https://novapharmanews.com/us/news/novo-nordisk-cagrisema-phase-3-obesity-results-catalyst 2026-06-10T07:47:34.973Z weekly 0.7 https://novapharmanews.com/apac/news/fosun-pharma-aribio-option-agreement 2026-06-10T05:16:58.578Z weekly 0.7 https://novapharmanews.com/us/news/triple-hormone-receptor-agonist-retatrutide-obesity-phase-3-results 2026-06-10T08:47:16.191Z weekly 0.7 https://novapharmanews.com/us/news/fda-industry-friendly-gene-therapy-guidance-bd 2026-06-10T07:14:12.650Z weekly 0.7 https://novapharmanews.com/us/news/johnson-and-johnson-asco-2026-data-adds-depth-to-jnj-valuation-story 2026-06-10T08:48:47.657Z weekly 0.7 https://novapharmanews.com/us/news/pfizer-berobenatide-obesity-drug-vesper-3-data 2026-06-10T05:17:21.722Z weekly 0.7 https://novapharmanews.com/us/news/puma-biotechnology-inducement-awards-nasdaq-5635c4-june-2026 2026-06-10T08:42:06.863Z weekly 0.7 https://novapharmanews.com/eu/news/world-lightproof-bottle-opaque-liners-market-pharma-growth-2035 2026-06-10T05:17:10.590Z weekly 0.7 https://novapharmanews.com/apac/news/pmda-regulatory-updates-orphan-drug-portal-asean-symposium 2026-06-10T07:25:59.066Z weekly 0.7 https://novapharmanews.com/eu/news/emea-2026-life-sciences-industry-cluster-report-market-analysis 2026-06-10T05:17:16.269Z weekly 0.7 https://novapharmanews.com/us/news/facet-life-sciences-appoints-frank-closurdo-vp-commercial-services 2026-06-10T05:17:31.460Z weekly 0.7 https://novapharmanews.com/us/news/pfizer-berobenatide-monthly-obesity-drug-phase-2b-data 2026-06-10T07:26:41.490Z weekly 0.7 https://novapharmanews.com/us/news/listeria-outbreak-soft-cheese-fda-investigation 2026-06-10T05:27:49.785Z weekly 0.7 https://novapharmanews.com/us/news/cdc-ebola-outbreak-central-africa-20000-cases-2026 2026-06-10T05:17:20.591Z weekly 0.7 https://novapharmanews.com/apac/news/nmpa-china-fda-drug-approval-2026-pathways-timelines-impact 2026-06-10T07:58:08.644Z weekly 0.7 https://novapharmanews.com/eu/news/maersk-europe-market-update-june-2026-pharma-supply-chains 2026-06-10T08:23:45.841Z weekly 0.7 https://novapharmanews.com/eu/news/regulatory-round-up-2-february-2026 2026-06-10T05:17:26.684Z weekly 0.7 https://novapharmanews.com/us/news/fda-issues-june-2026-guidance-gene-therapy-payor-comms-cmc-flexibilities 2026-06-10T08:44:34.374Z weekly 0.7 https://novapharmanews.com/us/news/friday-five-asco-takeaways-ada-china-deals-clinical-trials 2026-06-10T05:17:30.609Z weekly 0.7 https://novapharmanews.com/us/news/pharmalittle-roche-blackmail-skinny-labels-supreme-court 2026-06-10T05:17:32.612Z weekly 0.7 https://novapharmanews.com/us/news/ebola-2026-us-response-travel-restrictions-debate 2026-06-10T05:17:34.603Z weekly 0.7 https://novapharmanews.com/us/news/senior-nih-official-pushes-maha-strategy-to-skeptical-ada-audience 2026-06-10T05:17:36.602Z weekly 0.7 https://novapharmanews.com/us/news/newer-glp-1s-pushback-research-cuts-protest 2026-06-10T05:17:52.380Z weekly 0.7 https://novapharmanews.com/us/news/abivax-colitis-drug-hits-goal-cancer-cases-rattle-investors 2026-06-10T05:17:48.309Z weekly 0.7 https://novapharmanews.com/us/news/supreme-court-sides-with-generic-drug-maker-icosapent-ethyl 2026-06-10T05:48:39.155Z weekly 0.7 https://novapharmanews.com/eu/news/baker-company-benelux-joins-europabio-cell-culture-lab-safety 2026-06-10T05:17:44.608Z weekly 0.7 https://novapharmanews.com/us/news/rx-rundown-pfizer-hikma-newlimit-drug-approvals-catalyst-tracker 2026-06-10T05:17:46.610Z weekly 0.7 https://novapharmanews.com/us/news/mira-pharmaceuticals-global-rights-mira-55-skny-1 2026-06-10T05:29:13.252Z weekly 0.7 https://novapharmanews.com/us/news/4-biotech-stocks-investors-should-watch-in-2026-market-analysis 2026-06-10T08:08:00.666Z weekly 0.7 https://novapharmanews.com/us/news/alabama-board-medical-examiners-warning-non-fda-approved-peptides 2026-06-10T07:21:15.241Z weekly 0.7 https://novapharmanews.com/us/news/vertex-fda-accepts-bla-povetacicept-iga-nephropathy-accelerated-approval 2026-06-10T06:10:02.500Z weekly 0.7 https://novapharmanews.com/us/news/aurobindo-pharma-oai-classification-drug-approvals 2026-06-10T05:17:56.701Z weekly 0.7 https://novapharmanews.com/us/news/lee-tuberville-introduce-protections-for-homeopathic-medicine-fda-approval-framework 2026-06-10T05:17:58.609Z weekly 0.7 https://novapharmanews.com/us/news/daraxonrasib-pancreatic-cancer-survival-2026 2026-06-10T08:11:16.571Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-ensitrelvir-xocova-first-oral-covid-19-post-exposure-prophylaxis 2026-06-10T08:43:39.835Z weekly 0.7 https://novapharmanews.com/us/news/generic-drugmakers-skinny-label-victory-hikma-amarin 2026-06-10T05:18:04.623Z weekly 0.7 https://novapharmanews.com/us/news/texas-ag-investigating-energy-drinks-pharma-implications 2026-06-10T05:18:06.617Z weekly 0.7 https://novapharmanews.com/eu/news/myasthenia-gravis-clinical-trial-pipeline-expands-25-companies-delveinsight 2026-06-10T05:18:08.622Z weekly 0.7 https://novapharmanews.com/eu/news/mfn-drug-pricing-reshapes-international-life-sciences-licensing-deals 2026-06-10T05:18:10.702Z weekly 0.7 https://novapharmanews.com/eu/news/india-oman-cepa-fast-tracks-drug-approvals-cuts-export-barriers 2026-06-10T05:18:12.631Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-companion-diagnostic-inavolisib-hr-her2-pik3ca-mutated-breast-cancer 2026-06-10T05:18:14.631Z weekly 0.7 https://novapharmanews.com/us/news/peptide-reclassification-rfk-jr-fda-announcement-pharmacist-take 2026-06-10T07:08:05.050Z weekly 0.7 https://novapharmanews.com/apac/news/vietnam-india-middle-power-diplomacy-pharma-market-analysis 2026-06-10T05:18:18.640Z weekly 0.7 https://novapharmanews.com/us/news/scientists-uncover-new-hiding-spot-hiv-bone-marrow 2026-06-10T05:18:20.627Z weekly 0.7 https://novapharmanews.com/us/news/trump-administration-strips-job-protections-nih-officials-pharma-impact 2026-06-10T05:26:46.950Z weekly 0.7 https://novapharmanews.com/apac/news/nmpa-drug-approvals-2025-record-first-global-approvals 2026-06-10T05:18:24.625Z weekly 0.7 https://novapharmanews.com/eu/news/ema-ama-african-regulators-ebola-clinical-trials-2026 2026-06-10T05:18:26.632Z weekly 0.7 https://novapharmanews.com/eu/news/chmp-may-2026-output-shift-european-drug-development 2026-06-10T08:26:11.881Z weekly 0.7 https://novapharmanews.com/apac/news/cell-gene-therapy-approvals-china-regulatory-updates 2026-06-10T07:55:07.225Z weekly 0.7 https://novapharmanews.com/eu/news/eu-commission-advances-critical-medicines-act 2026-06-10T06:53:48.385Z weekly 0.7 https://novapharmanews.com/eu/news/who-europe-access-novel-medicines 2026-06-10T05:41:19.653Z weekly 0.7 https://novapharmanews.com/eu/news/chmp-negative-stance-acadia-rett-syndrome-drug 2026-06-10T05:40:38.375Z weekly 0.7 https://novapharmanews.com/us/news/pharma-in-focus-regulatory-updates 2026-06-10T05:26:15.836Z weekly 0.7 https://novapharmanews.com/apac/news/decade-ai-medical-device-regulation-2015-2025 2026-06-10T05:19:03.562Z weekly 0.7 https://novapharmanews.com/eu/news/owkin-astrazeneca-ai-collaboration-drug-research 2026-06-10T05:18:57.498Z weekly 0.7 https://novapharmanews.com/us/news/astrazeneca-daiichi-drug-approval-breast-cancer 2026-06-10T05:18:53.112Z weekly 0.7 https://novapharmanews.com/us/news/fda-flashback-breast-cancer-april-2026 2026-06-10T05:18:48.500Z weekly 0.7 https://novapharmanews.com/us/news/fierce-biotech-week-2026-recap 2026-06-10T05:18:47.240Z weekly 0.7 https://novapharmanews.com/eu/news/cancer-therapy-ost-her2-2026-ema-call 2026-06-10T05:18:38.649Z weekly 0.7 https://novapharmanews.com/eu/news/hayes-esmo-breast-cancer-award-2026 2026-06-10T05:18:36.649Z weekly 0.7 https://novapharmanews.com/eu/news/esmo-asia-nadia-harbeck-oncology-advances 2026-06-10T05:18:34.641Z weekly 0.7 https://novapharmanews.com/apac/news/smarter-medical-devices-ecosystem-india-regulatory-updates 2026-06-10T05:18:30.648Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-first-oral-covid-19-pep-drug-xocova 2026-06-10T07:52:20.030Z weekly 0.7 https://novapharmanews.com/us/news/legend-biotech-in-vivo-car-t-lymphoma-data-surge 2026-06-10T05:24:20.844Z weekly 0.7 https://novapharmanews.com/us/news/halomd-lawsuit-update-highmark-health-no-surprises-act 2026-06-10T05:37:49.749Z weekly 0.7 https://novapharmanews.com/apac/news/regulatory-round-up-drug-approvals-18-may-2026 2026-06-10T05:19:06.097Z weekly 0.7 https://novapharmanews.com/eu/news/us-europe-biosimilar-approvals-2026 2026-06-10T05:19:08.015Z weekly 0.7 https://novapharmanews.com/eu/news/key-cancer-drugs-esmo-2025 2026-06-10T05:19:09.363Z weekly 0.7 https://novapharmanews.com/us/news/stat-trump-s-medicaid-work-requirements-have-an-unwelcome-surprise-for-some-states-and-patients 2026-06-10T05:19:11.362Z weekly 0.7 https://novapharmanews.com/us/news/military-eating-disorders-prevalence-impact 2026-06-10T05:19:13.371Z weekly 0.7 https://novapharmanews.com/eu/news/european-navenibart-deal-biocryst-analysis 2026-06-10T05:19:15.368Z weekly 0.7 https://novapharmanews.com/apac/news/risen-pharma-phase-2-trial-rp902-alzheimers 2026-06-10T05:19:17.360Z weekly 0.7 https://novapharmanews.com/us/news/fda-blueprint-regulatory-risk-animal-testing-alternatives 2026-06-10T06:24:47.706Z weekly 0.7 https://novapharmanews.com/apac/news/regulatory-updates-optical-coherence-tomography-pharma 2026-06-10T05:19:21.380Z weekly 0.7 https://novapharmanews.com/us/news/china-drug-development-oncology-us 2026-06-10T05:19:23.377Z weekly 0.7 https://novapharmanews.com/eu/news/horizon-scanning-ema-regulatory-updates 2026-06-10T05:19:25.378Z weekly 0.7 https://novapharmanews.com/apac/news/datroway-approved-metastatic-tnbc 2026-06-10T05:19:27.380Z weekly 0.7 https://novapharmanews.com/eu/news/x4-pharmaceuticals-ema-chmp-positive-opinion-mavorixafor 2026-06-10T05:19:29.383Z weekly 0.7 https://novapharmanews.com/us/news/fda-declines-guidance-foreign-drug-imports 2026-06-10T05:19:45.875Z weekly 0.7 https://novapharmanews.com/eu/news/privosegtor-ema-prime-optic-neuritis 2026-06-10T05:19:33.369Z weekly 0.7 https://novapharmanews.com/eu/news/arrowhead-pharmaceuticals-positive-cardiometabolic-data-european-a 2026-06-10T05:19:35.377Z weekly 0.7 https://novapharmanews.com/eu/news/teva-olan-ema-acceptance 2026-06-10T08:46:49.495Z weekly 0.7 https://novapharmanews.com/eu/news/florian-lordick-esmo-president-2026-elections-open 2026-06-10T05:19:39.392Z weekly 0.7 https://novapharmanews.com/us/news/ophthalmology-pipeline-milestones-q2-2026 2026-06-10T08:01:39.931Z weekly 0.7 https://novapharmanews.com/eu/news/ema-approves-novo-wegovy-weight-loss-drug 2026-06-10T05:19:43.396Z weekly 0.7 https://novapharmanews.com/us/news/vir-biotechnology-stock-board-reshuffle-governance-votes 2026-06-10T06:11:15.318Z weekly 0.7 https://novapharmanews.com/apac/news/big-pharma-china-trials-scrutiny-oncology 2026-06-10T05:19:47.441Z weekly 0.7 https://novapharmanews.com/apac/news/premia-lind-lind-asia-ai-clinical-trials 2026-06-10T05:48:04.692Z weekly 0.7 https://novapharmanews.com/eu/news/definitive-trial-milestone-50-percent-recruitment 2026-06-10T05:19:52.451Z weekly 0.7 https://novapharmanews.com/apac/news/kissei-pharmaceutical-halts-tavneos-use-amid-deaths 2026-06-10T05:19:53.449Z weekly 0.7 https://novapharmanews.com/us/news/strengths-and-limitations-of-real-world-data-from-electronic-health-records-and-92ed37a9 2026-06-10T05:19:58.755Z weekly 0.7 https://novapharmanews.com/us/news/the-common-fund-data-ecosystem-cfde-449d7791 2026-06-10T05:19:57.447Z weekly 0.7 https://novapharmanews.com/us/news/the-gross-to-net-squeeze-how-physician-led-patient-education-reduces-gtn-erosion-17169d71 2026-06-10T05:19:59.457Z weekly 0.7 https://novapharmanews.com/us/news/a-secure-and-intelligent-drug-delivery-model-integrating-neural-networks-with-bl-853eecb6 2026-06-10T05:20:01.471Z weekly 0.7 https://novapharmanews.com/us/news/the-market-for-monoclonal-antibodies-trends-challenges-and-opportunities-7a342d06 2026-06-10T05:20:14.044Z weekly 0.7 https://novapharmanews.com/us/news/opinion-the-medical-billing-ai-arms-race-between-providers-and-insurance 2026-06-10T05:20:05.454Z weekly 0.7 https://novapharmanews.com/us/news/amish-healthcare-lessons-public-health 2026-06-10T05:20:07.473Z weekly 0.7 https://novapharmanews.com/us/news/nih-funding-cuts-ebola-preparedness-global-health 2026-06-10T05:20:19.664Z weekly 0.7 https://novapharmanews.com/us/news/ultra-processed-food-policy-demands-escalate-researchers-cite-systemic-issues 2026-06-10T05:20:11.467Z weekly 0.7 https://novapharmanews.com/apac/news/pmda-approves-new-pharmaceuticals-medical-devices-whats-new 2026-06-10T05:20:13.475Z weekly 0.7 https://novapharmanews.com/eu/news/eu-trade-policy-china-pharma-analysis 2026-06-10T05:20:16.450Z weekly 0.7 https://novapharmanews.com/eu/news/ema-january-drug-approvals-2025 2026-06-10T05:20:17.808Z weekly 0.7 https://novapharmanews.com/eu/news/chmp-drug-approvals-analysis 2026-06-10T07:56:02.613Z weekly 0.7 https://novapharmanews.com/us/news/munck-wilson-mandala-fort-worth-life-sciences-expansion 2026-06-10T07:52:23.608Z weekly 0.7 https://novapharmanews.com/us/news/fulcrum-therapeutics-stock-plunges-sickle-cell-drug-discontinuation 2026-06-10T05:20:26.959Z weekly 0.7 https://novapharmanews.com/us/news/senior-nih-scientist-research-fellow-charged-with-bringing-deactivated-mpox-virus-into-u-s 2026-06-10T05:38:24.435Z weekly 0.7 https://novapharmanews.com/us/news/cambridge-biotech-merger-acquisition-market-analysis 2026-06-10T07:57:19.857Z weekly 0.7 https://novapharmanews.com/us/news/outlook-therapeutics-lytenava-fda-resubmission-60-day-review 2026-06-10T08:43:02.468Z weekly 0.7 https://novapharmanews.com/us/news/hanmi-signs-licensing-deal-lilly-sonefpeglutide 2026-06-10T05:39:46.737Z weekly 0.7 https://novapharmanews.com/us/news/fda-final-guidance-pulmonary-tuberculosis-drug-development 2026-06-10T05:37:44.401Z weekly 0.7 https://novapharmanews.com/us/news/stat-pharmalittle-lilly-340b-ebola-vaccine-funding 2026-06-10T05:20:35.795Z weekly 0.7 https://novapharmanews.com/us/news/why-us-manufactured-pharmaceutical-packaging-equipment-matters 2026-06-10T05:20:37.814Z weekly 0.7 https://novapharmanews.com/us/news/virtual-end-doctors-office-waiting-room 2026-06-10T05:20:39.792Z weekly 0.7 https://novapharmanews.com/us/news/how-one-state-s-medical-meal-program-lowered-health-care-costs 2026-06-10T05:20:41.808Z weekly 0.7 https://novapharmanews.com/us/news/stat-corporate-medicine-telehealth-crackdown 2026-06-10T05:20:43.794Z weekly 0.7 https://novapharmanews.com/apac/news/global-rwe-guidance-regulatory-decision-making-updates 2026-06-10T05:20:45.830Z weekly 0.7 https://novapharmanews.com/apac/news/china-oncology-research-europe-alarm 2026-06-10T05:20:47.825Z weekly 0.7 https://novapharmanews.com/apac/news/asco-2026-asian-oncology-innovation-clinical-trials 2026-06-10T05:20:54.482Z weekly 0.7 https://novapharmanews.com/apac/news/beone-medicines-phase-3-herizon-gea-data-nejm 2026-06-10T08:41:12.681Z weekly 0.7 https://novapharmanews.com/apac/news/newron-pharmaceuticals-june-investor-conferences 2026-06-10T08:40:22.770Z weekly 0.7 https://novapharmanews.com/eu/news/mayer-brown-serb-pharmaceuticals-idefirix-acquisition 2026-06-10T08:26:10.339Z weekly 0.7 https://novapharmanews.com/us/news/fda-draft-guidance-biosimilar-pk-studies 2026-06-10T06:54:00.849Z weekly 0.7 https://novapharmanews.com/us/news/new-fda-approach-drug-prices-implications 2026-06-10T06:42:04.628Z weekly 0.7 https://novapharmanews.com/eu/news/x4-pharmaceuticals-mavorixafor-ema-approval 2026-06-10T05:37:02.376Z weekly 0.7 https://novapharmanews.com/eu/news/fda-approves-aldosterone-synthase-inhibitor-hypertension 2026-06-10T05:21:22.124Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-atezolizumab-ctdna-mrd-positive-mibc 2026-06-10T05:21:20.144Z weekly 0.7 https://novapharmanews.com/apac/news/dishman-carbogen-amcis-shanghai-nmpa-gmp-audit 2026-06-10T05:21:18.133Z weekly 0.7 https://novapharmanews.com/eu/news/italy-fourth-europe-clinical-research-enrollment 2026-06-10T05:21:14.115Z weekly 0.7 https://novapharmanews.com/apac/news/hong-kong-new-drug-approval-process 2026-06-10T05:21:08.129Z weekly 0.7 https://novapharmanews.com/eu/news/datroway-priority-review-metastatic-tnbc 2026-06-10T05:21:06.130Z weekly 0.7 https://novapharmanews.com/us/news/lilly-gilead-pharma-ma-boom-market-analysis 2026-06-10T05:21:02.619Z weekly 0.7 https://novapharmanews.com/us/news/inventiva-leadership-lanifibranor-phase-3-data 2026-06-10T05:20:59.832Z weekly 0.7 https://novapharmanews.com/us/news/fda-expands-market-access-ends-products 2026-06-10T05:20:57.900Z weekly 0.7 https://novapharmanews.com/us/news/longeveron-stockholder-letter-corporate-strategy-2026-goals 2026-06-10T05:20:53.813Z weekly 0.7 https://novapharmanews.com/eu/news/ema-implements-new-eu-pharma-rules-regulatory-updates 2026-06-10T05:36:08.377Z weekly 0.7 https://novapharmanews.com/eu/news/regeneron-pharma-ema-eye-drug-review-wolfe-target-trim 2026-06-10T05:41:12.201Z weekly 0.7 https://novapharmanews.com/eu/news/teva-olanzapine-lai-ema-review-schizophrenia 2026-06-10T07:37:31.915Z weekly 0.7 https://novapharmanews.com/eu/news/asco-2026-european-pharma-astrazeneca-roche-market-analysis 2026-06-10T05:21:34.399Z weekly 0.7 https://novapharmanews.com/eu/news/esmo-2025-nmi-bladder-cancer-highlights 2026-06-10T05:21:32.140Z weekly 0.7 https://novapharmanews.com/eu/news/datroway-trodelvy-first-line-tnbc-battle 2026-06-10T05:21:34.137Z weekly 0.7 https://novapharmanews.com/us/news/citius-pharmaceuticals-stock-update-cancer-anti-infective 2026-06-10T05:21:43.370Z weekly 0.7 https://novapharmanews.com/eu/news/idorsia-c-diff-vaccine-clinical-progress 2026-06-10T05:21:38.153Z weekly 0.7 https://novapharmanews.com/us/news/fda-guidance-animal-thyroid-products-august-2026 2026-06-10T05:21:40.150Z weekly 0.7 https://novapharmanews.com/us/news/global-regulatory-roundup-june-1-2026 2026-06-10T07:01:53.821Z weekly 0.7 https://novapharmanews.com/us/news/biotech-m-and-a-trends-2026-outlook 2026-06-10T05:36:04.178Z weekly 0.7 https://novapharmanews.com/us/news/big-pharma-small-deals-biotech-boon 2026-06-10T05:36:05.197Z weekly 0.7 https://novapharmanews.com/us/news/rallybio-avenzo-reverse-merger-oncology-deal 2026-06-10T05:21:48.140Z weekly 0.7 https://novapharmanews.com/us/news/legend-biotech-asco-data-carvykti-lb2102 2026-06-10T05:21:50.150Z weekly 0.7 https://novapharmanews.com/us/news/cdc-ebola-containment-clinical-trials-priority 2026-06-10T05:37:28.161Z weekly 0.7 https://novapharmanews.com/us/news/asia-biopharma-innovation-epicenter-drug-approvals 2026-06-10T05:21:54.151Z weekly 0.7 https://novapharmanews.com/us/news/dea-reschedules-marijuana-schedule-iii-expediting-medical-access-research 2026-06-10T07:57:23.821Z weekly 0.7 https://novapharmanews.com/us/news/fda-expert-panel-review-peptide-access-compounded-drug-market 2026-06-10T05:21:58.151Z weekly 0.7 https://novapharmanews.com/us/news/elite-pharma-fda-anda-generic-anticoagulant-26b 2026-06-10T05:22:00.154Z weekly 0.7 https://novapharmanews.com/us/news/cms-finalizes-medicaid-work-requirement-rules 2026-06-10T05:36:07.461Z weekly 0.7 https://novapharmanews.com/us/news/medicus-pharma-biotech-showcase-2026 2026-06-10T05:48:22.531Z weekly 0.7 https://novapharmanews.com/us/news/rigel-pharmaceuticals-licenses-veppanu 2026-06-10T05:22:06.155Z weekly 0.7 https://novapharmanews.com/us/news/fda-ai-clinical-trials-rfi-guide 2026-06-10T08:44:34.655Z weekly 0.7 https://novapharmanews.com/apac/news/estado-actual-y-acciones-para-impulsar-la-investigacion-clinica-en-mexico-2025-5b7db092 2026-06-10T05:22:18.094Z weekly 0.7 https://novapharmanews.com/us/news/formycon-ag-geschaftsbericht-2025-5ff7fa30 2026-06-10T05:22:12.177Z weekly 0.7 https://novapharmanews.com/us/news/fda-approvals-oncology-jan-mar-2026 2026-06-10T07:39:21.937Z weekly 0.7 https://novapharmanews.com/us/news/bayer-acquisition-eye-drug-biotech 2026-06-10T07:13:44.497Z weekly 0.7 https://novapharmanews.com/us/news/top-10-takeover-targets-2026 2026-06-10T05:46:12.895Z weekly 0.7 https://novapharmanews.com/us/news/fda-eases-restrictions-peptides-drug-approvals 2026-06-10T05:40:42.187Z weekly 0.7 https://novapharmanews.com/us/news/top-biotech-gainers-codx-nrxp-nvax-clinical-trials-update 2026-06-10T05:40:40.280Z weekly 0.7 https://novapharmanews.com/us/news/sunlight-glp-1-2026-fda-decision-compounded-semaglutide 2026-06-10T05:37:41.882Z weekly 0.7 https://novapharmanews.com/us/news/fda-peptides-bulk-drug-compounding 2026-06-10T05:22:44.008Z weekly 0.7 https://novapharmanews.com/us/news/fda-easing-restrictions-unproven-peptides 2026-06-10T05:22:36.238Z weekly 0.7 https://novapharmanews.com/us/news/2025-drug-approvals-biopharma-resilience 2026-06-10T05:22:24.172Z weekly 0.7 https://novapharmanews.com/us/news/us-fda-proposes-regulations-weight-loss-drug-compounding 2026-06-10T05:22:23.966Z weekly 0.7 https://novapharmanews.com/us/news/eli-lilly-acquires-centessa-pharmaceuticals-market-analysis 2026-06-10T05:22:22.164Z weekly 0.7 https://novapharmanews.com/us/news/fda-permanent-ban-compounded-glp-1s 2026-06-10T05:22:14.170Z weekly 0.7 https://novapharmanews.com/eu/news/fda-delays-astrazeneca-breast-cancer-drug-review 2026-06-10T05:37:43.513Z weekly 0.7 https://novapharmanews.com/us/news/healthcare-dealmaker-megamergers-2026 2026-06-10T05:22:58.213Z weekly 0.7 https://novapharmanews.com/eu/news/2026-italy-drug-medical-device-litigation-report 2026-06-10T05:22:56.270Z weekly 0.7 https://novapharmanews.com/eu/news/bio-pharma-outlook-2026-regulatory-updates 2026-06-10T05:22:54.178Z weekly 0.7 https://novapharmanews.com/apac/news/pharmaceuticals-market-size-share-analysis-2034 2026-06-10T05:22:52.182Z weekly 0.7 https://novapharmanews.com/eu/news/international-school-clinical-oncology-annual-congress-2026 2026-06-10T05:22:50.181Z weekly 0.7 https://novapharmanews.com/us/news/fsma-final-rule-traceability-requirements 2026-06-10T05:22:48.179Z weekly 0.7 https://novapharmanews.com/eu/news/ascentage-pharma-eha-2026-clinical-advances 2026-06-10T05:22:47.547Z weekly 0.7 https://novapharmanews.com/apac/news/early-access-disparities-innovative-therapies 2026-06-10T05:22:44.262Z weekly 0.7 https://novapharmanews.com/eu/news/rethinking-qa-qc-future-bio-pharmaceutical-analysis-2026 2026-06-10T05:22:40.201Z weekly 0.7 https://novapharmanews.com/us/news/fda-guidance-next-gen-sequencing-gene-therapy-safety 2026-06-10T05:22:38.187Z weekly 0.7 https://novapharmanews.com/us/news/altrx-glp-1-review-2026-fda-updates-semaglutide 2026-06-10T06:15:34.119Z weekly 0.7 https://novapharmanews.com/us/news/wockhardt-us-fda-approval-zaynich 2026-06-10T05:23:20.487Z weekly 0.7 https://novapharmanews.com/us/news/fda-decisions-q2-2026-drug-approvals 2026-06-10T05:23:14.207Z weekly 0.7 https://novapharmanews.com/us/news/pennsylvania-compounding-pharmacy-fda-warning-letter 2026-06-10T05:23:12.283Z weekly 0.7 https://novapharmanews.com/us/news/global-ma-trends-health-industries-2026-outlook 2026-06-10T05:23:10.204Z weekly 0.7 https://novapharmanews.com/us/news/longeveron-q1-2026-financial-results-business-update 2026-06-10T05:23:08.198Z weekly 0.7 https://novapharmanews.com/us/news/chinese-pharma-innovators-global-expansion 2026-06-10T05:23:04.190Z weekly 0.7 https://novapharmanews.com/us/news/china-approves-hernexeos-lung-cancer-treatment 2026-06-10T05:23:02.210Z weekly 0.7 https://novapharmanews.com/us/news/resilience-reinvention-biotech-maturity 2026-06-10T05:23:00.192Z weekly 0.7 https://novapharmanews.com/us/news/fda-device-guidance-agenda-2026 2026-06-10T05:23:49.149Z weekly 0.7 https://novapharmanews.com/apac/news/biomarkers-digital-technologies-oncology-asia-2026 2026-06-10T05:23:36.884Z weekly 0.7 https://novapharmanews.com/eu/news/lenz-therapeutics-vizz-ema-presbyopia 2026-06-10T05:23:34.209Z weekly 0.7 https://novapharmanews.com/apac/news/innovative-oncology-pharma-china 2026-06-10T05:23:32.208Z weekly 0.7 https://novapharmanews.com/us/news/fda-new-guidance-ai-regulatory-restraint 2026-06-10T05:23:30.209Z weekly 0.7 https://novapharmanews.com/eu/news/innovent-pfizer-cancer-drug-deal 2026-06-10T05:23:28.201Z weekly 0.7 https://novapharmanews.com/eu/news/arrowhead-pharmaceuticals-positive-clinical-data-eas-congress 2026-06-10T05:23:26.218Z weekly 0.7 https://novapharmanews.com/apac/news/asia-pacific-eclinical-solutions-market-report-2025-2030 2026-06-10T05:23:24.201Z weekly 0.7 https://novapharmanews.com/eu/news/innovent-biologics-shares-surge-pfizer-deal 2026-06-10T05:23:22.199Z weekly 0.7 https://novapharmanews.com/apac/news/uk-clinical-trials-oncology-impact 2026-06-10T05:23:20.200Z weekly 0.7 https://novapharmanews.com/us/news/lilly-38b-investment-infectious-disease-portfolio 2026-06-10T05:23:18.201Z weekly 0.7 https://novapharmanews.com/us/news/lunai-bioworks-brainstorm-therapeutics-ai-collaboration 2026-06-10T05:23:40.215Z weekly 0.7 https://novapharmanews.com/us/news/pharma-ma-boom-2026-market-analysis 2026-06-10T05:24:02.233Z weekly 0.7 https://novapharmanews.com/us/news/life-sciences-dealmaking-momentum-strategic-pressures 2026-06-10T05:24:01.681Z weekly 0.7 https://novapharmanews.com/us/news/regulatory-actions-may-2026 2026-06-10T05:24:00.239Z weekly 0.7 https://novapharmanews.com/us/news/states-confront-medical-chatbots-oversight-fda-inaction 2026-06-10T05:23:58.219Z weekly 0.7 https://novapharmanews.com/us/news/big-pharma-biotech-assets-patent-cliff 2026-06-10T05:23:55.185Z weekly 0.7 https://novapharmanews.com/us/news/ai-brain-organoids-parkinsons-rare-epilepsy-regulatory-updates 2026-06-10T05:23:52.218Z weekly 0.7 https://novapharmanews.com/us/news/fda-commissioner-resignation-drug-approvals 2026-06-10T05:23:50.245Z weekly 0.7 https://novapharmanews.com/us/news/big-pharma-ma-spree-march-ipo-drought 2026-06-10T05:23:48.214Z weekly 0.7 https://novapharmanews.com/us/news/pharmtech-regulatory-roundup-may-2026-drug-approvals 2026-06-10T05:23:46.217Z weekly 0.7 https://novapharmanews.com/us/news/bizengri-fda-national-priority-rare-bile-duct-cancer 2026-06-10T05:23:44.216Z weekly 0.7 https://novapharmanews.com/us/news/ai-breast-cancer-risk-prediction-tool-fda-approval 2026-06-10T05:23:42.218Z weekly 0.7 https://novapharmanews.com/eu/news/critical-medicines-act-council-parliament-deal 2026-06-10T08:47:38.701Z weekly 0.7 https://novapharmanews.com/eu/news/prac-meeting-highlights-may-2026 2026-06-10T08:06:02.861Z weekly 0.7 https://novapharmanews.com/apac/news/regulatory-round-up-drug-approvals-april-20-2026 2026-06-10T06:28:04.070Z weekly 0.7 https://novapharmanews.com/eu/news/imfinzi-approval-bladder-cancer 2026-06-10T05:24:24.246Z weekly 0.7 https://novapharmanews.com/apac/news/premia-lind-ai-clinical-trial-screening-asia-pacific 2026-06-10T05:24:22.240Z weekly 0.7 https://novapharmanews.com/apac/news/innovent-biologics-pfizer-10-5b-oncology-partnership 2026-06-10T05:24:18.246Z weekly 0.7 https://novapharmanews.com/apac/news/onconic-therapeutics-jakubo-phase-3-clinical-trials-china 2026-06-10T05:24:16.234Z weekly 0.7 https://novapharmanews.com/eu/news/2026-cell-therapy-regulatory-landscape 2026-06-10T05:24:14.249Z weekly 0.7 https://novapharmanews.com/eu/news/merz-therapeutics-kvvit-inbrija-agreement 2026-06-10T05:24:12.231Z weekly 0.7 https://novapharmanews.com/eu/news/esmo-2025-preview-astra-daiichi-gilead 2026-06-10T05:24:10.225Z weekly 0.7 https://novapharmanews.com/apac/news/clinical-trials-market-oncology-2034 2026-06-10T05:24:08.305Z weekly 0.7 https://novapharmanews.com/eu/news/imfinzi-fda-approval-bladder-cancer 2026-06-10T05:24:06.229Z weekly 0.7 https://novapharmanews.com/apac/news/global-drug-discovery-market-2035 2026-06-10T05:24:40.259Z weekly 0.7 https://novapharmanews.com/us/news/leap-therapeutics-stock-edges-higher 2026-06-10T05:24:38.460Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-durvalumab-bcg-high-risk-nmibc 2026-06-10T05:24:38.255Z weekly 0.7 https://novapharmanews.com/us/news/experimental-igg4-rd-drug-fda-submission 2026-06-10T05:24:36.255Z weekly 0.7 https://novapharmanews.com/us/news/seven-biopharma-trends-2026-clinical-trials 2026-06-10T05:24:35.712Z weekly 0.7 https://novapharmanews.com/apac/news/middle-east-pharma-markets-api-china-2026 2026-06-10T05:24:32.247Z weekly 0.7 https://novapharmanews.com/apac/news/sun-pharma-organon-acquisition-market-analysis 2026-06-10T05:24:28.261Z weekly 0.7 https://novapharmanews.com/eu/news/camizestrant-eu-approval-advanced-er-positive-breast-cancer 2026-06-10T07:53:30.267Z weekly 0.7 https://novapharmanews.com/eu/news/critical-medicines-act-europe-medicines-shortages 2026-06-10T06:44:03.027Z weekly 0.7 https://novapharmanews.com/us/news/us-fda-decision-date-camizestrant-extended 2026-06-10T05:36:27.791Z weekly 0.7 https://novapharmanews.com/us/news/biopharma-dealmaking-2025-market-analysis 2026-06-10T05:25:18.289Z weekly 0.7 https://novapharmanews.com/apac/news/regulatory-strategy-reimagined-trends-accelerating-drug-development 2026-06-10T05:25:11.061Z weekly 0.7 https://novapharmanews.com/us/news/fda-loosens-regulations-digital-health-tools 2026-06-10T05:25:09.526Z weekly 0.7 https://novapharmanews.com/eu/news/hansa-licenses-idefirix-serb-133m 2026-06-10T05:25:07.283Z weekly 0.7 https://novapharmanews.com/eu/news/ema-management-board-march-2026-clinical-trials 2026-06-10T05:25:02.506Z weekly 0.7 https://novapharmanews.com/eu/news/imfinzi-approved-bladder-cancer-combo 2026-06-10T05:24:58.486Z weekly 0.7 https://novapharmanews.com/us/news/global-firms-china-deals-economic-uncertainty 2026-06-10T05:24:55.156Z weekly 0.7 https://novapharmanews.com/apac/news/exosome-based-therapeutics-market-2033-report 2026-06-10T05:24:54.389Z weekly 0.7 https://novapharmanews.com/apac/news/ai-tools-clinical-trials-life-sciences 2026-06-10T05:24:52.394Z weekly 0.7 https://novapharmanews.com/apac/news/apac-clinical-trial-growth-oncology 2026-06-10T05:24:51.058Z weekly 0.7 https://novapharmanews.com/us/news/gsk-alfasigma-licensing-agreement-servier-acquisition 2026-06-10T05:24:48.256Z weekly 0.7 https://novapharmanews.com/eu/news/tarsier-pharma-ipo-nyse-listings-expand 2026-06-10T05:24:42.263Z weekly 0.7 https://novapharmanews.com/us/news/eli-lilly-acquires-vaccine-developers-38b 2026-06-10T08:19:51.653Z weekly 0.7 https://novapharmanews.com/eu/news/ai-accelerates-novo-nordisk-parkinsons-cell-therapy 2026-06-10T05:29:31.987Z weekly 0.7 https://novapharmanews.com/eu/news/european-critical-medicines-act-market-analysis 2026-06-10T05:25:16.953Z weekly 0.7 https://novapharmanews.com/apac/news/brenus-pharma-stc-1010-fda-acceptance 2026-06-10T08:26:22.582Z weekly 0.7 https://novapharmanews.com/us/news/fda-guidelines-generic-bioequivalence-oncology 2026-06-10T05:25:30.949Z weekly 0.7 https://novapharmanews.com/us/news/lifesaving-upgrades-fda-oncology-approvals 2026-06-10T05:25:28.952Z weekly 0.7 https://novapharmanews.com/apac/news/immunotherapy-pet-ct-imaging-demand-australia 2026-06-10T05:25:24.944Z weekly 0.7 https://novapharmanews.com/us/news/top-10-anticipated-drug-launches-2026 2026-06-10T05:25:22.965Z weekly 0.7 https://novapharmanews.com/us/news/fda-restricts-compounding-weight-loss-drugs 2026-06-10T05:25:20.945Z weekly 0.7 https://novapharmanews.com/apac/news/india-vietnam-relations-diplomatic-push 2026-06-10T05:25:18.948Z weekly 0.7 https://novapharmanews.com/eu/news/ema-fda-good-ai-practice-drug-development 2026-06-10T05:25:54.969Z weekly 0.7 https://novapharmanews.com/eu/news/may-2026-global-health-wash-funding-opportunities 2026-06-10T05:25:52.964Z weekly 0.7 https://novapharmanews.com/eu/news/europe-boost-clinical-trials 2026-06-10T05:25:50.986Z weekly 0.7 https://novapharmanews.com/eu/news/eu-draft-deal-essential-medicine-shortages 2026-06-10T05:25:48.961Z weekly 0.7 https://novapharmanews.com/us/news/industry-groups-fda-guidance-form-483 2026-06-10T05:25:46.960Z weekly 0.7 https://novapharmanews.com/us/news/chinas-licensing-boom-global-pipelines 2026-06-10T05:25:44.965Z weekly 0.7 https://novapharmanews.com/apac/news/nuance-pharma-ind-clearance-actair-china 2026-06-10T05:25:42.959Z weekly 0.7 https://novapharmanews.com/eu/news/serd-therapy-anti-proliferative-activity-er-her2-breast-cancer 2026-06-10T05:25:40.961Z weekly 0.7 https://novapharmanews.com/us/news/fda-clarifies-3-year-exclusivity-guidance 2026-06-10T05:25:38.960Z weekly 0.7 https://novapharmanews.com/eu/news/us-eu-pharmaceutical-regulations-concerns 2026-06-10T05:25:36.958Z weekly 0.7 https://novapharmanews.com/us/news/sgs-acquires-keystone-bioanalytical-drug-development 2026-06-10T05:25:34.959Z weekly 0.7 https://novapharmanews.com/eu/news/fda-real-time-clinical-trials-progress 2026-06-10T05:25:32.950Z weekly 0.7 https://novapharmanews.com/eu/news/critical-medicines-act-impact-pharmaceutical-manufacturing-europe 2026-06-10T05:26:14.158Z weekly 0.7 https://novapharmanews.com/apac/news/60-degrees-pharmaceuticals-tafenoquine-clinical-trial-babesiosis 2026-06-10T05:26:10.981Z weekly 0.7 https://novapharmanews.com/us/news/best-biotech-stocks-may-2026-clinical-trials 2026-06-10T05:26:06.980Z weekly 0.7 https://novapharmanews.com/apac/news/bukwang-pharmaceutical-dreamcis-aws-clinical-trials 2026-06-10T05:26:04.975Z weekly 0.7 https://novapharmanews.com/apac/news/lundbeck-korean-approval-vyepti-oncology-migraine 2026-06-10T05:26:04.347Z weekly 0.7 https://novapharmanews.com/eu/news/maat-pharma-q1-2026-business-update 2026-06-10T05:26:00.980Z weekly 0.7 https://novapharmanews.com/us/news/fda-vs-ema-camizestrant-controversy 2026-06-10T05:25:58.974Z weekly 0.7 https://novapharmanews.com/us/news/astellas-xtandi-patent-cliff-strategic-moves 2026-06-10T05:25:56.979Z weekly 0.7 https://novapharmanews.com/eu/news/esmo-breast-cancer-congress-2026-highlights 2026-06-10T05:26:14.989Z weekly 0.7 https://novapharmanews.com/us/news/fda-new-form-483-response-guidance 2026-06-10T05:26:13.004Z weekly 0.7 https://novapharmanews.com/apac/news/health-news-round-up-immunotherapy-pcos-clopidogrel-trials 2026-06-10T05:26:26.993Z weekly 0.7 https://novapharmanews.com/us/news/fda-drug-approval-decisions-may-2026 2026-06-10T05:26:24.996Z weekly 0.7 https://novapharmanews.com/apac/news/clinical-trials-day-2026-oncology-study-growth 2026-06-10T05:26:24.302Z weekly 0.7 https://novapharmanews.com/us/news/liminatus-pharma-innocsai-merger-market-analysis 2026-06-10T05:26:22.994Z weekly 0.7 https://novapharmanews.com/us/news/biomarin-swot-analysis-rare-disease-competitive-headwinds 2026-06-10T05:26:20.993Z weekly 0.7 https://novapharmanews.com/eu/news/ireland-clinical-trials-eu-comparison 2026-06-10T05:26:16.990Z weekly 0.7 https://novapharmanews.com/eu/news/chmp-meeting-highlights-drug-approvals-april-2026 2026-06-10T05:26:29.007Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-17-drugs-continuous-manufacturing 2026-06-10T08:26:52.282Z weekly 0.7 https://novapharmanews.com/eu/news/eu-lawmakers-critical-medicines-act-deal 2026-06-10T05:26:43.009Z weekly 0.7 https://novapharmanews.com/eu/news/european-biotechs-cell-gene-therapy-manufacturing 2026-06-10T05:26:41.080Z weekly 0.7 https://novapharmanews.com/us/news/rfk-jr-drug-approval-speed-oncology 2026-06-10T05:26:39.005Z weekly 0.7 https://novapharmanews.com/us/news/krystal-biotech-q1-earnings-beat-catalysts-2026-2027 2026-06-10T05:26:37.016Z weekly 0.7 https://novapharmanews.com/apac/news/clinical-trials-day-2026-research-rising-oncology 2026-06-10T05:26:35.109Z weekly 0.7 https://novapharmanews.com/eu/news/efpia-warns-access-gap-us-pricing-reforms 2026-06-10T05:26:33.016Z weekly 0.7 https://novapharmanews.com/us/news/fda-fast-track-oncology-drugs-april-2026 2026-06-10T05:27:01.223Z weekly 0.7 https://novapharmanews.com/apac/news/kelun-merck-lung-cancer-combo-china-trial 2026-06-10T05:26:59.020Z weekly 0.7 https://novapharmanews.com/apac/news/ildong-pharmaceutical-stock-earnings-pipeline-insights 2026-06-10T05:26:57.017Z weekly 0.7 https://novapharmanews.com/us/news/fda-guidance-animal-testing-alternatives-concerns 2026-06-10T05:26:55.021Z weekly 0.7 https://novapharmanews.com/eu/news/mhra-consultation-rare-disease-therapy 2026-06-10T05:26:53.036Z weekly 0.7 https://novapharmanews.com/us/news/aptar-pharma-fda-research-contract-progress 2026-06-10T05:26:51.008Z weekly 0.7 https://novapharmanews.com/us/news/fda-in-flux-may-2026-drug-approvals-update 2026-06-10T05:26:47.010Z weekly 0.7 https://novapharmanews.com/us/news/best-cancer-stocks-2026-investment 2026-06-10T05:26:45.010Z weekly 0.7 https://novapharmanews.com/us/news/new-fda-guidance-ends-nicotine-pouches 2026-06-10T05:31:49.832Z weekly 0.7 https://novapharmanews.com/us/news/biomarin-swot-analysis-rare-disease-biotech 2026-06-10T05:27:05.042Z weekly 0.7 https://novapharmanews.com/eu/news/first-glp-1-gene-therapy-clinical-trial-europe 2026-06-10T05:27:01.033Z weekly 0.7 https://novapharmanews.com/us/news/2026-pharma-ma-breakout-year 2026-06-10T06:03:49.316Z weekly 0.7 https://novapharmanews.com/us/news/takeda-novartis-layoffs-pharma-impact 2026-06-10T05:27:15.039Z weekly 0.7 https://novapharmanews.com/us/news/regeneron-pharma-stock-institutional-buying-insights 2026-06-10T05:27:13.022Z weekly 0.7 https://novapharmanews.com/us/news/migraine-drugmaker-reverse-merger-market-analysis 2026-06-10T05:27:11.059Z weekly 0.7 https://novapharmanews.com/us/news/fda-lifting-restrictions-compounded-peptides 2026-06-10T05:27:09.037Z weekly 0.7 https://novapharmanews.com/us/news/fda-alert-pulmonology-drug-approvals 2026-06-10T05:27:07.024Z weekly 0.7 https://novapharmanews.com/eu/news/february-batch-novel-medicines-ema-chmp-approval 2026-06-10T05:27:23.048Z weekly 0.7 https://novapharmanews.com/apac/news/zte-partners-china-national-clinical-research-center 2026-06-10T05:27:21.116Z weekly 0.7 https://novapharmanews.com/apac/news/novartis-pluvicto-stronger-psa-responses-prostate-cancer 2026-06-10T05:27:19.472Z weekly 0.7 https://novapharmanews.com/us/news/oct-east-coast-2026-recap 2026-06-10T05:27:41.971Z weekly 0.7 https://novapharmanews.com/eu/news/isct-2026-annual-recap 2026-06-10T05:27:36.765Z weekly 0.7 https://novapharmanews.com/us/news/thma-cpe-circle-2026-recap 2026-06-10T05:27:25.053Z weekly 0.7 https://novapharmanews.com/us/news/fda-bayesian-methodology-drug-development 2026-06-10T05:27:41.516Z weekly 0.7 https://novapharmanews.com/us/news/sellas-nears-key-aml-data-dual-trials 2026-06-10T05:27:37.735Z weekly 0.7 https://novapharmanews.com/eu/news/global-pharmacovigilance-reporting-comparative-analysis 2026-06-10T05:27:31.038Z weekly 0.7 https://novapharmanews.com/apac/news/asia-pacific-regulatory-updates-tga-guidance 2026-06-10T05:27:39.063Z weekly 0.7 https://novapharmanews.com/eu/news/cma-deal-eu-medicine-supply-chains-analysis 2026-06-10T05:27:37.149Z weekly 0.7 https://novapharmanews.com/us/news/layoff-tracker-takeda-novartis-restructuring 2026-06-10T08:15:54.577Z weekly 0.7 https://novapharmanews.com/eu/news/x4-pharmaceuticals-ema-chmp-mavorixafor-approval 2026-06-10T05:27:56.182Z weekly 0.7 https://novapharmanews.com/eu/news/future-european-medicine-clinical-research 2026-06-10T05:27:49.064Z weekly 0.7 https://novapharmanews.com/eu/news/europes-drug-innovation-edge-risk-dutch-industry-group 2026-06-10T05:27:43.138Z weekly 0.7 https://novapharmanews.com/us/news/top-10-biopharma-ma-deals-2025 2026-06-10T05:27:41.067Z weekly 0.7 https://novapharmanews.com/eu/news/breast-cancer-experts-esmo-2026-abstracts-preview 2026-06-10T05:27:53.084Z weekly 0.7 https://novapharmanews.com/apac/news/fierce-pharma-asia-bms-hengrui-deal-takeda-layoffs 2026-06-10T05:27:51.085Z weekly 0.7 https://novapharmanews.com/apac/news/global-pharmacovigilance-reporting-regulatory-updates 2026-06-10T06:45:03.575Z weekly 0.7 https://novapharmanews.com/us/news/layoff-tracker-takeda-novartis-restructure 2026-06-10T05:34:50.907Z weekly 0.7 https://novapharmanews.com/eu/news/q1-2026-life-sciences-law-update-clinical-trials 2026-06-10T05:28:03.078Z weekly 0.7 https://novapharmanews.com/us/news/ma-in-pharmaceuticals-market-analysis 2026-06-10T05:28:01.080Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-atezolizumab-muscle-invasive-bladder-cancer 2026-06-10T05:27:59.068Z weekly 0.7 https://novapharmanews.com/us/news/big-pharma-ma-mega-year-patent-expiries 2026-06-10T05:28:20.964Z weekly 0.7 https://novapharmanews.com/eu/news/ema-critical-medicines-act-market-analysis 2026-06-10T05:28:15.085Z weekly 0.7 https://novapharmanews.com/apac/news/india-cdsco-prior-intimation-system-clinical-trials 2026-06-10T05:28:11.080Z weekly 0.7 https://novapharmanews.com/eu/news/regulatory-round-up-may-11-2026 2026-06-10T05:28:09.177Z weekly 0.7 https://novapharmanews.com/us/news/ucb-acquires-antibody-treatment-maker-autoimmune-disease 2026-06-10T05:28:07.086Z weekly 0.7 https://novapharmanews.com/apac/news/asia-bacitracin-ointment-market-analysis-regulatory-updates 2026-06-10T05:28:05.085Z weekly 0.7 https://novapharmanews.com/us/news/pharma-ma-roundup-april-2026 2026-06-10T05:28:27.108Z weekly 0.7 https://novapharmanews.com/us/news/fda-leadership-changes-crisis-drug-approvals 2026-06-10T05:28:25.088Z weekly 0.7 https://novapharmanews.com/us/news/regulatory-round-up-fda-cancer-drug-approvals 2026-06-10T05:28:23.089Z weekly 0.7 https://novapharmanews.com/eu/news/europes-biotech-dilemma-discovery-scale-clinical-trials 2026-06-10T05:28:21.108Z weekly 0.7 https://novapharmanews.com/apac/news/the-week-in-pharma-action-reaction-insight-may-15-2026 2026-06-10T05:28:19.104Z weekly 0.7 https://novapharmanews.com/us/news/10-clinical-trials-to-watch-2026 2026-06-10T05:28:17.098Z weekly 0.7 https://novapharmanews.com/us/news/bio-it-world-conference-2026-recap 2026-06-10T05:28:29.130Z weekly 0.7 https://novapharmanews.com/us/news/fda-approvals-cancer-drugs-may-2026 2026-06-10T05:43:45.016Z weekly 0.7 https://novapharmanews.com/us/news/makary-resigns-fda-commissioner-drug-approvals 2026-06-10T05:28:33.097Z weekly 0.7 https://novapharmanews.com/us/news/fda-oncology-drug-approvals-2026 2026-06-10T08:18:05.311Z weekly 0.7 https://novapharmanews.com/eu/news/countries-compete-reform-trials-global-sponsors 2026-06-10T05:28:54.217Z weekly 0.7 https://novapharmanews.com/eu/news/esmo-updates-ovarian-cancer-guidelines 2026-06-10T05:28:53.272Z weekly 0.7 https://novapharmanews.com/eu/news/latest-new-meds-ema-chmp-approval 2026-06-10T05:28:49.257Z weekly 0.7 https://novapharmanews.com/us/news/fda-dual-approval-tdxd-her2-early-breast-cancer 2026-06-10T05:28:47.533Z weekly 0.7 https://novapharmanews.com/us/news/four-fda-actions-reshaping-drug-development-2026 2026-06-10T05:28:47.115Z weekly 0.7 https://novapharmanews.com/us/news/6-biotechs-next-ma-target 2026-06-10T05:28:45.202Z weekly 0.7 https://novapharmanews.com/us/news/amgen-inc-stock-lung-cancer-setback-steady-cash-flow 2026-06-10T05:28:45.111Z weekly 0.7 https://novapharmanews.com/us/news/fda-blocks-melanoma-drug-confusion-makary 2026-06-10T05:28:41.105Z weekly 0.7 https://novapharmanews.com/us/news/fda-policy-tracker-2026-psychedelics-regulatory-updates 2026-06-10T05:28:37.103Z weekly 0.7 https://novapharmanews.com/eu/news/20-posts-not-to-miss-esmo-breast-cancer-congress-2026 2026-06-10T05:29:10.388Z weekly 0.7 https://novapharmanews.com/apac/news/fierce-pharma-asia-bms-hengrui-takeda-daiichi 2026-06-10T05:28:57.270Z weekly 0.7 https://novapharmanews.com/eu/news/crinetics-palsonify-sales-enrollment-updates 2026-06-10T05:28:55.268Z weekly 0.7 https://novapharmanews.com/us/news/novel-drug-approvals-2026-fda 2026-06-10T08:45:21.569Z weekly 0.7 https://novapharmanews.com/us/news/bbsw-ai-solution-event-daily-roundup 2026-06-10T05:48:22.581Z weekly 0.7 https://novapharmanews.com/us/news/bbsw-ai-solution-event-biotech-innovation-us 2026-06-10T05:48:22.540Z weekly 0.7 https://novapharmanews.com/us/news/bbsw-ai-solution-debuts-for-pharma-insights 2026-06-10T05:48:22.680Z weekly 0.7 https://novapharmanews.com/us/news/dia-2024-regulatory-preview 2026-06-10T04:59:00.988Z weekly 0.7 https://novapharmanews.com/us/news/dia-2024-regulatory-affairs-preview 2026-06-10T05:29:09.272Z weekly 0.7 https://novapharmanews.com/us/news/dia-2024-event-preview 2026-06-10T05:29:11.275Z weekly 0.7 https://novapharmanews.com/us/news/dia-2024-regulatory-conference-preview 2026-06-10T05:29:13.274Z weekly 0.7 https://novapharmanews.com/us/news/bio-it-world-conference-oncology-day-1 2026-06-10T05:48:23.848Z weekly 0.7 https://novapharmanews.com/us/news/biomed-israel-2024-highlights-us 2026-06-10T05:29:15.279Z weekly 0.7 https://novapharmanews.com/us/news/fierce-biotech-week-highlights-trends 2026-06-10T04:59:04.916Z weekly 0.7 https://novapharmanews.com/us/news/scope-x-2026-day-1-roundup 2026-06-10T05:48:22.838Z weekly 0.7 https://novapharmanews.com/us/news/bbsw-ai-solution-biotech-research-us 2026-06-10T05:48:23.103Z weekly 0.7 https://novapharmanews.com/us/news/biomed-israel-2026-highlights-us-implications 2026-06-10T05:29:21.284Z weekly 0.7 https://novapharmanews.com/us/news/biomed-israel-daily-highlights 2026-06-10T05:29:27.395Z weekly 0.7 https://novapharmanews.com/us/news/asgct-2024-gene-therapy-advances 2026-06-10T05:29:25.300Z weekly 0.7 https://novapharmanews.com/us/news/oct-east-coast-daily-roundup 2026-06-10T05:29:27.289Z weekly 0.7 https://novapharmanews.com/us/news/ispor-2026-cardiology-highlights 2026-06-10T05:29:29.289Z weekly 0.7 https://novapharmanews.com/us/news/us-japan-healthcare-conf-2026-highlights 2026-06-10T04:59:06.919Z weekly 0.7 https://novapharmanews.com/us/news/cog-2024-highlights-trends 2026-06-10T05:29:31.292Z weekly 0.7 https://novapharmanews.com/apac/news/pda-manufacturing-apac-highlights 2026-06-10T04:59:08.925Z weekly 0.7 https://novapharmanews.com/us/news/bionj-biopartnering-conference-highlights 2026-06-10T05:29:33.307Z weekly 0.7 https://novapharmanews.com/us/news/asgct-manufacturing-innovations-day1 2026-06-10T07:53:20.056Z weekly 0.7 https://novapharmanews.com/us/news/asgct-2024-gene-therapy-advancements-day-1-roundup 2026-06-10T05:29:47.028Z weekly 0.7 https://novapharmanews.com/us/news/novo-nordisk-record-q1-revenue-wegovy-ozempic 2026-06-10T08:30:22.725Z weekly 0.7 https://novapharmanews.com/us/news/ispor-2026-cardiology-cost-effectiveness 2026-06-10T05:29:41.300Z weekly 0.7 https://novapharmanews.com/apac/news/pda-apac-manufacturing-innovations-day-1-roundup 2026-06-10T05:29:43.316Z weekly 0.7 https://novapharmanews.com/eu/news/isct-2026-eu-manufacturing-day-1 2026-06-10T05:29:45.320Z weekly 0.7 https://novapharmanews.com/us/news/asgct-2024-day-1-gene-therapy-advancements 2026-06-10T07:43:23.236Z weekly 0.7 https://novapharmanews.com/us/news/oct-east-coast-day-1-roundup 2026-06-10T05:29:49.320Z weekly 0.7 https://novapharmanews.com/us/news/biomed-israel-2026-day1-us-biotech-trends 2026-06-10T05:29:51.319Z weekly 0.7 https://novapharmanews.com/us/news/bionj-biopartnering-conference-biotech-innovation 2026-06-10T05:29:53.315Z weekly 0.7 https://novapharmanews.com/us/news/biomed-israel-2026-us-biotech-investors 2026-06-10T05:29:57.100Z weekly 0.7 https://novapharmanews.com/us/news/asgct-2026-gene-therapy-manufacturing-innovations 2026-06-10T05:29:57.326Z weekly 0.7 https://novapharmanews.com/us/news/us-japan-healthcare-conf-2026-day1-roundup 2026-06-10T05:30:09.673Z weekly 0.7 https://novapharmanews.com/us/news/bionj-biopartnering-conference-day-1-highlights 2026-06-10T05:30:04.576Z weekly 0.7 https://novapharmanews.com/us/news/biomed-israel-day-1-biotech-innovation 2026-06-10T05:30:03.404Z weekly 0.7 https://novapharmanews.com/apac/news/pda-apac-pharma-manufacturing-day-1-roundup 2026-06-10T04:59:11.587Z weekly 0.7 https://novapharmanews.com/us/news/us-japan-healthcare-2026-day1-policy-tech 2026-06-10T05:30:07.987Z weekly 0.7 https://novapharmanews.com/us/news/ispor-2026-cardiology-day-1-roundup 2026-06-10T05:30:07.403Z weekly 0.7 https://novapharmanews.com/us/news/fierce-biotech-week-innovations-trends 2026-06-10T05:30:09.603Z weekly 0.7 https://novapharmanews.com/us/news/biomed-israel-daily-roundup 2026-06-10T05:30:11.537Z weekly 0.7 https://novapharmanews.com/apac/news/pda-apac-manufacturing-innovations-day1 2026-06-10T04:59:12.954Z weekly 0.7 https://novapharmanews.com/us/news/us-japan-healthcare-2026-day1-highlights 2026-06-10T05:30:13.527Z weekly 0.7 https://novapharmanews.com/us/news/biomed-israel-2026-us-investor-roundup 2026-06-10T08:22:13.908Z weekly 0.7 https://novapharmanews.com/us/news/asgct-cell-therapy-manufacturing-innovations 2026-06-10T05:30:17.535Z weekly 0.7 https://novapharmanews.com/apac/news/pda-apac-manufacturing-day-1-roundup 2026-06-10T04:59:15.051Z weekly 0.7 https://novapharmanews.com/us/news/us-japan-healthcare-2026-day-1-roundup 2026-06-10T05:30:19.528Z weekly 0.7 https://novapharmanews.com/us/news/ispor-2026-cardiology-day1-roundup 2026-06-10T05:30:21.539Z weekly 0.7 https://novapharmanews.com/us/news/biomed-israel-2026-us-investors 2026-06-10T05:30:23.542Z weekly 0.7 https://novapharmanews.com/us/news/biomed-israel-day-1-highlights 2026-06-10T05:30:25.545Z weekly 0.7 https://novapharmanews.com/us/news/fierce-biotech-week-daily-roundup 2026-06-10T05:30:40.599Z weekly 0.7 https://novapharmanews.com/us/news/bionj-biopartnering-conference-day-1 2026-06-10T05:30:29.537Z weekly 0.7 https://novapharmanews.com/us/news/asgct-2026-manufacturing-day-1-roundup 2026-06-10T05:30:31.544Z weekly 0.7 https://novapharmanews.com/us/news/biomed-israel-2026-us-biotech-roundup 2026-06-10T05:30:33.541Z weekly 0.7 https://novapharmanews.com/us/news/asgct-2024-gene-therapy-advancements-day-1 2026-06-10T05:30:35.555Z weekly 0.7 https://novapharmanews.com/us/news/thma-cpe-circle-highlights-key-trends 2026-06-10T05:30:37.560Z weekly 0.7 https://novapharmanews.com/us/news/excipient-world-conference-highlights 2026-06-10T05:30:39.643Z weekly 0.7 https://novapharmanews.com/eu/news/raps-euro-convergence-regulatory-highlights 2026-06-10T05:30:41.559Z weekly 0.7 https://novapharmanews.com/us/news/asgct-cell-gene-therapy-manufacturing-innovations 2026-06-10T05:30:43.544Z monthly 0.5 https://novapharmanews.com/apac/news/apac-clinical-event-preview 2026-06-10T04:59:16.958Z monthly 0.5 https://novapharmanews.com/eu/news/isct-2026-eu-manufacturing-day-1-roundup 2026-06-10T05:30:45.559Z monthly 0.5 https://novapharmanews.com/us/news/asgct-manufacturing-innovations 2026-06-10T04:59:22.312Z monthly 0.5 https://novapharmanews.com/us/news/thma-cpe-circle-daily-roundup 2026-06-10T05:30:47.548Z monthly 0.5 https://novapharmanews.com/us/news/asgct-2024-gene-therapy-advancements 2026-06-10T05:30:49.558Z monthly 0.5 https://novapharmanews.com/us/news/thma-oncology-forum-highlights-us 2026-06-10T05:31:02.296Z monthly 0.5 https://novapharmanews.com/us/news/fdli-2026-annual-highlights 2026-06-10T04:59:25.798Z monthly 0.5 https://novapharmanews.com/eu/news/raps-euro-convergence-regulatory-insights 2026-06-10T05:30:53.551Z monthly 0.5 https://novapharmanews.com/us/news/aphl-2026-highlights-innovations 2026-06-10T04:59:29.194Z monthly 0.5 https://novapharmanews.com/us/news/fdli-annual-2026-regulatory-insights 2026-06-10T05:30:55.559Z monthly 0.5 https://novapharmanews.com/us/news/APHL-2026-annual-day-1-roundup 2026-06-10T04:59:24.988Z monthly 0.5 https://novapharmanews.com/us/news/aphl-2026-annual-day-1-highlights 2026-06-10T05:30:57.573Z monthly 0.5 https://novapharmanews.com/us/news/thma-oncology-forum-daily-roundup 2026-06-10T05:30:59.562Z monthly 0.5 https://novapharmanews.com/eu/news/european-research-revolution-key-takeaways 2026-06-10T05:31:01.563Z monthly 0.5 https://novapharmanews.com/us/news/ipec-annual-meeting-highlights-us 2026-06-10T05:31:03.679Z monthly 0.5 https://novapharmanews.com/eu/news/raps-euro-convergence-regulatory-updates 2026-06-10T05:31:05.676Z monthly 0.5 https://novapharmanews.com/us/news/fdli-annual-2026-daily-roundup 2026-06-10T05:31:07.696Z monthly 0.5 https://novapharmanews.com/us/news/thma-oncology-forum-day1-roundup 2026-06-10T05:31:09.679Z monthly 0.5 https://novapharmanews.com/us/news/fdli-annual-2026-regulatory-insights-policy-updates 2026-06-10T04:59:27.061Z monthly 0.5 https://novapharmanews.com/us/news/thma-oncology-forum-day-1-roundup 2026-06-10T05:31:11.691Z monthly 0.5 https://novapharmanews.com/us/news/fdli-annual-2026-regulatory-updates 2026-06-10T05:31:13.684Z monthly 0.5 https://novapharmanews.com/eu/news/raps-euro-convergence-day-1-regulatory-updates 2026-06-10T05:31:27.827Z monthly 0.5 https://novapharmanews.com/eu/news/swiss-biotech-day-key-innovations-partnerships 2026-06-10T04:59:28.966Z monthly 0.5 https://novapharmanews.com/eu/news/european-research-revolution-day-1 2026-06-10T05:31:17.688Z monthly 0.5 https://novapharmanews.com/eu/news/raps-euro-convergence-regulatory-insights-day-1 2026-06-10T05:31:19.687Z monthly 0.5 https://novapharmanews.com/eu/news/european-research-revolution-day-1-highlights 2026-06-10T05:31:21.695Z monthly 0.5 https://novapharmanews.com/eu/news/raps-euro-convergence-regulatory-updates-day-1 2026-06-10T04:59:30.970Z monthly 0.5 https://novapharmanews.com/apac/news/cryoport-q1-2026-financial-results-clinical-trials-cell-gene-therapy 2026-06-10T05:31:23.701Z monthly 0.5 https://novapharmanews.com/apac/news/ascidian-acdn-01-stellar-trial-stargardt-disease-dose-escalation-complete 2026-06-10T05:31:25.712Z monthly 0.5 https://novapharmanews.com/apac/news/quiver-bioscience-nih-heal-grant-qv-2421-chronic-pain-trials 2026-06-10T05:31:27.699Z monthly 0.5 https://novapharmanews.com/apac/news/lunai-bioworks-20-million-cns-drug-delivery-alzheimer-treatment 2026-06-10T05:31:29.700Z monthly 0.5 https://novapharmanews.com/apac/news/stryker-australia-tga-approval-temporomandibular-joint-prosthesis 2026-06-10T05:31:32.985Z monthly 0.5 https://novapharmanews.com/apac/news/tga-section-41hd-medical-device-emergency-import-approvals-australia 2026-06-10T05:31:33.707Z monthly 0.5 https://novapharmanews.com/eu/news/biotheryx-btx-9341-phase-1a-results-esmo-breast-cancer-congress-2026 2026-06-10T05:31:35.702Z monthly 0.5 https://novapharmanews.com/us/news/palvella-qtorin-rapamycin-phase-2-trial-angiokeratomas 2026-06-10T05:31:37.708Z monthly 0.5 https://novapharmanews.com/us/news/neurocrine-biosciences-nbip-2118-phase-1-obesity-trial 2026-06-10T05:31:39.695Z monthly 0.5 https://novapharmanews.com/us/news/caplyta-lumateperone-tops-adjunctive-depression-treatments-meta-analysis 2026-06-10T05:31:41.701Z monthly 0.5 https://novapharmanews.com/us/news/cellenkos-fda-clearance-ck0802-phase-2a-trial-steroid-refractory-gvhd 2026-06-10T04:59:32.982Z monthly 0.5 https://novapharmanews.com/us/news/cellenkos-fda-clearance-ck0802-phase-1b-2a-trial-steroid-refractory-gvhd 2026-06-10T05:31:54.500Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-guardant360-cdx-veppanu-breast-cancer-diagnostic 2026-06-10T04:59:34.972Z monthly 0.5 https://novapharmanews.com/us/news/opus-genetics-opgx-lca5-fda-rare-disease-evidence-program 2026-06-10T05:31:45.704Z monthly 0.5 https://novapharmanews.com/eu/news/raps-euro-convergence-2026-day-1-roundup 2026-06-10T05:31:47.716Z monthly 0.5 https://novapharmanews.com/eu/news/heart-failure-2026-vutrisiran-data-european-pharma-news 2026-06-10T05:31:49.712Z monthly 0.5 https://novapharmanews.com/apac/news/telix-tlx250-px-zircaix-kidney-cancer-diagnosis-phase-3-zircon 2026-06-10T06:52:11.287Z monthly 0.5 https://novapharmanews.com/apac/news/arrowhead-pharmaceuticals-redemplo-plozasiran-tga-approval-australia-fcs 2026-06-10T05:31:53.720Z monthly 0.5 https://novapharmanews.com/apac/news/mifepristone-access-supreme-court-hold-planned-parenthood-5th-circuit 2026-06-10T05:31:55.855Z monthly 0.5 https://novapharmanews.com/eu/news/cvrx-benefit-hf-trial-barostim-heart-failure-first-patient 2026-06-10T05:31:57.856Z monthly 0.5 https://novapharmanews.com/eu/news/agenus-q1-2026-financial-report-botensilimab-balstilimab-update 2026-06-10T05:31:59.858Z monthly 0.5 https://novapharmanews.com/eu/news/oncolytics-biotech-pelareorep-colorectal-cancer-durable-responses 2026-06-10T05:32:01.858Z monthly 0.5 https://novapharmanews.com/eu/news/crispr-therapeutics-q1-2026-casgevy-global-approval 2026-06-10T05:32:03.861Z monthly 0.5 https://novapharmanews.com/us/news/clene-cnm-au8-fda-accelerated-approval-als-treatment-2024 2026-06-10T04:59:36.973Z monthly 0.5 https://novapharmanews.com/us/news/alpha-tau-alpha-dart-100-percent-disease-control-pancreatic-cancer-ddw-2026 2026-06-10T05:32:05.862Z monthly 0.5 https://novapharmanews.com/us/news/takeda-tak-881-positive-phase-2-3-results-primary-immunodeficiency-disease 2026-06-10T05:32:18.257Z monthly 0.5 https://novapharmanews.com/us/news/accord-healthcare-relaunches-tadalafil-tablets-generic-ed-treatment 2026-06-10T05:32:09.862Z monthly 0.5 https://novapharmanews.com/us/news/inspiremd-fda-approval-switchguard-neuro-protection-cguardians-iii-trial 2026-06-10T05:32:14.181Z monthly 0.5 https://novapharmanews.com/apac/news/xtalpi-pep08-prmt5-inhibitor-phase-1-cancer-trial-enrollment 2026-06-10T05:32:13.867Z monthly 0.5 https://novapharmanews.com/apac/news/spontan-phase-ii-data-10-minute-onset-fda-requirements-erectile-dysfunction 2026-06-10T05:32:15.948Z monthly 0.5 https://novapharmanews.com/apac/news/ironwood-pharmaceuticals-short-bowel-syndrome-tpn-survey-ddw-2026 2026-06-10T05:32:17.869Z monthly 0.5 https://novapharmanews.com/apac/news/edwards-lifesciences-resilia-tissue-10-year-commence-trial-results 2026-06-10T05:32:19.880Z monthly 0.5 https://novapharmanews.com/apac/news/novo-nordisk-wegovy-china-launch-eli-lilly-obesity-market 2026-06-10T05:32:28.138Z monthly 0.5 https://novapharmanews.com/apac/news/arrowhead-pharmaceuticals-tga-approval-redemplo-plozasiran-australia-fcs 2026-06-10T04:59:38.973Z monthly 0.5 https://novapharmanews.com/apac/news/biomarin-palynziq-fda-approval-adolescent-pku-patients 2026-06-10T05:32:23.874Z monthly 0.5 https://novapharmanews.com/apac/news/rois-us-expansion-global-cdmo-fda-approval-injectable-manufacturing 2026-06-10T05:32:25.882Z monthly 0.5 https://novapharmanews.com/apac/news/fda-approves-travere-filspari-fsgs-treatment-adults-children 2026-06-10T05:32:27.875Z monthly 0.5 https://novapharmanews.com/eu/news/vanda-pharmaceuticals-nereus-tradipitant-motion-sickness-drug-launch 2026-06-10T04:59:40.980Z monthly 0.5 https://novapharmanews.com/eu/news/takeda-tak-881-phase-3-trial-primary-immunodeficiency-disease-results 2026-06-10T05:32:29.879Z monthly 0.5 https://novapharmanews.com/eu/news/pulse-biosciences-atrial-fibrillation-treatment-100-percent-success-rate-2026 2026-06-10T04:59:42.986Z monthly 0.5 https://novapharmanews.com/eu/news/sq-innovation-lasix-onyu-subcut-hf-ii-trial-results-heart-failure-2026 2026-06-10T05:32:31.884Z monthly 0.5 https://novapharmanews.com/eu/news/krystal-biotech-q1-2026-results-vyjuvek-expansion-registrational-studies 2026-06-10T05:32:33.972Z monthly 0.5 https://novapharmanews.com/eu/news/acurx-dna-pol-iiic-inhibitors-microbiome-preservation-mrsa-escmid-2026 2026-06-10T05:32:35.879Z monthly 0.5 https://novapharmanews.com/eu/news/biocryst-navenibart-european-licensing-deal-neopharmed-gentili 2026-06-10T04:59:44.983Z monthly 0.5 https://novapharmanews.com/eu/news/biosimulation-market-11-billion-2031-drug-development 2026-06-10T05:32:45.175Z monthly 0.5 https://novapharmanews.com/eu/news/grin-therapeutics-phase-3-beeline-study-radiprodil-europe-grin-ndd 2026-06-10T08:50:14.953Z monthly 0.5 https://novapharmanews.com/eu/news/fda-approves-langlara-biosimilar-lantus-insulin-lannett-company 2026-06-10T04:59:46.986Z monthly 0.5 https://novapharmanews.com/eu/news/vertex-casgevy-gene-therapy-global-expansion-q1-2026-results 2026-06-10T04:59:48.976Z monthly 0.5 https://novapharmanews.com/eu/news/oncolytics-biotech-pelareorep-durable-responses-ras-mutant-colorectal-cancer 2026-06-10T08:34:15.104Z monthly 0.5 https://novapharmanews.com/eu/news/nuvation-bio-ibtrozi-q1-2026-revenue-ros1-nsclc 2026-06-10T05:32:43.898Z monthly 0.5 https://novapharmanews.com/us/news/crispr-therapeutics-casgevy-global-approvals-60000-patients 2026-06-10T07:55:22.717Z monthly 0.5 https://novapharmanews.com/us/news/clene-cnm-au8-fda-accelerated-approval-pathway-als-treatment 2026-06-10T04:59:53.078Z monthly 0.5 https://novapharmanews.com/us/news/atossa-therapeutics-fda-rare-pediatric-disease-designation-z-endoxifen-mccune-albright-syndrome 2026-06-10T05:32:46.002Z monthly 0.5 https://novapharmanews.com/us/news/mbiota-elemental-ibs-treatment-ddw-2026-clinical-trial 2026-06-10T05:32:47.998Z monthly 0.5 https://novapharmanews.com/us/news/novartis-fabhalta-health-canada-approval-c3g-treatment 2026-06-10T04:59:55.005Z monthly 0.5 https://novapharmanews.com/us/news/asco-2026-cellectar-waldenstrom-macroglobulinemia 2026-06-10T05:32:50.000Z monthly 0.5 https://novapharmanews.com/us/news/alpha-tau-alpha-dart-pancreatic-cancer-trials-ddw-2026 2026-06-10T04:59:56.989Z monthly 0.5 https://novapharmanews.com/us/news/cytokinetics-aficamten-phase-3-trial-results-non-obstructive-hypertrophic-cardiomyopathy-may-2026 2026-06-10T05:32:52.001Z monthly 0.5 https://novapharmanews.com/us/news/inflarx-izicopan-reactive-metabolite-liver-safety-study 2026-06-10T05:32:54.006Z monthly 0.5 https://novapharmanews.com/us/news/macrogenics-expands-zynyz-royalty-agreement-sagard-healthcare 2026-06-10T05:32:56.015Z monthly 0.5 https://novapharmanews.com/us/news/akebia-vadadustat-mortality-reduction-kidney-disease-jasn-study 2026-06-10T05:32:58.003Z monthly 0.5 https://novapharmanews.com/us/news/inflarx-izicopan-favorable-liver-metabolism-safety-profile-2026 2026-06-10T05:33:00.011Z monthly 0.5 https://novapharmanews.com/us/news/celcuity-gedatolisib-phase-3-viktoria-1-trial-pik3ca-mutant-cancer 2026-06-10T04:59:58.998Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-langlara-interchangeable-biosimilar-lantus-insulin-lannett 2026-06-10T05:00:08.414Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-guardant360-cdx-companion-diagnostic-pfizer-veppanu-breast-cancer 2026-06-10T06:17:14.247Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-incyte-jakafi-xr-extended-release-myelofibrosis 2026-06-10T05:00:05.024Z monthly 0.5 https://novapharmanews.com/us/news/arvinas-veppanu-vepdegestrant-fda-approval-first-protac-drug-esr1-breast-cancer 2026-06-10T08:39:41.784Z monthly 0.5 https://novapharmanews.com/us/news/excipient-world-conference-daily-roundup 2026-06-10T05:33:02.021Z monthly 0.5 https://novapharmanews.com/us/news/APHL-2026-annual-meeting-day-1-highlights 2026-06-10T05:33:04.018Z monthly 0.5 https://novapharmanews.com/us/news/aphl-2026-day-1-roundup 2026-06-10T05:33:06.038Z monthly 0.5 https://novapharmanews.com/eu/news/swiss-biotech-day-daily-roundup 2026-06-10T05:33:08.032Z monthly 0.5 https://novapharmanews.com/apac/news/fda-approves-auvelity-new-mdd-treatment 2026-06-10T05:33:10.020Z monthly 0.5 https://novapharmanews.com/apac/news/sun-pharma-organon-partnership-india 2026-06-10T05:33:12.017Z monthly 0.5 https://novapharmanews.com/eu/news/fda-approves-auvelity-mdd-axsome-therapeutics 2026-06-10T05:33:14.029Z monthly 0.5 https://novapharmanews.com/eu/news/purdue-pharma-shutdown-oxycontin-settlement 2026-06-10T04:58:24.886Z monthly 0.5 https://novapharmanews.com/eu/news/eular-2026-immutep-imp761-phase-1-preview 2026-06-10T05:00:20.898Z monthly 0.5 https://novapharmanews.com/us/news/thma-pharmacy-growth-priorities-2026 2026-06-10T05:33:16.023Z monthly 0.5 https://novapharmanews.com/us/news/cphi-americas-2026-pharma-manufacturing-trends 2026-06-10T08:26:23.186Z monthly 0.5 https://novapharmanews.com/us/news/ipec-americas-annual-meeting-daily-roundup 2026-06-10T05:33:20.032Z monthly 0.5 https://novapharmanews.com/us/news/excipient-world-conference-day-1-highlights 2026-06-10T05:00:11.022Z monthly 0.5 https://novapharmanews.com/us/news/aphl-2026-annual-day-1-roundup 2026-06-10T05:33:22.036Z monthly 0.5 https://novapharmanews.com/apac/news/ucb-acquires-candid-therapeutics-2-2-billion-t-cell-engager-autoimmune 2026-06-10T06:01:31.477Z monthly 0.5 https://novapharmanews.com/eu/news/novelty-nobility-agc-biologics-bispecific-antibody-manufacturing-partnership 2026-06-10T05:33:24.106Z monthly 0.5 https://novapharmanews.com/eu/news/smartee-denti-technology-mandibular-repositioning-eas-congress-2026 2026-06-10T05:33:26.034Z monthly 0.5 https://novapharmanews.com/us/news/xtalpi-pep08-prmt5-inhibitor-phase-1-cancer-trial-enrollment 2026-06-10T05:33:28.035Z monthly 0.5 https://novapharmanews.com/us/news/mirum-pharmaceuticals-vistas-volixibat-primary-sclerosing-cholangitis-results-may-2026 2026-06-10T05:33:30.038Z monthly 0.5 https://novapharmanews.com/us/news/everads-therapy-suprachoroidal-injector-clinical-data-ophthalmology-science 2026-06-10T05:33:33.544Z monthly 0.5 https://novapharmanews.com/us/news/ucb-acquires-candid-therapeutics-autoimmune-deal 2026-06-10T05:33:44.397Z monthly 0.5 https://novapharmanews.com/us/news/spinogenix-tazbentetol-neuroprotective-glaucoma-diabetic-retinopathy-arvo-2026 2026-06-10T05:33:36.039Z monthly 0.5 https://novapharmanews.com/us/news/niktimvo-axatilimab-approved-australia-chronic-gvhd-treatment 2026-06-10T05:00:15.166Z monthly 0.5 https://novapharmanews.com/us/news/ipec-annual-meeting-2026-no-pharma-news 2026-06-10T05:33:47.428Z monthly 0.5 https://novapharmanews.com/eu/news/swiss-biotech-day-2026-ai-oncology-microbiome 2026-06-10T05:33:40.035Z monthly 0.5 https://novapharmanews.com/us/news/excipient-world-conference-2026-daily-roundup 2026-06-10T05:33:42.970Z monthly 0.5 https://novapharmanews.com/us/news/aphl-2026-annual-meeting-opens-public-health-lab-focus 2026-06-10T05:33:44.178Z monthly 0.5 https://novapharmanews.com/apac/news/fda-approves-auvelity-mdd-new-antidepressant 2026-06-10T04:58:26.891Z monthly 0.5 https://novapharmanews.com/eu/news/purdue-pharma-dissolution-approved-opioid-crisis 2026-06-10T05:33:46.041Z monthly 0.5 https://novapharmanews.com/eu/news/auvelity-fda-approval-axsome-therapeutics 2026-06-10T05:33:48.052Z monthly 0.5 https://novapharmanews.com/us/news/axsome-fda-approval-alzheimers-agitation 2026-06-10T05:33:50.055Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-first-non-antipsychotic-dementia-agitation 2026-06-10T05:33:52.051Z monthly 0.5 https://novapharmanews.com/apac/news/a2-milk-company-recalls-platinum-infant-formula-health-risk 2026-06-10T05:33:54.042Z monthly 0.5 https://novapharmanews.com/us/news/edwards-lifesciences-resilia-tissue-10-year-durability-aortic-valve-trial 2026-06-10T05:33:56.044Z monthly 0.5 https://novapharmanews.com/us/news/biomarin-voxzogo-achondroplasia-long-term-data-pes-2026 2026-06-10T05:00:17.022Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-incyte-jakafi-xr-extended-release-myelofibrosis-polycythemia-vera 2026-06-10T05:00:19.062Z monthly 0.5 https://novapharmanews.com/apac/news/fda-approves-auvelity-axsome-therapeutics-mdd 2026-06-10T05:33:59.068Z monthly 0.5 https://novapharmanews.com/eu/news/fda-approves-auvelity-for-major-depressive-disorder 2026-06-10T05:34:00.070Z monthly 0.5 https://novapharmanews.com/us/news/plozasiran-tga-approval-australia-redemplo-fcs 2026-06-10T04:58:14.941Z monthly 0.5 https://novapharmanews.com/apac/news/vector-science-therapeutics-microneedle-catheter-patent-intratumoral-drug-delivery 2026-06-10T05:34:02.058Z monthly 0.5 https://novapharmanews.com/apac/news/apotex-generic-ozempic-semaglutide-health-canada-approval-2026 2026-06-10T05:00:21.016Z monthly 0.5 https://novapharmanews.com/apac/news/keenova-terlivaz-terlipressin-clinical-data-digestive-disease-week-2026 2026-06-10T05:34:04.057Z monthly 0.5 https://novapharmanews.com/apac/news/kodiak-sciences-ksi-101-clinical-data-macular-edema-conferences 2026-06-10T05:34:06.055Z monthly 0.5 https://novapharmanews.com/eu/news/synbiotech-microbiome-womens-healthy-aging-vitafoods-2026 2026-06-10T05:34:08.136Z monthly 0.5 https://novapharmanews.com/eu/news/curaleaf-torsten-greif-board-appointment-european-cannabis 2026-06-10T05:34:10.055Z monthly 0.5 https://novapharmanews.com/eu/news/pharmaceutical-manufacturing-software-market-787-billion-2030 2026-06-10T05:34:12.061Z monthly 0.5 https://novapharmanews.com/eu/news/goodrx-ozempic-pill-type-2-diabetes-149-monthly 2026-06-10T05:34:14.066Z monthly 0.5 https://novapharmanews.com/us/news/neurocrine-crenessity-two-year-pediatric-cah-study-results 2026-06-10T05:00:32.673Z monthly 0.5 https://novapharmanews.com/us/news/cairn-surgical-breast-cancer-locator-system-pivotal-trial-results 2026-06-10T05:34:25.396Z monthly 0.5 https://novapharmanews.com/us/news/restore-vision-rv-001-gene-therapy-retinitis-pigmentosa-clinical-results 2026-06-10T05:34:18.074Z monthly 0.5 https://novapharmanews.com/us/news/archimed-acquires-esperion-therapeutics-cardiometabolic-deal-2026 2026-06-10T07:23:44.038Z monthly 0.5 https://novapharmanews.com/us/news/oculis-dme-research-arvo-2026-presentation 2026-06-10T05:34:22.083Z monthly 0.5 https://novapharmanews.com/us/news/rhythm-pharmaceuticals-imcivree-european-commission-approval-hypothalamic-obesity 2026-06-10T05:34:24.070Z monthly 0.5 https://novapharmanews.com/us/news/atara-biotherapeutics-ebvallo-fda-complete-response-letter-securities-lawsuit 2026-06-10T07:22:54.600Z monthly 0.5 https://novapharmanews.com/us/news/vanda-pharmaceuticals-nereus-tradipitant-motion-sickness-drug-available 2026-06-10T05:34:28.072Z monthly 0.5 https://novapharmanews.com/us/news/novo-nordisk-oral-ozempic-fda-approved-pill-glp1-type-2-diabetes-cardiovascular 2026-06-10T05:00:25.023Z monthly 0.5 https://novapharmanews.com/us/news/zeta-surgical-fda-clearance-brain-surgery-navigation-system 2026-06-10T05:34:30.074Z monthly 0.5 https://novapharmanews.com/us/news/viatris-low-dose-estrogen-contraceptive-patch-acog-2026 2026-06-10T05:34:32.091Z monthly 0.5 https://novapharmanews.com/us/news/axsome-auvelity-fda-approval-alzheimers-agitation-treatment 2026-06-10T05:00:27.022Z monthly 0.5 https://novapharmanews.com/us/news/incyte-jakafi-xr-fda-approval-myelofibrosis-polycythemia-vera-gvhd 2026-06-10T05:34:34.086Z monthly 0.5 https://novapharmanews.com/us/news/arvinas-fda-approval-veppanu-vepdegestrant-protac-esr1-breast-cancer 2026-06-10T08:37:28.866Z monthly 0.5 https://novapharmanews.com/apac/news/plozasiran-tga-approval-australia-redemplo-fcs 2026-06-10T04:58:28.888Z monthly 0.5 https://novapharmanews.com/eu/news/plozasiran-tga-approval-australia-fcs 2026-06-10T08:05:35.357Z monthly 0.5 https://novapharmanews.com/us/news/moderna-fda-talks-phase-4-covid-vaccine-data 2026-06-10T05:34:38.093Z monthly 0.5 https://novapharmanews.com/apac/news/namsa-lexitas-partnership-ophthalmic-medical-device-development 2026-06-10T05:34:40.404Z monthly 0.5 https://novapharmanews.com/apac/news/verified-clinical-trials-chubb-partnership-patient-safety-data-quality 2026-06-10T05:34:43.065Z monthly 0.5 https://novapharmanews.com/apac/news/huahui-health-beone-medicines-hh160-trispecific-antibody-oncology-partnership 2026-06-10T05:34:44.273Z monthly 0.5 https://novapharmanews.com/apac/news/amgen-q1-2026-financial-results-double-digit-growth 2026-06-10T05:34:46.119Z monthly 0.5 https://novapharmanews.com/apac/news/haier-biomedical-international-revenue-growth-2025 2026-06-10T05:34:48.092Z monthly 0.5 https://novapharmanews.com/apac/news/tga-combination-boundary-products-guidance-apac-pharmaceutical 2026-06-10T05:34:50.096Z monthly 0.5 https://novapharmanews.com/apac/news/genprex-israel-patent-reqorsa-gene-therapy-pd1-antibodies-cancer 2026-06-10T05:34:52.093Z monthly 0.5 https://novapharmanews.com/apac/news/prolacta-human-milk-fortifiers-prescription-drug-status-japan-jasmine-trial 2026-06-10T05:00:31.018Z monthly 0.5 https://novapharmanews.com/eu/news/stoke-therapeutics-zorevunersen-dravet-syndrome-q1-2026-results 2026-06-10T05:35:01.971Z monthly 0.5 https://novapharmanews.com/eu/news/uniqure-amt-130-gene-therapy-uk-approval-huntingtons-disease 2026-06-10T05:00:33.019Z monthly 0.5 https://novapharmanews.com/eu/news/northwest-biotherapeutics-annalisa-jenkins-dcvax-cancer-vaccine-adviser 2026-06-10T05:34:58.989Z monthly 0.5 https://novapharmanews.com/eu/news/cerus-intercept-blood-system-european-regulatory-review-phase-3-trials 2026-06-10T05:34:58.110Z monthly 0.5 https://novapharmanews.com/eu/news/bio-rad-q1-2026-ivdr-compliance-costs-european-diagnostics 2026-06-10T05:35:02.889Z monthly 0.5 https://novapharmanews.com/eu/news/fda-advisory-committee-recommends-astrazeneca-truqap-pten-deficient-prostate-cancer 2026-06-10T05:00:42.394Z monthly 0.5 https://novapharmanews.com/eu/news/alkeus-gildeuretinol-stargardt-disease-arvo-2026-data 2026-06-10T05:35:02.113Z monthly 0.5 https://novapharmanews.com/eu/news/setpoint-medical-multiple-sclerosis-trial-neuroimmune-therapy 2026-06-10T05:35:04.118Z monthly 0.5 https://novapharmanews.com/eu/news/emergent-biosolutions-q1-2026-financial-results 2026-06-10T05:35:06.119Z monthly 0.5 https://novapharmanews.com/eu/news/telix-tlx101-px-pixlumi-brain-cancer-imaging-european-approval 2026-06-10T05:35:08.111Z monthly 0.5 https://novapharmanews.com/us/news/mrm-health-mh002-fda-fast-track-ulcerative-colitis 2026-06-10T05:00:43.718Z monthly 0.5 https://novapharmanews.com/us/news/cadrenal-therapeutics-cad-1005-fda-phase-3-heparin-induced-thrombocytopenia 2026-06-10T05:35:10.110Z monthly 0.5 https://novapharmanews.com/us/news/redhill-rhb-204-comparable-efficacy-rhb-104-crohns-disease-map-treatment 2026-06-10T05:35:12.264Z monthly 0.5 https://novapharmanews.com/us/news/phathom-pharmaceuticals-voquezna-q1-2026-earnings-profitability-guidance 2026-06-10T05:35:14.250Z monthly 0.5 https://novapharmanews.com/us/news/contineum-therapeutics-pipe-791-positive-phase-1b-chronic-pain-results 2026-06-10T05:35:23.621Z monthly 0.5 https://novapharmanews.com/us/news/summit-therapeutics-ivonescimab-overall-survival-lung-cancer-asco-2026 2026-06-10T08:51:02.404Z monthly 0.5 https://novapharmanews.com/us/news/ac-immune-aci-24-alzheimers-trial-final-cohort-aci-19764-phase-1 2026-06-10T05:35:18.254Z monthly 0.5 https://novapharmanews.com/us/news/addex-dipraglurant-brain-injury-recovery-2025-results 2026-06-10T05:35:20.252Z monthly 0.5 https://novapharmanews.com/us/news/ac-immune-final-cohort-abate-trial-anti-abeta-alzheimer-treatment 2026-06-10T05:00:41.028Z monthly 0.5 https://novapharmanews.com/us/news/mabwell-9mw2821-cervical-cancer-esmo-gc-2026 2026-06-10T05:35:22.251Z monthly 0.5 https://novapharmanews.com/us/news/aquestive-therapeutics-securities-fraud-lawsuit-anaphylm-fda-review 2026-06-10T05:35:24.254Z monthly 0.5 https://novapharmanews.com/us/news/immunitybio-ibrx-fda-warning-letter-ankt-lawsuit-2026 2026-06-10T05:35:26.254Z monthly 0.5 https://novapharmanews.com/us/news/fda-advisory-committee-recommends-astrazeneca-truqap-pten-deficient-prostate-cancer 2026-06-10T05:00:43.033Z monthly 0.5 https://novapharmanews.com/us/news/eli-lilly-foundayo-orforglipron-fda-approval-obesity-q1-2026-results 2026-06-10T08:42:29.822Z monthly 0.5 https://novapharmanews.com/us/news/theradaptive-fda-approval-osteoadapt-sp-phase-3-spinal-fusion-trial 2026-06-10T05:00:47.047Z monthly 0.5 https://novapharmanews.com/eu/news/eu-biopharma-clinical-trials-ai-gene-therapy 2026-06-10T05:35:28.268Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-q1-2026-licensing-deals 2026-06-10T08:14:50.142Z monthly 0.5 https://novapharmanews.com/us/news/fierce-biotech-week-2026-ai-oncology-preview 2026-06-10T05:35:32.258Z monthly 0.5 https://novapharmanews.com/us/news/ipec-excipient-world-biologics-summit-2026-preview 2026-06-10T05:35:34.278Z monthly 0.5 https://novapharmanews.com/apac/news/axoft-55m-series-a-brain-computer-interface-clinical-trials 2026-06-10T05:35:36.275Z monthly 0.5 https://novapharmanews.com/apac/news/vivacta-bio-50-million-series-a-funding-gt801-car-t-therapy 2026-06-10T05:35:38.279Z monthly 0.5 https://novapharmanews.com/apac/news/taimei-technology-ai-clinical-trials-biokorea-2026 2026-06-10T05:35:40.282Z monthly 0.5 https://novapharmanews.com/apac/news/energenesis-energi-f703dfu-diabetic-foot-ulcer-ewma-2026 2026-06-10T05:35:42.276Z monthly 0.5 https://novapharmanews.com/apac/news/ascletis-pharma-diabetes-drug-data-ada-2026-scientific-sessions 2026-06-10T05:35:44.262Z monthly 0.5 https://novapharmanews.com/apac/news/tlx597-tx-psma-radioligand-therapy-optimal-trial-prostate-cancer 2026-06-10T05:35:47.195Z monthly 0.5 https://novapharmanews.com/apac/news/immunitybio-securities-fraud-lawsuit-anktiva-fda-warning-letter 2026-06-10T05:00:49.056Z monthly 0.5 https://novapharmanews.com/eu/news/hutchmed-sovleplenib-priority-review-breakthrough-designation-china-autoimmune-hemolytic-anemia 2026-06-10T05:35:48.287Z monthly 0.5 https://novapharmanews.com/eu/news/fda-real-world-evidence-framework-medtech-ventripoint-10-billion 2026-06-10T05:36:00.706Z monthly 0.5 https://novapharmanews.com/us/news/teva-acquires-emalex-ecopipam-tourette-syndrome-drug-700-million 2026-06-10T05:35:52.270Z monthly 0.5 https://novapharmanews.com/us/news/purespring-therapeutics-nphs2-genetic-variants-adult-onset-fsgs-study 2026-06-10T05:35:59.067Z monthly 0.5 https://novapharmanews.com/us/news/viking-therapeutics-vk2735-phase-3-obesity-trials-enrolled-q1-2026 2026-06-10T05:00:51.056Z monthly 0.5 https://novapharmanews.com/us/news/relay-therapeutics-q1-2026-earnings-zovegalisib-updates-may-5 2026-06-10T05:35:56.289Z monthly 0.5 https://novapharmanews.com/us/news/neurocrine-ingrezza-tardive-dyskinesia-improvement-threshold-study 2026-06-10T05:35:59.371Z monthly 0.5 https://novapharmanews.com/us/news/novo-nordisk-denecimig-hemophilia-a-phase-3-trial-nejm 2026-06-10T05:36:00.522Z monthly 0.5 https://novapharmanews.com/us/news/addex-gabab-pam-ipf-chronic-cough-preclinical-results 2026-06-10T05:36:16.533Z monthly 0.5 https://novapharmanews.com/us/news/iga-nephropathy-market-forecast-2036-novartis-zigakibart-immunotherapies 2026-06-10T05:36:15.916Z monthly 0.5 https://novapharmanews.com/us/news/perimeter-medical-claire-oct-ai-fda-approval-breast-cancer-surgery 2026-06-10T05:00:53.047Z monthly 0.5 https://novapharmanews.com/us/news/regeneron-q1-2026-earnings-dupixent-eylea-hd-sales-growth 2026-06-10T07:09:59.961Z monthly 0.5 https://novapharmanews.com/us/news/sprout-pharmaceuticals-addyi-flibanserin-time-top-10-influential-health-companies-2026 2026-06-10T05:36:12.192Z monthly 0.5 https://novapharmanews.com/eu/news/biopharma-clinical-trials-eu-daily-insights 2026-06-10T05:00:57.072Z monthly 0.5 https://novapharmanews.com/us/news/clinical-outsourcing-2026-key-takeaways 2026-06-10T07:39:51.789Z monthly 0.5 https://novapharmanews.com/us/news/clinical-outsourcing-trends-2026-key-takeaways 2026-06-10T05:01:01.060Z monthly 0.5 https://novapharmanews.com/us/news/ieee-cog-2026-industry-day-game-dev-tutorials 2026-06-10T05:01:03.056Z monthly 0.5 https://novapharmanews.com/apac/news/chinabio-partnering-forum-2026-highlights 2026-06-10T05:36:08.454Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-biotech-dealmaking 2026-06-10T05:36:15.390Z monthly 0.5 https://novapharmanews.com/us/news/clinical-outsourcing-group-pharma-takeaways 2026-06-10T05:36:12.444Z monthly 0.5 https://novapharmanews.com/apac/news/chinabio-partnering-forum-biotech-deals-apac 2026-06-10T05:36:14.455Z monthly 0.5 https://novapharmanews.com/apac/news/insilico-rentosertib-inhalation-ind-clearance-ai-drug-clinical-trial 2026-06-10T05:01:05.062Z monthly 0.5 https://novapharmanews.com/apac/news/thailand-asean-medical-device-market-gateway-2029 2026-06-10T07:16:41.986Z monthly 0.5 https://novapharmanews.com/apac/news/yangtze-river-pharmaceutical-group-international-revenue-growth-2025 2026-06-10T05:36:18.457Z monthly 0.5 https://novapharmanews.com/apac/news/soleno-therapeutics-securities-fraud-lawsuit-phase-3-clinical-trials 2026-06-10T05:36:20.448Z monthly 0.5 https://novapharmanews.com/apac/news/newleos-ntx-2001-phase-1b-trial-alcohol-use-disorder 2026-06-10T05:36:22.482Z monthly 0.5 https://novapharmanews.com/apac/news/citius-oncology-lymphir-first-international-shipment-europe 2026-06-10T05:36:24.465Z monthly 0.5 https://novapharmanews.com/apac/news/eirgenix-japan-biosimilar-expansion-cphi-2026 2026-06-10T05:36:26.456Z monthly 0.5 https://novapharmanews.com/eu/news/european-commission-approves-poherdy-pertuzumab-biosimilar-henlius-organon 2026-06-10T05:01:07.056Z monthly 0.5 https://novapharmanews.com/eu/news/puretech-lyt-200-clinical-results-myeloid-malignancies-2025 2026-06-10T05:36:28.539Z monthly 0.5 https://novapharmanews.com/eu/news/enterobiotix-19m-funding-phase-2b-ibs-microbiome-trial 2026-06-10T06:01:01.428Z monthly 0.5 https://novapharmanews.com/eu/news/ray-therapeutics-rtx-015-ema-prime-designation-retinitis-pigmentosa 2026-06-10T05:36:32.459Z monthly 0.5 https://novapharmanews.com/eu/news/x4-pharmaceuticals-xolremdi-mavorixafor-european-approval-whim-syndrome 2026-06-10T05:01:09.054Z monthly 0.5 https://novapharmanews.com/eu/news/norgine-xolremdi-mavorixafor-whim-syndrome-european-approval 2026-06-10T05:01:11.053Z monthly 0.5 https://novapharmanews.com/eu/news/norgine-xolremdi-mavorixafor-european-approval-whim-syndrome-treatment 2026-06-10T05:01:13.082Z monthly 0.5 https://novapharmanews.com/eu/news/ema-expert-panel-covid-19-mrna-vaccine-trust-spikevax-comirnaty 2026-06-10T05:36:34.461Z monthly 0.5 https://novapharmanews.com/eu/news/henlius-organon-poherdy-first-pertuzumab-biosimilar-approved-europe 2026-06-10T05:01:15.071Z monthly 0.5 https://novapharmanews.com/us/news/fda-clinical-hold-newron-evenamide-phase-3-trial-treatment-resistant-schizophrenia 2026-06-10T06:06:14.498Z monthly 0.5 https://novapharmanews.com/us/news/teva-q1-2026-results-ponlimsi-fda-approval-olanzapine-lai 2026-06-10T05:36:38.460Z monthly 0.5 https://novapharmanews.com/us/news/teva-acquires-emalex-ecopipam-tourette-syndrome-drug 2026-06-10T05:01:17.057Z monthly 0.5 https://novapharmanews.com/us/news/teva-ponlimsi-biosimilar-fda-approval-prolia-q1-2026-results 2026-06-10T05:36:40.462Z monthly 0.5 https://novapharmanews.com/us/news/bayer-asundexian-stroke-trial-esoc-2026-abstracts 2026-06-10T05:36:42.464Z monthly 0.5 https://novapharmanews.com/us/news/tempest-therapeutics-tpst-2003-car-t-multiple-myeloma-isct-2026 2026-06-10T05:36:44.475Z monthly 0.5 https://novapharmanews.com/us/news/pfizer-elrexfio-progression-free-survival-multiple-myeloma-phase-3-trial 2026-06-10T05:01:19.077Z monthly 0.5 https://novapharmanews.com/us/news/rein-therapeutics-lti-03-phase-2-trial-enrollment-update-ipf 2026-06-10T05:36:52.874Z monthly 0.5 https://novapharmanews.com/us/news/laguna-biotherapeutics-fda-clearance-lgna-100-pediatric-leukemia-trial 2026-06-10T05:36:48.461Z monthly 0.5 https://novapharmanews.com/us/news/expression-therapeutics-fda-fast-track-hemophilia-a-stem-cell-therapy 2026-06-10T05:36:50.471Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-gilead-bictegravir-lenacapavir-hiv-treatment 2026-06-10T05:01:21.060Z monthly 0.5 https://novapharmanews.com/us/news/regeneron-otarmeni-gene-therapy-free-hearing-loss-government-agreement 2026-06-10T05:36:52.556Z monthly 0.5 https://novapharmanews.com/eu/news/eu-biopharma-clinical-trials-daily-roundup 2026-06-10T05:01:23.083Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-biotech-deals 2026-06-10T05:01:25.077Z monthly 0.5 https://novapharmanews.com/us/news/cog-2024-daily-highlights 2026-06-10T05:36:54.479Z monthly 0.5 https://novapharmanews.com/apac/news/chinabio-partnering-forum-biotech-deals-investment 2026-06-10T05:01:27.081Z monthly 0.5 https://novapharmanews.com/us/news/asco-2026-oncology-data-readouts 2026-06-10T08:49:59.085Z monthly 0.5 https://novapharmanews.com/us/news/asco-2026-oncology-trials-preview 2026-06-10T05:36:58.561Z monthly 0.5 https://novapharmanews.com/us/news/fda-redi-conference-2026-regulatory-strategies 2026-06-10T05:37:00.485Z monthly 0.5 https://novapharmanews.com/eu/news/eu-biopharma-clinical-trials-daily-insights 2026-06-10T05:37:02.482Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-biotech-deals-investment 2026-06-10T05:37:05.506Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-biotech-deals-day-1 2026-06-10T05:01:29.082Z monthly 0.5 https://novapharmanews.com/apac/news/trialcliniq-150k-investment-caduceus-capital-ai-clinical-trial-recruitment 2026-06-10T05:37:06.492Z monthly 0.5 https://novapharmanews.com/apac/news/argo-biopharma-bw-50218-phase-1-trial-first-patient-sirna-therapy 2026-06-10T05:37:08.487Z monthly 0.5 https://novapharmanews.com/apac/news/claruvis-retoxin-first-recombinant-botulinum-toxin-approval-china 2026-06-10T05:01:31.083Z monthly 0.5 https://novapharmanews.com/apac/news/jyong-biotech-botreso-botanical-drug-market-access-strategy-2026 2026-06-10T05:37:10.493Z monthly 0.5 https://novapharmanews.com/apac/news/arcera-life-sciences-fosun-pharma-neurodegenerative-disease-collaboration 2026-06-10T05:37:12.490Z monthly 0.5 https://novapharmanews.com/apac/news/samsung-bioepis-atlatl-partnership-asia-pacific-biotech-innovation 2026-06-10T05:37:27.244Z monthly 0.5 https://novapharmanews.com/apac/news/tga-implantable-medical-devices-regulatory-framework-australia-2024 2026-06-10T05:37:16.489Z monthly 0.5 https://novapharmanews.com/apac/news/immunic-appoints-michael-panzara-chief-medical-officer-vidofludimus-calcium 2026-06-10T05:37:18.489Z monthly 0.5 https://novapharmanews.com/apac/news/zhengye-biotechnology-fiscal-2025-financial-results-veterinary-vaccines 2026-06-10T05:37:20.493Z monthly 0.5 https://novapharmanews.com/eu/news/vivosim-labs-ai-tool-predicts-drug-diarrhea-without-animal-testing 2026-06-10T05:37:29.562Z monthly 0.5 https://novapharmanews.com/eu/news/boehringer-ingelheim-survodutide-weight-loss-phase-2-trial-results 2026-06-10T05:37:24.489Z monthly 0.5 https://novapharmanews.com/eu/news/idorsia-quviviq-74-percent-sales-growth-q1-2026-european-expansion 2026-06-10T05:37:26.492Z monthly 0.5 https://novapharmanews.com/eu/news/small-molecule-api-market-202-billion-2036-generic-drugs 2026-06-10T05:37:28.545Z monthly 0.5 https://novapharmanews.com/eu/news/silexion-therapeutics-sil204-phase-2-3-trial-kras-pancreatic-cancer 2026-06-10T05:01:33.090Z monthly 0.5 https://novapharmanews.com/eu/news/novo-nordisk-wegovy-data-women-obesity-european-congress-2026 2026-06-10T07:18:08.663Z monthly 0.5 https://novapharmanews.com/eu/news/solid-biosciences-sgt-003-european-orphan-drug-designation-duchenne-muscular-dystrophy 2026-06-10T05:37:33.183Z monthly 0.5 https://novapharmanews.com/eu/news/cytokinetics-myqorzo-aficamten-esc-heart-failure-2026-congress 2026-06-10T05:37:34.543Z monthly 0.5 https://novapharmanews.com/eu/news/artiva-biotherapeutics-allonk-fda-fast-track-rheumatoid-arthritis 2026-06-10T05:37:36.612Z monthly 0.5 https://novapharmanews.com/eu/news/sq-innovation-lasix-onyu-ce-marking-approval-european-market 2026-06-10T05:37:38.560Z monthly 0.5 https://novapharmanews.com/us/news/aop-health-rapiblyk-landiolol-first-patient-treatment-us 2026-06-10T05:37:40.557Z monthly 0.5 https://novapharmanews.com/us/news/emergent-biosolutions-substipharm-japanese-encephalitis-vaccine-manufacturing-partnership 2026-06-10T05:37:42.551Z monthly 0.5 https://novapharmanews.com/us/news/cordis-selution-slr-drug-eluting-balloon-japan-launch 2026-06-10T05:37:44.550Z monthly 0.5 https://novapharmanews.com/us/news/zealand-pharma-survodutide-weight-loss-phase-3-trial-results 2026-06-10T05:37:46.562Z monthly 0.5 https://novapharmanews.com/us/news/ashvattha-therapeutics-migaldendranib-diabetic-macular-edema-amd-data 2026-06-10T05:37:48.563Z monthly 0.5 https://novapharmanews.com/us/news/aclaris-ati-052-phase-1a-trial-results-45-day-half-life 2026-06-10T05:01:35.098Z monthly 0.5 https://novapharmanews.com/us/news/trevi-therapeutics-q1-2026-earnings-haduvio-chronic-cough-updates 2026-06-10T05:37:50.564Z monthly 0.5 https://novapharmanews.com/us/news/soligenix-hybryte-phase-3-flash2-trial-interim-results-ctcl 2026-06-10T05:37:52.564Z monthly 0.5 https://novapharmanews.com/us/news/avicanna-us-cannabis-rescheduling-medical-research-development 2026-06-10T05:38:00.880Z monthly 0.5 https://novapharmanews.com/us/news/innocare-orelabrutinib-phase-3-trial-sle-treatment 2026-06-10T05:37:56.567Z monthly 0.5 https://novapharmanews.com/us/news/orca-bio-orca-q-fda-rmat-designation-blood-cancers 2026-06-10T05:37:58.561Z monthly 0.5 https://novapharmanews.com/us/news/formblends-2026-peptide-report-rfk-hhs-glp1-therapy-access 2026-06-10T05:38:06.115Z monthly 0.5 https://novapharmanews.com/us/news/c-ray-therapeutics-fda-copper-64-drug-master-file-approval 2026-06-10T05:38:02.568Z monthly 0.5 https://novapharmanews.com/us/news/brc-therapeutics-fda-clearance-brc-002-phase-1-trial-crps 2026-06-10T05:38:04.600Z monthly 0.5 https://novapharmanews.com/us/news/vanda-pharmaceuticals-imsidolimab-generalized-pustular-psoriasis-nejm-evidence 2026-06-10T05:38:06.576Z monthly 0.5 https://novapharmanews.com/us/news/astrazeneca-breztri-aerosphere-approved-first-triple-therapy-asthma-patients-12-older 2026-06-10T05:01:47.888Z monthly 0.5 https://novapharmanews.com/us/news/vensica-medical-fda-ind-approval-vixe-xeomin-needle-free-delivery-overactive-bladder 2026-06-10T05:01:39.087Z monthly 0.5 https://novapharmanews.com/us/news/abbvie-upadacitinib-rinvoq-fda-application-alopecia-areata 2026-06-10T05:01:41.104Z monthly 0.5 https://novapharmanews.com/us/news/novartis-q1-2026-earnings-remibrutinib-chmp-approval-pipeline-growth 2026-06-10T05:38:08.680Z monthly 0.5 https://novapharmanews.com/us/news/wave-life-sciences-wve-007-phase-2a-fda-approval-obesity-diabetes 2026-06-10T05:38:10.612Z monthly 0.5 https://novapharmanews.com/eu/news/biopharma-clinical-trials-daily-roundup 2026-06-10T05:38:26.469Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-emergent-evolveimmune-deals 2026-06-10T05:38:14.601Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-deal-surge-lilly-sun 2026-06-10T05:38:16.598Z monthly 0.5 https://novapharmanews.com/apac/news/chinabio-partnering-forum-biotech-investment-trends 2026-06-10T05:01:43.076Z monthly 0.5 https://novapharmanews.com/us/news/pharma-compliance-congress-annex-1-challenges 2026-06-10T05:38:18.602Z monthly 0.5 https://novapharmanews.com/us/news/cog-2024-day-1-highlights 2026-06-10T05:38:20.588Z monthly 0.5 https://novapharmanews.com/us/news/clinical-outsourcing-group-event-day-1 2026-06-10T05:38:22.592Z monthly 0.5 https://novapharmanews.com/us/news/clinical-outsourcing-group-daily-roundup 2026-06-10T05:38:24.601Z monthly 0.5 https://novapharmanews.com/us/news/ascrs-2026-opus-genetics-phentolamine-preview 2026-06-10T08:18:54.164Z monthly 0.5 https://novapharmanews.com/us/news/fdli-2026-fda-strategic-priorities 2026-06-10T05:38:36.917Z monthly 0.5 https://novapharmanews.com/us/news/cog-2024-day-1-roundup 2026-06-10T05:38:42.964Z monthly 0.5 https://novapharmanews.com/us/news/clinical-outsourcing-group-2026-daily-roundup 2026-06-10T05:38:37.019Z monthly 0.5 https://novapharmanews.com/apac/news/akso-health-group-brain-computer-interface-rd-program-neurotechnology 2026-06-10T05:38:37.861Z monthly 0.5 https://novapharmanews.com/apac/news/evofem-solosec-distribution-agreement-sub-saharan-africa 2026-06-10T05:38:34.606Z monthly 0.5 https://novapharmanews.com/apac/news/psg-2026-specialty-drug-benefits-report-cost-management-coverage-strategies 2026-06-10T05:38:36.614Z monthly 0.5 https://novapharmanews.com/apac/news/wuxi-apptec-q1-2026-revenue-growth-backlog-results 2026-06-10T05:01:54.923Z monthly 0.5 https://novapharmanews.com/apac/news/img-pharma-acquires-matsumoto-pharmaceutical-japan-expansion 2026-06-10T05:38:38.619Z monthly 0.5 https://novapharmanews.com/apac/news/aquestive-therapeutics-anaphylm-class-action-lawsuit-approval-timeline 2026-06-10T05:38:40.626Z monthly 0.5 https://novapharmanews.com/apac/news/biomarin-completes-amicus-therapeutics-acquisition-galafold-pompe-therapies 2026-06-10T05:32:33.162Z monthly 0.5 https://novapharmanews.com/eu/news/elanco-negasunt-tanidil-emergency-authorization-screwworm-livestock 2026-06-10T05:38:42.617Z monthly 0.5 https://novapharmanews.com/eu/news/opella-essentiale-excel-trial-fatty-liver-disease-masld-results 2026-06-10T05:38:44.620Z monthly 0.5 https://novapharmanews.com/eu/news/advanced-bifurcation-systems-acquires-svelte-medical-coronary-stent-deal 2026-06-10T05:38:50.551Z monthly 0.5 https://novapharmanews.com/eu/news/zentiva-appeals-eu-court-urban-wastewater-directive-generic-medicines 2026-06-10T05:38:48.636Z monthly 0.5 https://novapharmanews.com/eu/news/ab-science-loan-repayment-deferral-agreement-2026 2026-06-10T05:38:50.610Z monthly 0.5 https://novapharmanews.com/eu/news/mundipharma-rezzayo-rezafungin-phase-iii-respect-trial-results-fungal-disease-prevention 2026-06-10T05:38:52.616Z monthly 0.5 https://novapharmanews.com/eu/news/crinetics-palsonify-paltusotine-eu-approval-acromegaly-treatment 2026-06-10T05:38:54.620Z monthly 0.5 https://novapharmanews.com/us/news/cellenkos-fda-clearance-ck0801-phase-2-aplastic-anemia-trial 2026-06-10T05:38:56.614Z monthly 0.5 https://novapharmanews.com/us/news/astrazeneca-saphnelo-autoinjector-fda-approved-lupus-self-administration 2026-06-10T05:38:58.627Z monthly 0.5 https://novapharmanews.com/us/news/dmx-200-action3-trial-statistical-power-blinded-review 2026-06-10T05:39:03.251Z monthly 0.5 https://novapharmanews.com/us/news/concept-medical-sirona-trial-3-year-data-charing-cross-2026 2026-06-10T05:39:02.702Z monthly 0.5 https://novapharmanews.com/us/news/intellia-lonvo-z-fda-submission-crispr-hereditary-angioedema 2026-06-10T05:39:04.640Z monthly 0.5 https://novapharmanews.com/us/news/cordis-selution-slr-drug-eluting-balloon-japan-launch-2026 2026-06-10T05:39:06.641Z monthly 0.5 https://novapharmanews.com/us/news/tovecimig-biliary-tract-cancer-trial-results-companion-002 2026-06-10T05:39:08.620Z monthly 0.5 https://novapharmanews.com/us/news/intellia-lonvoguran-ziclumeran-phase-3-hereditary-angioedema-gene-editing 2026-06-10T05:39:10.621Z monthly 0.5 https://novapharmanews.com/us/news/sagimet-biosciences-denifanstat-phase-3-acne-trial-2026 2026-06-10T05:39:12.636Z monthly 0.5 https://novapharmanews.com/us/news/apollomics-vebreltinib-phase-2-3-ind-submission-nsclc-treatment 2026-06-10T05:39:14.629Z monthly 0.5 https://novapharmanews.com/us/news/aclaris-therapeutics-ati-052-phase-1a-results-ati-2138-update-april-2026 2026-06-10T05:39:16.632Z monthly 0.5 https://novapharmanews.com/us/news/ose-immunotherapeutics-pegrizeprument-vel-101-fda-orphan-drug-designation-heart-transplant 2026-06-10T05:39:18.639Z monthly 0.5 https://novapharmanews.com/us/news/jazz-pharmaceuticals-ziihera-fda-priority-review-her2-cancer 2026-06-10T05:39:20.637Z monthly 0.5 https://novapharmanews.com/us/news/nccn-adds-nuvation-bio-taletrectinib-ibtrozi-cancer-guidelines-ros1-nsclc-brain-metastases 2026-06-10T07:20:09.839Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-imaavy-nipocalimab-warm-autoimmune-hemolytic-anemia 2026-06-10T05:39:24.653Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-caplyta-lumateperone-snda-schizophrenia-relapse-prevention 2026-06-10T07:15:53.907Z monthly 0.5 https://novapharmanews.com/us/news/apotex-fda-approval-generic-infuvite-pediatric-injection-exclusivity 2026-06-10T05:39:28.640Z monthly 0.5 https://novapharmanews.com/us/news/clinical-outsourcing-group-pharma-news-roundup-april-28-2026 2026-06-10T05:39:30.649Z monthly 0.5 https://novapharmanews.com/us/news/4th-annual-cog-2026-no-pharma-news 2026-06-10T05:39:39.192Z monthly 0.5 https://novapharmanews.com/us/news/pharma-compliance-congress-day-1-roundup 2026-06-10T05:39:34.650Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-patient-centric-trials-workforce 2026-06-10T05:39:36.649Z monthly 0.5 https://novapharmanews.com/us/news/pharma-compliance-congress-regulatory-updates-day-1 2026-06-10T05:39:39.879Z monthly 0.5 https://novapharmanews.com/us/news/testosterone-therapy-fda-update-regulatory-advances 2026-06-10T05:39:40.649Z monthly 0.5 https://novapharmanews.com/us/news/glp-1-eating-disorder-risk-true-facts 2026-06-10T05:39:42.659Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2026-ai-pathology-oncolytic-virus 2026-06-10T05:39:44.689Z monthly 0.5 https://novapharmanews.com/us/news/interphex-2026-phillips-medisize-sensing 2026-06-10T05:39:46.656Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-ai-patient-centricity 2026-06-10T05:39:48.653Z monthly 0.5 https://novapharmanews.com/eu/news/pharma-2026-eu-biopharma-medtech-highlights 2026-06-10T07:33:13.545Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-eu-funding-dealmaking-highlights 2026-06-10T05:39:52.666Z monthly 0.5 https://novapharmanews.com/eu/news/asco-2026-olverembatinib-gastric-cancer-trials 2026-06-10T05:39:55.537Z monthly 0.5 https://novapharmanews.com/eu/news/pharma-sustainability-2026-packaging-preview 2026-06-10T05:39:58.643Z monthly 0.5 https://novapharmanews.com/us/news/pharma-compliance-congress-day-1-regulatory-updates 2026-06-10T05:39:58.657Z monthly 0.5 https://novapharmanews.com/apac/news/eyebright-medical-2025-annual-report-sustainability-results 2026-06-10T05:40:00.674Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-japanese-pharmacopoeia-medical-device-standards-regulatory-science 2026-06-10T08:24:11.190Z monthly 0.5 https://novapharmanews.com/eu/news/boston-scientific-securities-class-action-lawsuit-may-2026 2026-06-10T05:40:05.122Z monthly 0.5 https://novapharmanews.com/eu/news/brii-bio-elebsiran-hepatitis-b-control-apasl-2026-analysis 2026-06-10T05:40:07.216Z monthly 0.5 https://novapharmanews.com/us/news/ascletis-asc30-oral-glp-1-diabetes-phase-2-trial-enrollment-complete 2026-06-10T05:40:09.114Z monthly 0.5 https://novapharmanews.com/us/news/ascletis-asc30-phase-ii-enrollment-complete-oral-glp1-diabetes 2026-06-10T05:40:12.245Z monthly 0.5 https://novapharmanews.com/us/news/sun-pharma-acquires-organon-11-75-billion-merger-2026 2026-06-10T07:57:20.202Z monthly 0.5 https://novapharmanews.com/us/news/boston-scientific-farapulse-watchman-heart-rhythm-2026-data 2026-06-10T05:40:16.227Z monthly 0.5 https://novapharmanews.com/us/news/veradermics-vdphl01-phase-2-3-trial-results-male-pattern-hair-loss 2026-06-10T05:40:18.230Z monthly 0.5 https://novapharmanews.com/us/news/veradermics-vdphl01-phase-2-3-trial-results-conference-call 2026-06-10T05:40:29.564Z monthly 0.5 https://novapharmanews.com/us/news/adagio-medical-vclas-ventricular-ablation-system-pivotal-trial-results 2026-06-10T05:40:22.237Z monthly 0.5 https://novapharmanews.com/us/news/pharma-compliance-congress-2026-opens 2026-06-10T05:40:24.232Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-immunology-daily-roundup 2026-06-10T07:15:02.260Z monthly 0.5 https://novapharmanews.com/apac/news/pmc-organometallix-price-increase-all-products-may-2026 2026-06-10T05:40:28.240Z monthly 0.5 https://novapharmanews.com/apac/news/tga-personalised-medical-device-regulations-guidance-2024 2026-06-10T05:40:30.241Z monthly 0.5 https://novapharmanews.com/us/news/atara-biotherapeutics-securities-class-action-lawsuit-may-2026-deadline 2026-06-10T05:40:32.244Z monthly 0.5 https://novapharmanews.com/us/news/aquestive-therapeutics-class-action-lawsuit-fda-application 2026-06-10T05:40:34.247Z monthly 0.5 https://novapharmanews.com/us/news/pulse-biosciences-npulse-cardiac-catheter-heart-rhythm-2026-trial-data 2026-06-10T06:31:44.439Z monthly 0.5 https://novapharmanews.com/us/news/abbott-tactiflex-duo-ablation-catheter-afib-results-hrs-2026 2026-06-10T05:40:38.248Z monthly 0.5 https://novapharmanews.com/us/news/medtronic-affera-sphere-9-catheter-fda-breakthrough-device-designation-ventricular-tachycardia 2026-06-10T05:40:40.243Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-rexatilux-ranibizumab-eye-treatment 2026-06-10T05:40:44.890Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-redemplo-plozasiran-european-approval 2026-06-10T05:40:44.247Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-viatris-palbociclib-generic-cancer-treatment 2026-06-10T05:40:46.520Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-itvisma-onasemnogene-abeparvovec-sma-gene-therapy 2026-06-10T05:40:48.508Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-cenrifki-tolebrutinib-multiple-sclerosis 2026-06-10T07:44:26.979Z monthly 0.5 https://novapharmanews.com/eu/news/ema-approves-first-rna-veterinary-vaccine-nobivac-nxt-cats 2026-06-10T08:20:37.758Z monthly 0.5 https://novapharmanews.com/eu/news/ema-approves-plozasiran-redemplo-familial-chylomicronaemia-syndrome-fcs 2026-06-10T07:23:41.106Z monthly 0.5 https://novapharmanews.com/eu/news/ema-chmp-recommends-tolebrutinib-cenrifki-five-medicines-approval-april-2026 2026-06-10T08:01:56.941Z monthly 0.5 https://novapharmanews.com/us/news/fda-gdufa-generic-drug-user-fee-amendments-2024-updates 2026-06-10T05:40:58.520Z monthly 0.5 https://novapharmanews.com/us/news/fda-omufa-user-fee-program-otc-monograph-drugs 2026-06-10T05:41:09.865Z monthly 0.5 https://novapharmanews.com/us/news/fda-gdufa-iv-reauthorization-2028-2032-generic-drug-user-fees 2026-06-10T05:41:02.519Z monthly 0.5 https://novapharmanews.com/us/news/fda-testosterone-therapy-low-libido-hypogonadism-2024 2026-06-10T05:41:04.526Z monthly 0.5 https://novapharmanews.com/us/news/fda-reduces-animal-testing-drug-development-alternatives-2024 2026-06-10T05:41:06.537Z monthly 0.5 https://novapharmanews.com/us/news/cms-fda-rapid-coverage-pathway-breakthrough-medical-devices-medicare 2026-06-10T05:41:11.294Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-otarmeni-first-gene-therapy-genetic-hearing-loss 2026-06-10T05:41:14.458Z monthly 0.5 https://novapharmanews.com/us/news/fda-accelerates-mental-health-treatment-access-executive-order 2026-06-10T05:41:12.627Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-immunology-day-1-roundup 2026-06-10T05:41:14.626Z monthly 0.5 https://novapharmanews.com/us/news/scope-x-2026-clinical-ops-data-ai-boston 2026-06-10T05:41:16.633Z monthly 0.5 https://novapharmanews.com/us/news/oct-east-coast-2026-clinical-trial-innovation 2026-06-10T05:41:18.627Z monthly 0.5 https://novapharmanews.com/apac/news/sunnybrook-41-million-investment-clinical-trials-canada 2026-06-10T05:41:20.623Z monthly 0.5 https://novapharmanews.com/apac/news/wuxi-biologics-chengdu-microbial-manufacturing-completion-2026 2026-06-10T06:12:51.565Z monthly 0.5 https://novapharmanews.com/apac/news/quasar-medical-thailand-manufacturing-facility-medtech-expansion 2026-06-10T05:41:24.635Z monthly 0.5 https://novapharmanews.com/apac/news/daewoong-nabota-master-class-prabotulinumtoxina-safety-2026 2026-06-10T05:41:26.631Z monthly 0.5 https://novapharmanews.com/apac/news/amcor-35m-healthcare-packaging-facility-malaysia-medical-supply-chain 2026-06-10T05:41:28.638Z monthly 0.5 https://novapharmanews.com/apac/news/transcarent-smithrx-partnership-pharmacy-benefits-platform 2026-06-10T05:41:30.642Z monthly 0.5 https://novapharmanews.com/apac/news/hanchorbio-bloomberg-partnership-drug-development-intelligence 2026-06-10T05:41:32.630Z monthly 0.5 https://novapharmanews.com/eu/news/aetna-prior-authorization-reform-88-percent-standardized-2026 2026-06-10T05:41:45.017Z monthly 0.5 https://novapharmanews.com/eu/news/guerbet-lipiodol-ultra-fluid-eu-approval-vascular-embolization 2026-06-10T05:41:43.639Z monthly 0.5 https://novapharmanews.com/eu/news/rna-therapy-clinical-trials-market-3-4-billion-2035-forecast 2026-06-10T05:41:38.638Z monthly 0.5 https://novapharmanews.com/eu/news/oncotelic-therapeutics-partnership-strategy-update-2026 2026-06-10T05:41:40.639Z monthly 0.5 https://novapharmanews.com/eu/news/clinuvel-scenesse-phase-iii-vitiligo-trial-ema-approval-2026 2026-06-10T05:41:42.637Z monthly 0.5 https://novapharmanews.com/us/news/frankfurt-court-upholds-besremi-arbitral-award-aop-health-pharmaessentia 2026-06-10T05:41:45.286Z monthly 0.5 https://novapharmanews.com/us/news/novartis-coartem-baby-who-prequalification-malaria-treatment-newborns 2026-06-10T07:18:11.658Z monthly 0.5 https://novapharmanews.com/us/news/miracell-smart-m-cell-alzheimers-stem-cell-therapy-results 2026-06-10T05:41:48.853Z monthly 0.5 https://novapharmanews.com/us/news/berlin-heals-positive-cmic-iii-heart-failure-device-results 2026-06-10T05:41:50.859Z monthly 0.5 https://novapharmanews.com/us/news/citius-pharmaceuticals-5-million-direct-offering-stock-nasdaq 2026-06-10T05:41:52.868Z monthly 0.5 https://novapharmanews.com/us/news/haemonetics-vascade-mvp-xl-safety-efficacy-study-large-bore-venous-closure 2026-06-10T05:41:54.854Z monthly 0.5 https://novapharmanews.com/us/news/briohealth-solutions-fda-approval-pediatric-briovad-heart-device-trial 2026-06-10T05:42:07.358Z monthly 0.5 https://novapharmanews.com/us/news/cgbio-fda-clearance-easymade-ti-titanium-implant 2026-06-10T05:41:58.867Z monthly 0.5 https://novapharmanews.com/us/news/cerapedics-vizient-supplier-agreement-pearlmatrix-p15-bone-graft 2026-06-10T05:42:00.872Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-immunology-clinical-research-day-1 2026-06-10T05:42:02.857Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-immunology-clinical-research-daily-roundup 2026-06-10T05:42:09.274Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-immunology-clinical-research-trends 2026-06-10T05:42:06.866Z monthly 0.5 https://novapharmanews.com/apac/news/catalym-visugromab-phase-2-3-trial-cancer-cachexia-first-patient-dosed 2026-06-10T06:23:16.368Z monthly 0.5 https://novapharmanews.com/apac/news/spinogenix-spg601-clarity-trial-fragile-x-syndrome-phase-2b-3 2026-06-10T05:42:10.867Z monthly 0.5 https://novapharmanews.com/apac/news/tga-biologicals-regulatory-framework-advanced-therapies-australia 2026-06-10T05:42:17.497Z monthly 0.5 https://novapharmanews.com/eu/news/renovorx-tamp-therapy-asco-2026-tiger-pac-trial-data 2026-06-10T05:42:17.573Z monthly 0.5 https://novapharmanews.com/eu/news/genomics-services-market-24-billion-2033-precision-medicine 2026-06-10T05:42:28.104Z monthly 0.5 https://novapharmanews.com/eu/news/accenture-invests-iridius-ai-compliance-life-sciences 2026-06-10T05:42:25.048Z monthly 0.5 https://novapharmanews.com/eu/news/pharmaceutical-q1-2026-sales-growth-momentum 2026-06-10T05:42:21.188Z monthly 0.5 https://novapharmanews.com/eu/news/cumberland-pharmaceuticals-apotex-strategic-integration-partnership 2026-06-10T05:42:22.988Z monthly 0.5 https://novapharmanews.com/us/news/cortec-brain-interchange-bci-fda-tap-program-stroke-rehabilitation 2026-06-10T05:42:24.979Z monthly 0.5 https://novapharmanews.com/us/news/tivic-health-rebrands-valion-bio-entolimod-acute-radiation-syndrome-fda-fast-track 2026-06-10T05:47:49.584Z monthly 0.5 https://novapharmanews.com/us/news/edwards-lifesciences-q1-2026-results-tmtt-sales-guidance-raise 2026-06-10T05:42:28.985Z monthly 0.5 https://novapharmanews.com/us/news/immunitybio-ibrx-fda-warning-letter-class-action-lawsuit-anktiva 2026-06-10T06:52:52.182Z monthly 0.5 https://novapharmanews.com/us/news/transmedics-chops-organ-preservation-system-ishlt-2026 2026-06-10T05:42:32.999Z monthly 0.5 https://novapharmanews.com/us/news/abbvie-fda-complete-response-letter-trenibotulinumtoxine-trenibote-manufacturing 2026-06-10T05:42:34.984Z monthly 0.5 https://novapharmanews.com/us/news/alpha-tau-fda-approval-alpha-dart-pancreatic-cancer-trial-expansion 2026-06-10T05:42:36.992Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-regeneron-otarmeni-gene-therapy-genetic-hearing-loss 2026-06-10T05:42:38.990Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-immunology-parexel-hiring 2026-06-10T05:42:40.992Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-eu-day1-roundup 2026-06-10T05:42:55.560Z monthly 0.5 https://novapharmanews.com/us/news/generic-drug-forum-2026-highlights 2026-06-10T06:39:35.182Z monthly 0.5 https://novapharmanews.com/eu/news/tilray-brands-us-medical-cannabis-expansion-rescheduling-2026 2026-06-10T05:42:47.004Z monthly 0.5 https://novapharmanews.com/us/news/capricor-therapeutics-hope-3-phase-3-deramiocel-duchenne-muscular-dystrophy-aan-2026 2026-06-10T05:42:49.072Z monthly 0.5 https://novapharmanews.com/us/news/bbsw-ai-solution-event-pharma-ai-future 2026-06-10T05:42:51.001Z monthly 0.5 https://novapharmanews.com/apac/news/samsung-bioepis-sbe303-phase-1-trial-sandoz-partnership-2026 2026-06-10T05:42:53.001Z monthly 0.5 https://novapharmanews.com/apac/news/fosun-health-wins-awards-globalhealth-asia-pacific-forum-2026 2026-06-10T05:42:55.013Z monthly 0.5 https://novapharmanews.com/apac/news/minjuvi-tafasitamab-approved-australia-follicular-lymphoma 2026-06-10T05:42:57.003Z monthly 0.5 https://novapharmanews.com/eu/news/ccbd-car-t-cell-therapy-maryland-community-oncology 2026-06-10T05:42:59.004Z monthly 0.5 https://novapharmanews.com/eu/news/samacare-prior-authorization-benchmarks-medical-benefit-drugs 2026-06-10T05:43:01.024Z monthly 0.5 https://novapharmanews.com/eu/news/repertoire-immune-medicines-rptr-1-201-phase-1-2-trial-advanced-solid-tumors 2026-06-10T05:43:03.004Z monthly 0.5 https://novapharmanews.com/eu/news/alpha-tau-alpha-dart-pancreatic-cancer-acapella-trial-first-patient 2026-06-10T05:43:05.007Z monthly 0.5 https://novapharmanews.com/eu/news/alpha-tau-alpha-dart-pancreatic-cancer-acapella-trial-europe 2026-06-10T05:43:07.010Z monthly 0.5 https://novapharmanews.com/eu/news/blinatumomab-pediatric-leukemia-safety-study-final-stage 2026-06-10T05:43:09.025Z monthly 0.5 https://novapharmanews.com/eu/news/healthcare-third-party-logistics-market-growth-502-billion-2034 2026-06-10T05:43:18.978Z monthly 0.5 https://novapharmanews.com/eu/news/pharmaceutical-intermediates-market-57-billion-2035-generic-drugs 2026-06-10T05:43:13.013Z monthly 0.5 https://novapharmanews.com/us/news/dupixent-approved-pediatric-chronic-spontaneous-urticaria-sanofi-regeneron 2026-06-10T05:43:15.017Z monthly 0.5 https://novapharmanews.com/us/news/ose-immunotherapeutics-tedopi-ovarian-cancer-asco-2026-presentation 2026-06-10T05:43:17.013Z monthly 0.5 https://novapharmanews.com/us/news/nectero-therapeutics-east-system-two-year-safety-data-abdominal-aortic-aneurysm 2026-06-10T05:43:19.027Z monthly 0.5 https://novapharmanews.com/us/news/novo-nordisk-oral-semaglutide-children-type-2-diabetes-pioneer-teens-trial 2026-06-10T07:01:43.688Z monthly 0.5 https://novapharmanews.com/us/news/neurosterix-ntx-253-schizophrenia-phase-1-trial-q2-2026 2026-06-10T07:42:53.639Z monthly 0.5 https://novapharmanews.com/us/news/greenwich-lifesciences-glsi-100-asco-2026-breast-cancer-immunotherapy 2026-06-10T05:43:25.022Z monthly 0.5 https://novapharmanews.com/us/news/mabwell-9mw2821-nectin-4-adc-phase-iii-triple-negative-breast-cancer 2026-06-10T05:43:35.915Z monthly 0.5 https://novapharmanews.com/us/news/clearpoint-neuro-fda-clearance-velocity-alpha-surgical-drill-system 2026-06-10T05:43:37.452Z monthly 0.5 https://novapharmanews.com/us/news/vistagen-refisolone-fda-approval-menopause-hot-flashes-phase-2-trial 2026-06-10T05:43:33.339Z monthly 0.5 https://novapharmanews.com/us/news/avai-bio-fda-cellular-rejuvenation-trial-anti-aging-market-120-billion 2026-06-10T05:43:33.129Z monthly 0.5 https://novapharmanews.com/us/news/cipla-fda-approval-first-generic-ventolin-hfa-albuterol-sulfate 2026-06-10T05:43:35.130Z monthly 0.5 https://novapharmanews.com/us/news/dupixent-approved-chronic-spontaneous-urticaria-children-sanofi 2026-06-10T05:43:37.210Z monthly 0.5 https://novapharmanews.com/us/news/oncology-data-trends-2026-preview 2026-06-10T05:43:39.309Z monthly 0.5 https://novapharmanews.com/us/news/redi-2026-fda-regulatory-strategies-conference-preview 2026-06-10T05:43:41.214Z monthly 0.5 https://novapharmanews.com/us/news/bionj-biopartnering-conference-2026-preview 2026-06-10T05:43:43.218Z monthly 0.5 https://novapharmanews.com/us/news/fierce-biotech-week-2026-boston-preview 2026-06-10T05:43:45.228Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-day-1-eu-takeaways 2026-06-10T05:43:47.215Z monthly 0.5 https://novapharmanews.com/us/news/biomed-israel-2026-ai-biotech-preview 2026-06-10T05:43:49.218Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-eu-day-1-roundup 2026-06-10T05:43:51.222Z monthly 0.5 https://novapharmanews.com/us/news/oct-east-coast-2026-cro-trends-outsourcing 2026-06-10T05:43:53.309Z monthly 0.5 https://novapharmanews.com/us/news/interphex-2026-biotech-day-1-roundup 2026-06-10T05:43:55.219Z monthly 0.5 https://novapharmanews.com/apac/news/calluna-pharma-cal101-phase-2-enrollment-ipf-treatment 2026-06-10T05:43:57.231Z monthly 0.5 https://novapharmanews.com/apac/news/anixa-biosciences-lira-cel-car-t-ovarian-cancer-survival-data 2026-06-10T05:43:59.238Z monthly 0.5 https://novapharmanews.com/apac/news/hengrui-pharma-q1-2026-anti-pd-l1-tgf-beta-fusion-protein-approved-china 2026-06-10T05:44:01.241Z monthly 0.5 https://novapharmanews.com/apac/news/sonorous-neurovascular-fda-clearance-boscath-catheter-2026 2026-06-10T08:43:12.234Z monthly 0.5 https://novapharmanews.com/apac/news/alphamab-oncology-jskn016-trop2-her3-bispecific-adc-her2-negative-breast-cancer-asco-2026 2026-06-10T05:44:05.229Z monthly 0.5 https://novapharmanews.com/apac/news/rfid-technology-pharmaceutical-supply-chain-15-billion-2032 2026-06-10T05:44:07.246Z monthly 0.5 https://novapharmanews.com/apac/news/wuxi-biologics-south-korea-gmp-certification-bispecific-antibody-manufacturing 2026-06-10T05:44:09.233Z monthly 0.5 https://novapharmanews.com/apac/news/australia-tga-therapeutic-sunscreen-regulatory-framework-2024 2026-06-10T05:44:11.232Z monthly 0.5 https://novapharmanews.com/eu/news/belite-bio-tinlarebant-nda-submission-stargardt-disease-phase-3-dragon-trial 2026-06-10T05:44:13.323Z monthly 0.5 https://novapharmanews.com/eu/news/abivax-obefazimod-phase-3-data-digestive-disease-week-2026 2026-06-10T05:44:15.243Z monthly 0.5 https://novapharmanews.com/eu/news/pet-service-holding-2025-annual-results-veterinary-regulatory-changes 2026-06-10T05:44:26.869Z monthly 0.5 https://novapharmanews.com/eu/news/femasys-femaseed-complete-fertility-solution-obgyn-acog-2026 2026-06-10T05:44:19.263Z monthly 0.5 https://novapharmanews.com/eu/news/mauna-kea-technologies-ce-mark-mdr-approval-european-expansion 2026-06-10T05:44:21.240Z monthly 0.5 https://novapharmanews.com/eu/news/pembrolizumab-lenvatinib-clear-cell-cancer-trial-results 2026-06-10T08:30:58.486Z monthly 0.5 https://novapharmanews.com/eu/news/roche-gazyva-fda-acceptance-lupus-treatment-phase-iii-allegory 2026-06-10T05:44:25.261Z monthly 0.5 https://novapharmanews.com/eu/news/dupixent-first-biologic-approved-chronic-spontaneous-urticaria-children 2026-06-10T05:44:27.243Z monthly 0.5 https://novapharmanews.com/eu/news/ipsen-ojemda-tovorafenib-eu-approval-pediatric-brain-cancer-braf 2026-06-10T05:44:34.075Z monthly 0.5 https://novapharmanews.com/us/news/alterity-ath434-multiple-system-atrophy-phase-2-results 2026-06-10T05:44:31.256Z monthly 0.5 https://novapharmanews.com/us/news/tempest-therapeutics-tpst-2003-car-t-manufacturing-milestone-2026 2026-06-10T05:44:33.245Z monthly 0.5 https://novapharmanews.com/us/news/phanes-therapeutics-spevatamig-phase-2-results-pancreatic-cancer-asco-2026 2026-06-10T05:44:35.326Z monthly 0.5 https://novapharmanews.com/us/news/netris-pharma-np137-pancreatic-cancer-phase-1b-nature-results 2026-06-10T06:12:50.142Z monthly 0.5 https://novapharmanews.com/us/news/neurosterix-ntx-253-phase-1-schizophrenia-trial-q2-2026 2026-06-10T05:44:51.154Z monthly 0.5 https://novapharmanews.com/us/news/mabwell-9mw2821-toripalimab-asco-2026-urothelial-carcinoma 2026-06-10T05:44:48.068Z monthly 0.5 https://novapharmanews.com/us/news/fda-complete-response-letter-atara-biotherapeutics-ebvallo-tabelecleucel-securities-lawsuit 2026-06-10T05:44:43.256Z monthly 0.5 https://novapharmanews.com/us/news/immunitybio-ibrx-securities-lawsuit-fda-warning-letter-cancer-claims 2026-06-10T08:23:18.385Z monthly 0.5 https://novapharmanews.com/us/news/nrx-pharmaceuticals-fda-positive-feedback-preservative-free-ketamine-generic 2026-06-10T05:44:51.717Z monthly 0.5 https://novapharmanews.com/us/news/labcorp-fda-approved-pd-l1-companion-diagnostic-keytruda-ovarian-cancer 2026-06-10T05:44:49.259Z monthly 0.5 https://novapharmanews.com/us/news/veloxis-pegrizeprument-fda-orphan-drug-designation-heart-transplant 2026-06-10T05:44:51.338Z monthly 0.5 https://novapharmanews.com/us/news/dupixent-approved-children-chronic-spontaneous-urticaria-csu 2026-06-10T05:44:53.264Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-eu-daily-roundup 2026-06-10T05:44:55.273Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-eu-day-1-highlights 2026-06-10T06:16:47.278Z monthly 0.5 https://novapharmanews.com/eu/news/pharma-news-today-opioid-crisis-drug-pricing-supply-chain 2026-06-10T05:44:59.272Z monthly 0.5 https://novapharmanews.com/eu/news/fda-idvynso-ascentage-asco-2026 2026-06-10T05:45:01.277Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2026-oncology-highlights 2026-06-10T05:45:03.279Z monthly 0.5 https://novapharmanews.com/apac/news/kelun-biotech-sacituzumab-tirumotecan-asco-2026-presentations 2026-06-10T05:45:05.272Z monthly 0.5 https://novapharmanews.com/apac/news/novi-health-glp-1-hybrid-care-model-clinical-real-world-gap 2026-06-10T05:45:07.284Z monthly 0.5 https://novapharmanews.com/apac/news/duchesnay-peripharm-regulatory-reform-womens-health-access-canada 2026-06-10T05:45:21.485Z monthly 0.5 https://novapharmanews.com/apac/news/australia-tga-updates-ivd-regulations-medical-device-manufacturers 2026-06-10T05:45:11.269Z monthly 0.5 https://novapharmanews.com/apac/news/washington-state-life-sciences-industry-growth-2024 2026-06-10T05:45:13.280Z monthly 0.5 https://novapharmanews.com/eu/news/redhill-opaganib-neuroblastoma-triple-negative-breast-cancer-aacr-2026 2026-06-10T05:45:15.275Z monthly 0.5 https://novapharmanews.com/eu/news/redhill-opaganib-neuroblastoma-breast-cancer-aacr-2026 2026-06-10T05:45:17.277Z monthly 0.5 https://novapharmanews.com/eu/news/sab-biotherapeutics-sab-142-c-peptide-preservation-type-1-diabetes-phase-1-trial 2026-06-10T05:45:20.322Z monthly 0.5 https://novapharmanews.com/eu/news/boston-scientific-q1-2026-earnings-clinical-trial-results 2026-06-10T05:45:21.615Z monthly 0.5 https://novapharmanews.com/eu/news/cervomed-neflamapimod-brain-volume-increase-dementia-lewy-bodies-aan-2026 2026-06-10T05:45:25.071Z monthly 0.5 https://novapharmanews.com/eu/news/cervomed-neflamapimod-dementia-lewy-bodies-aan-2026-results 2026-06-10T05:45:25.276Z monthly 0.5 https://novapharmanews.com/eu/news/celerion-thl-partners-majority-investment-clinical-research 2026-06-10T05:45:27.360Z monthly 0.5 https://novapharmanews.com/eu/news/veristat-acquires-certara-regulatory-writing-business-european-expansion 2026-06-10T07:43:12.765Z monthly 0.5 https://novapharmanews.com/eu/news/lung-cancer-therapeutics-market-142-billion-precision-medicine-2036 2026-06-10T05:45:31.282Z monthly 0.5 https://novapharmanews.com/eu/news/drug-delivery-devices-market-growth-forecast-2032-biologics 2026-06-10T05:45:33.289Z monthly 0.5 https://novapharmanews.com/eu/news/polycythemia-vera-market-transformation-protagonist-therapeutics-rusfertide-2036 2026-06-10T05:45:35.287Z monthly 0.5 https://novapharmanews.com/eu/news/ipsen-ojemda-tovorafenib-first-targeted-therapy-pediatric-brain-tumors-eu-approval 2026-06-10T06:18:48.559Z monthly 0.5 https://novapharmanews.com/eu/news/sanofi-tzield-fda-approval-children-type-1-diabetes-delay 2026-06-10T05:45:39.303Z monthly 0.5 https://novapharmanews.com/us/news/denali-therapeutics-fda-approval-avlayah-tividenofusp-alfa-hunter-syndrome 2026-06-10T05:45:41.292Z monthly 0.5 https://novapharmanews.com/us/news/pfizer-lorbrena-braftovi-asco-2026-cancer-trials 2026-06-10T05:45:43.306Z monthly 0.5 https://novapharmanews.com/us/news/capricor-deramiocel-phase-3-hope-3-duchenne-muscular-dystrophy-aan-2026 2026-06-10T05:45:45.296Z monthly 0.5 https://novapharmanews.com/us/news/boston-scientific-q1-2026-earnings-results-revenue-growth 2026-06-10T05:45:51.620Z monthly 0.5 https://novapharmanews.com/us/news/ractigen-rag-17-als-phase-1-trial-results-2026 2026-06-10T05:45:49.297Z monthly 0.5 https://novapharmanews.com/us/news/avacta-ava6103-cancer-drug-aacr-2026-data-enhertu-comparison 2026-06-10T05:45:51.322Z monthly 0.5 https://novapharmanews.com/us/news/innovent-ibi363-clinical-data-asco-2026 2026-06-10T05:45:53.508Z monthly 0.5 https://novapharmanews.com/us/news/fda-extends-sanofi-sarclisa-subcutaneous-review-multiple-myeloma 2026-06-10T05:46:05.403Z monthly 0.5 https://novapharmanews.com/us/news/nrx-pharmaceuticals-fda-feedback-preservative-free-ketamine-generic 2026-06-10T05:46:01.662Z monthly 0.5 https://novapharmanews.com/us/news/lupin-launches-generic-dapagliflozin-metformin-xr-tablets-us-xigduo-alternative 2026-06-10T05:46:00.157Z monthly 0.5 https://novapharmanews.com/us/news/sanofi-tzield-fda-approval-children-type-1-diabetes-delay 2026-06-10T06:05:16.371Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-sanofi-tzield-children-type-1-diabetes-delay 2026-06-10T05:46:03.909Z monthly 0.5 https://novapharmanews.com/eu/news/pharma-2026-eu-daily-roundup 2026-06-10T05:46:05.921Z monthly 0.5 https://novapharmanews.com/eu/news/pharma-2026-eu-day-1-roundup 2026-06-10T05:46:08.343Z monthly 0.5 https://novapharmanews.com/us/news/generic-drug-forum-us-market-access 2026-06-10T05:46:10.231Z monthly 0.5 https://novapharmanews.com/us/news/interphex-2026-biotech-innovations-day-1 2026-06-10T05:46:12.228Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2024-daily-oncology-research-roundup 2026-06-10T05:46:14.229Z monthly 0.5 https://novapharmanews.com/eu/news/pharma-news-purdue-sentencing-supply-chain-asco 2026-06-10T05:46:16.261Z monthly 0.5 https://novapharmanews.com/us/news/generic-drugs-forum-2026-fda-event-opens 2026-06-10T05:46:18.247Z monthly 0.5 https://novapharmanews.com/us/news/interphex-2026-avantor-biolife-aes-highlights 2026-06-10T05:46:20.238Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2024-oncology-news-day-1 2026-06-10T05:46:22.252Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2024-oncology-research-highlights-day-1 2026-06-10T05:46:24.251Z monthly 0.5 https://novapharmanews.com/eu/news/slas-europe-2026-lab-automation-screening 2026-06-10T08:51:11.998Z monthly 0.5 https://novapharmanews.com/eu/news/pharma-partnering-eu-2026-biotech-bdl-preview 2026-06-10T05:46:28.241Z monthly 0.5 https://novapharmanews.com/us/news/fda-redi-conference-2026-preview 2026-06-09T11:22:29.282Z monthly 0.5 https://novapharmanews.com/us/news/scopex-2026-causal-ai-ml-clinical-trials-preview 2026-06-10T05:46:32.246Z monthly 0.5 https://novapharmanews.com/us/news/pharma-manufacturing-innovation-us-2026 2026-06-10T05:46:34.243Z monthly 0.5 https://novapharmanews.com/eu/news/eu-pharma-innovation-trends-2026 2026-06-10T08:25:23.847Z monthly 0.5 https://novapharmanews.com/us/news/ispor-2026-cardiology-heor-preview 2026-06-10T05:46:38.263Z monthly 0.5 https://novapharmanews.com/us/news/bbsw-ai-solution-2026-biotech-preview 2026-06-10T05:46:40.252Z monthly 0.5 https://novapharmanews.com/us/news/bio-it-world-2026-ai-oncology-preview 2026-06-10T05:46:42.341Z monthly 0.5 https://novapharmanews.com/us/news/ispor-2026-heor-policy-pharma-pricing 2026-06-10T05:46:44.258Z monthly 0.5 https://novapharmanews.com/us/news/2nd-annual-cog-2026-pharma-preview 2026-06-10T05:46:46.277Z monthly 0.5 https://novapharmanews.com/us/news/biomed-israel-2026-preview 2026-06-10T05:46:48.260Z monthly 0.5 https://novapharmanews.com/us/news/asgct-2026-calidi-biotherapeutics-redtail-preview 2026-06-10T05:46:50.261Z monthly 0.5 https://novapharmanews.com/apac/news/pda-apac-pharma-manufacturing-trends-2026 2026-06-10T05:46:59.962Z monthly 0.5 https://novapharmanews.com/eu/news/isct-2026-cell-gene-therapy-manufacturing-dublin 2026-06-10T05:46:54.274Z monthly 0.5 https://novapharmanews.com/us/news/asgct-2026-gene-therapy-preview 2026-06-10T05:46:56.263Z monthly 0.5 https://novapharmanews.com/us/news/asgct-2026-gene-therapy-manufacturing-preview 2026-06-10T05:46:58.344Z monthly 0.5 https://novapharmanews.com/us/news/thma-cpe-circle-2026-pharma-exec-networking 2026-06-10T05:47:00.273Z monthly 0.5 https://novapharmanews.com/us/news/thma-oncology-forum-2026-pharma-insights 2026-06-10T05:47:02.283Z monthly 0.5 https://novapharmanews.com/eu/news/raps-euro-convergence-2026-eu-mdr-regulatory-tech 2026-06-10T05:47:14.881Z monthly 0.5 https://novapharmanews.com/eu/news/european-research-revolution-clinical-trial-tech 2026-06-10T05:47:17.123Z monthly 0.5 https://novapharmanews.com/us/news/aphl-2026-annual-preview 2026-06-10T05:47:08.271Z monthly 0.5 https://novapharmanews.com/eu/news/swiss-biotech-day-2026-preview 2026-06-10T05:47:17.186Z monthly 0.5 https://novapharmanews.com/us/news/excipient-world-2026-preview 2026-06-10T05:47:12.276Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-2026-biotech-dealmaking 2026-06-10T05:47:15.284Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-summit-2026-preview 2026-06-10T05:47:16.447Z monthly 0.5 https://novapharmanews.com/eu/news/eu-biopharma-clinical-trials-oncology-asco-aua 2026-06-10T05:47:18.616Z monthly 0.5 https://novapharmanews.com/us/news/clinical-outsourcing-trends-2026 2026-06-10T05:47:20.479Z monthly 0.5 https://novapharmanews.com/us/news/4th-annual-cog-preview 2026-06-10T05:47:22.486Z monthly 0.5 https://novapharmanews.com/apac/news/chinabio-partnering-forum-2026-apac-biotech-preview 2026-06-10T05:47:24.575Z monthly 0.5 https://novapharmanews.com/us/news/pharma-compliance-congress-2026-preview 2026-06-10T05:47:26.493Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2026-pembrolizumab-bowel-cancer-moderna-melanoma 2026-06-10T05:47:28.493Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2026-day3-immunotherapy-kras-mrna 2026-06-10T05:47:30.475Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-immunology-clinical-research-preview 2026-06-10T05:47:32.488Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-2024-preview 2026-06-10T05:47:34.483Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-2024-preview-eu 2026-06-10T05:47:36.485Z monthly 0.5 https://novapharmanews.com/apac/news/suvoda-agentic-ai-rtsm-clinical-trial-startup-reduction 2026-06-10T05:47:38.485Z monthly 0.5 https://novapharmanews.com/apac/news/dayspring-pharma-cg2001-foam-phase-ii-trial-androgenetic-alopecia-results 2026-06-10T05:47:40.590Z monthly 0.5 https://novapharmanews.com/apac/news/myome-board-appointments-healthcare-leaders-ai-genomics 2026-06-10T05:47:42.496Z monthly 0.5 https://novapharmanews.com/apac/news/synbiotech-l-plantarum-fs4722-hyperuricemia-prevention-preclinical 2026-06-10T05:47:44.502Z monthly 0.5 https://novapharmanews.com/apac/news/nasal-sprays-market-29-billion-2036-allergy-growth 2026-06-10T05:47:46.495Z monthly 0.5 https://novapharmanews.com/apac/news/andelyn-biosciences-encell-gene-therapy-manufacturing-partnership 2026-06-10T05:47:48.500Z monthly 0.5 https://novapharmanews.com/apac/news/turbine-crown-bioscience-ai-organoid-cancer-drug-discovery-partnership 2026-06-10T05:47:50.507Z monthly 0.5 https://novapharmanews.com/apac/news/australia-tga-medicinal-cannabis-pediatric-access-guidelines-2024 2026-06-10T05:47:52.499Z monthly 0.5 https://novapharmanews.com/apac/news/australia-tga-unapproved-therapeutic-goods-special-access-scheme-guidance 2026-06-10T08:26:14.539Z monthly 0.5 https://novapharmanews.com/apac/news/ghit-fund-invests-8-5-million-malaria-ntd-drug-development-gsk-eisai 2026-06-10T05:47:56.511Z monthly 0.5 https://novapharmanews.com/apac/news/ghit-fund-8-5-million-malaria-ntd-drug-development-gsk-eisai 2026-06-10T08:45:23.379Z monthly 0.5 https://novapharmanews.com/eu/news/kelun-biotech-sac-tmt-asco-2026-presentations 2026-06-10T05:48:09.815Z monthly 0.5 https://novapharmanews.com/eu/news/prescriberpoint-ai-prior-authorization-platform-clinician-acceptance-rate 2026-06-10T05:48:02.508Z monthly 0.5 https://novapharmanews.com/eu/news/grail-galleri-cancer-detection-asco-2026-results 2026-06-10T07:24:22.193Z monthly 0.5 https://novapharmanews.com/eu/news/eupraxia-pharmaceuticals-positive-resolve-trial-eosinophilic-esophagitis-data 2026-06-10T05:48:06.522Z monthly 0.5 https://novapharmanews.com/eu/news/cellcarta-regask-ai-platform-regulatory-compliance-efficiency 2026-06-10T07:33:32.575Z monthly 0.5 https://novapharmanews.com/eu/news/leerink-partners-medincell-outperform-uzedy-risperidone-lai-fda-approval 2026-06-10T05:48:19.483Z monthly 0.5 https://novapharmanews.com/eu/news/getinge-cardiohelp-ii-ce-mark-intergard-synergy-eu-mdr-approval 2026-06-10T06:44:03.553Z monthly 0.5 https://novapharmanews.com/eu/news/karyopharm-phase-3-sentry-trial-asco-2026-myelofibrosis 2026-06-10T05:48:14.511Z monthly 0.5 https://novapharmanews.com/eu/news/allogene-therapeutics-expands-cemacabtagene-ansegedleucel-alpha3-trial-south-korea-australia 2026-06-10T05:48:16.787Z monthly 0.5 https://novapharmanews.com/eu/news/biocon-health-canada-approval-denosumab-biosimilars-bosaya-vevzuo 2026-06-10T05:48:18.595Z monthly 0.5 https://novapharmanews.com/us/news/francis-medical-vanquish-prostate-ablation-midwest-first-procedure 2026-06-10T05:48:28.429Z monthly 0.5 https://novapharmanews.com/us/news/aquestive-therapeutics-anaphylm-fda-deficiencies-class-action-lawsuit 2026-06-10T05:48:23.115Z monthly 0.5 https://novapharmanews.com/us/news/efemoral-medical-bioresorbable-scaffold-97-percent-patency-peripheral-artery-disease 2026-06-10T05:48:24.557Z monthly 0.5 https://novapharmanews.com/us/news/kyverna-miv-cel-stiff-person-syndrome-trial-results-breakthrough 2026-06-10T05:48:26.544Z monthly 0.5 https://novapharmanews.com/us/news/invera-medical-90-percent-vein-closure-chronic-venous-disease-trial-results 2026-06-10T05:48:28.529Z monthly 0.5 https://novapharmanews.com/us/news/reva-medical-motiv-scaffold-superior-results-critical-limb-ischemia-trial 2026-06-10T05:48:30.556Z monthly 0.5 https://novapharmanews.com/us/news/ractigen-rag-17-als-phase-1-results-neurofilament-reduction 2026-06-10T05:48:32.556Z monthly 0.5 https://novapharmanews.com/us/news/mabwell-nectin-4-adc-bulumtatug-fuvedotin-cervical-cancer-nejm-case-report 2026-06-10T05:48:34.663Z monthly 0.5 https://novapharmanews.com/us/news/outlook-therapeutics-fda-dispute-resolution-lytenava-bevacizumab 2026-06-10T05:48:36.551Z monthly 0.5 https://novapharmanews.com/us/news/follicular-lymphoma-clinical-trials-45-companies-2026 2026-06-10T05:48:38.556Z monthly 0.5 https://novapharmanews.com/us/news/obsidian-therapeutics-obx-115-phase-2-melanoma-asco-2026 2026-06-10T05:48:40.541Z monthly 0.5 https://novapharmanews.com/us/news/icecure-medical-prosense-revenue-increases-30-percent-q1-2026 2026-06-10T05:48:42.546Z monthly 0.5 https://novapharmanews.com/us/news/nuvalent-neladalkib-alkove-1-trial-data-asco-2026-alk-positive-nsclc 2026-06-10T05:48:44.556Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-merck-idvynso-hiv-treatment-doravirine-islatravir 2026-06-10T07:53:55.846Z monthly 0.5 https://novapharmanews.com/apac/news/peptidream-asahi-kasei-ak1940-phase-1-clinical-trial 2026-06-10T05:48:48.542Z monthly 0.5 https://novapharmanews.com/apac/news/rznomics-rz-001-hepatocellular-carcinoma-trial-results-aacr-2026 2026-06-10T05:48:50.552Z monthly 0.5 https://novapharmanews.com/apac/news/biogen-acquires-felzartamab-tj-biopharma-china 2026-06-10T05:48:52.546Z monthly 0.5 https://novapharmanews.com/apac/news/argo-biopharma-bw-40202-phase-ii-trials-sirna-therapy 2026-06-10T05:48:54.550Z monthly 0.5 https://novapharmanews.com/apac/news/mabwell-bioscience-pics-gmp-inspection-denosumab-biosimilars-jordan 2026-06-10T05:48:56.552Z monthly 0.5 https://novapharmanews.com/apac/news/mabwell-t-mab-jordan-gmp-inspection-denosumab-biosimilars-approval 2026-06-10T05:48:58.564Z monthly 0.5 https://novapharmanews.com/apac/news/quality-executive-partners-vienni-virtuosi-india-pharmaceutical-training 2026-06-10T05:49:00.580Z monthly 0.5 https://novapharmanews.com/apac/news/synsmart-amporin-partnership-small-molecule-therapeutics-degenerative-diseases 2026-06-10T05:49:02.566Z monthly 0.5 https://novapharmanews.com/apac/news/australia-tga-otc-medicine-registration-guidelines-update 2026-06-10T05:49:07.236Z monthly 0.5 https://novapharmanews.com/apac/news/methylphenidate-shortage-update-concerta-ritalin-rubifen-supply-2026 2026-06-10T05:49:06.567Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-approves-peripheral-rotablator-pro-visual-ice-cryoablation-system-japan 2026-06-10T05:49:08.861Z monthly 0.5 https://novapharmanews.com/eu/news/cigna-healthcare-imuldosa-biosimilar-preferred-coverage-accord-biopharma 2026-06-10T05:49:14.942Z monthly 0.5 https://novapharmanews.com/eu/news/briacell-bria-ots-phase-3-breast-cancer-quality-life-aacr-2026 2026-06-10T05:49:12.862Z monthly 0.5 https://novapharmanews.com/eu/news/pharmaceutical-isolators-market-782-billion-eu-gmp-annex-1 2026-06-10T05:49:14.863Z monthly 0.5 https://novapharmanews.com/eu/news/mabwell-pics-gmp-compliance-jordan-fda-biopharmaceutical-manufacturing 2026-06-10T05:49:16.855Z monthly 0.5 https://novapharmanews.com/eu/news/implantica-refluxstop-device-safety-study-602-patients-europe 2026-06-10T05:49:18.905Z monthly 0.5 https://novapharmanews.com/eu/news/askbio-ametefgene-parvec-phase-ii-parkinson-gene-therapy 2026-06-10T08:16:41.546Z monthly 0.5 https://novapharmanews.com/us/news/lenz-therapeutics-vizz-presbyopia-uk-mhra-approval-submission 2026-06-10T05:49:22.869Z monthly 0.5 https://novapharmanews.com/us/news/pasithea-pas-004-fda-rare-pediatric-disease-designation-nf1 2026-06-10T05:49:24.858Z monthly 0.5 https://novapharmanews.com/us/news/clearmind-medicine-cmnd-100-safety-endpoint-alcohol-use-disorder-trial 2026-06-10T05:49:26.858Z monthly 0.5 https://novapharmanews.com/us/news/sapience-therapeutics-st316-phase-2-colorectal-cancer-results 2026-06-10T05:49:29.979Z monthly 0.5 https://novapharmanews.com/us/news/tozorakimab-phase-3-miranda-trial-copd-exacerbations-reduction 2026-06-10T05:49:39.509Z monthly 0.5 https://novapharmanews.com/us/news/abogen-abo2203-mrna-cancer-therapy-b-cell-lymphoma-trial-aacr-2026 2026-06-10T05:49:37.188Z monthly 0.5 https://novapharmanews.com/us/news/verismo-synkir-110-phase-1-trial-results-aacr-2026 2026-06-10T05:49:41.896Z monthly 0.5 https://novapharmanews.com/us/news/inhibrx-ozekibart-inbrx-109-colorectal-cancer-clinical-update-webcast 2026-06-10T05:49:45.066Z monthly 0.5 https://novapharmanews.com/us/news/akeso-cadonilimab-pancreatic-cancer-phase-2-trial-results 2026-06-10T05:49:46.158Z monthly 0.5 https://novapharmanews.com/us/news/debiopharm-lunresertib-fda-fast-track-ovarian-cancer 2026-06-10T05:49:40.871Z monthly 0.5 https://novapharmanews.com/us/news/adcendo-adce-t02-expansion-phase-adce-d01-fda-orphan-drug-designation 2026-06-10T05:49:42.866Z monthly 0.5 https://novapharmanews.com/us/news/fda-accepts-genentech-gazyva-lupus-treatment-application 2026-06-10T05:49:44.885Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-padcev-keytruda-bladder-cancer-astellas 2026-06-10T05:49:49.878Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-dermaclear-severe-acne-2026 2026-06-10T05:49:48.876Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-cell-therapy-multiple-sclerosis-2024 2026-06-10T05:49:50.872Z monthly 0.5 https://novapharmanews.com/us/news/fda-biosimilar-substitution-policy-update-2024 2026-06-10T05:49:52.885Z monthly 0.5 https://novapharmanews.com/eu/news/ema-biosimilar-policy-impact-2024 2026-06-10T05:49:54.884Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-paxlovid-covid19-treatment-eua-2024 2026-06-10T05:49:56.886Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-riabni-rituximab-biosimilar-nhl-2024 2026-06-10T07:54:34.432Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-adagrasib-kras-g12c-nsclc-2024 2026-06-10T05:50:00.888Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-apretude-injectable-prep-hiv-2024 2026-06-10T07:08:05.695Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-skin-renew-new-indication-severe-eczema-2024 2026-06-10T05:50:04.882Z monthly 0.5 https://novapharmanews.com/us/news/fda-update-diabetes-therapy-label-warning-2024 2026-06-10T05:50:06.888Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-genopharm-geno-cure-targeted-cancer-2024 2026-06-10T05:50:08.891Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-allerclear-otc-seasonal-allergies-2024 2026-06-10T05:50:10.921Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-bact-away-antibiotic-resistant-infections-2024 2026-06-10T05:50:12.898Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-algorithma-algo-1-trd-2024 2026-06-10T05:50:17.011Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-trial-update-semaglutide-obesity-2024 2026-06-10T05:50:16.896Z monthly 0.5 https://novapharmanews.com/apac/news/alamar-biosciences-nasdaq-ipo-precision-proteomics-debut 2026-06-10T05:50:18.924Z monthly 0.5 https://novapharmanews.com/apac/news/act-genomics-101-gene-panel-cancer-testing-upgrade-2026 2026-06-10T05:50:20.965Z monthly 0.5 https://novapharmanews.com/apac/news/qdenga-dengue-vaccine-approved-australia-tga-four-serotypes 2026-06-10T05:50:22.927Z monthly 0.5 https://novapharmanews.com/eu/news/ema-iris-psur-submission-requirements-september-2025 2026-06-10T05:50:24.956Z monthly 0.5 https://novapharmanews.com/us/news/revolution-medicines-zoldonrasib-phase-1-data-kras-g12d-lung-cancer-aacr-2026 2026-06-10T05:50:26.920Z monthly 0.5 https://novapharmanews.com/us/news/epibiologics-epi-326-phase-1-trial-egfr-cancer 2026-06-10T05:50:28.931Z monthly 0.5 https://novapharmanews.com/us/news/sbc-medical-group-secondary-offering-3-1-million-shares 2026-06-10T05:50:31.003Z monthly 0.5 https://novapharmanews.com/us/news/fda-terminates-gas-delivery-engine-ventilator-recall-16650a 2026-06-10T06:56:18.454Z monthly 0.5 https://novapharmanews.com/us/news/philip-morris-iqos-fda-reauthorization-modified-risk-tobacco-product 2026-06-10T05:50:34.998Z monthly 0.5 https://novapharmanews.com/us/news/ascentage-pharma-preclinical-cancer-studies-aacr-2026 2026-06-10T05:50:46.664Z monthly 0.5 https://novapharmanews.com/us/news/whitehawk-therapeutics-hwk-007-adc-data-aacr-2026 2026-06-10T05:50:38.945Z monthly 0.5 https://novapharmanews.com/us/news/pulnovo-medical-100-million-medtronic-investment-pulmonary-hypertension 2026-06-10T05:50:40.935Z monthly 0.5 https://novapharmanews.com/us/news/nuance-pharma-ohtuvayre-enhance-china-phase-3-copd-results-chest-journal 2026-06-10T05:50:42.926Z monthly 0.5 https://novapharmanews.com/us/news/lundbeck-vyepti-migraine-cognitive-symptoms-infuse-study-2026 2026-06-10T08:27:09.618Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-biosimilar-clone-remicade-2026 2026-06-10T05:50:46.940Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-arterioflow-pad-2024 2026-06-10T05:50:48.934Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-v-protect-vaccine-2026 2026-06-10T05:50:50.935Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-inno-med-inhaler-tech-asthma-2024 2026-06-10T05:50:56.452Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-duo-boost-type-2-diabetes-2024 2026-06-10T05:50:55.056Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-rgen-101-raregen-orphan-drug-2024 2026-06-10T05:50:56.947Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-inflammex-ulcerative-colitis-2026 2026-06-10T05:50:58.938Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-synapton-alzheimers-2026 2026-06-10T05:51:00.956Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-generic-epipen-mylan-2024 2026-06-10T05:51:02.953Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-prevnar-20-pediatric-indication-2024 2026-06-10T05:51:04.943Z monthly 0.5 https://novapharmanews.com/apac/news/zai-lab-zl-1503-bispecific-antibody-itch-relief-atopic-diseases 2026-06-10T05:51:06.948Z monthly 0.5 https://novapharmanews.com/apac/news/zai-lab-zl-1503-bispecific-antibody-atopic-disease-itch-relief-preclinical-data 2026-06-10T05:51:08.963Z monthly 0.5 https://novapharmanews.com/apac/news/antengene-novel-cancer-programs-aacr-2026-adc-tce-therapies 2026-06-10T05:51:10.950Z monthly 0.5 https://novapharmanews.com/apac/news/antengene-adc-antengager-tce-programs-aacr-2026 2026-06-10T05:51:12.957Z monthly 0.5 https://novapharmanews.com/apac/news/australia-tga-therapeutic-vaping-pharmacy-access-regulatory-framework 2026-06-10T05:51:14.964Z monthly 0.5 https://novapharmanews.com/apac/news/tga-medical-device-regulations-ai-software-therapeutic-products-australia 2026-06-10T05:51:16.975Z monthly 0.5 https://novapharmanews.com/eu/news/adagene-muzastotug-triple-combination-therapy-hepatocellular-carcinoma-aacr-2026 2026-06-10T05:51:18.966Z monthly 0.5 https://novapharmanews.com/eu/news/hytn-innovations-hard-cannabis-remediation-technology-gmp-processing-germany 2026-06-10T05:51:20.965Z monthly 0.5 https://novapharmanews.com/eu/news/sanofi-nuvaxovid-covid-vaccine-better-tolerability-mnexspike-phase-4-study 2026-06-10T05:51:22.967Z monthly 0.5 https://novapharmanews.com/eu/news/brand-institute-ema-approval-ai-pharmaceutical-branding-brandi-platform 2026-06-10T05:51:24.958Z monthly 0.5 https://novapharmanews.com/eu/news/ema-drug-patent-cliff-2026-european-exclusivities-expire 2026-06-10T05:51:26.966Z monthly 0.5 https://novapharmanews.com/eu/news/ema-chmp-recommends-six-new-medicines-approval-february-2024 2026-06-10T05:51:28.969Z monthly 0.5 https://novapharmanews.com/eu/news/ema-recommends-adstiladrin-gene-therapy-bladder-cancer-march-2026 2026-06-10T05:51:31.071Z monthly 0.5 https://novapharmanews.com/us/news/health-canada-approves-bracco-vueway-gadopiclenol-mri-contrast 2026-06-10T05:51:32.972Z monthly 0.5 https://novapharmanews.com/us/news/salubris-jk06-phase-1-2-cancer-trial-aacr-2024 2026-06-10T05:51:34.970Z monthly 0.5 https://novapharmanews.com/us/news/innate-pharma-iph5201-matisse-phase-2-aacr-2026-plenary-session 2026-06-10T05:51:36.974Z monthly 0.5 https://novapharmanews.com/us/news/accent-therapeutics-atx-295-kif18a-inhibitor-aacr-2026-cancer-data 2026-06-10T05:51:38.972Z monthly 0.5 https://novapharmanews.com/us/news/zai-lab-zl-1503-bispecific-antibody-atopic-disease-itch-relief 2026-06-10T05:51:40.973Z monthly 0.5 https://novapharmanews.com/us/news/zai-lab-zl-1503-bispecific-antibody-itch-relief-atopic-dermatitis-preclinical 2026-06-10T05:51:42.982Z monthly 0.5 https://novapharmanews.com/us/news/fda-reauthorizes-philip-morris-iqos-modified-risk-tobacco-product 2026-06-10T05:51:44.971Z monthly 0.5 https://novapharmanews.com/us/news/zai-lab-zl-1503-bispecific-antibody-itch-relief-atopic-disease-preclinical-data 2026-06-10T05:51:46.989Z monthly 0.5 https://novapharmanews.com/us/news/olema-oncology-palazestrant-op-3136-preclinical-data-aacr-2026 2026-06-10T05:51:48.995Z monthly 0.5 https://novapharmanews.com/us/news/ucb-acquires-neurona-therapeutics-nrtx-1001-epilepsy-cell-therapy 2026-06-10T05:52:01.550Z monthly 0.5 https://novapharmanews.com/us/news/xodus-medical-fda-clearance-hot-pink-pad-surgical-temperature-management 2026-06-10T05:51:57.780Z monthly 0.5 https://novapharmanews.com/us/news/argenx-vyvgart-myasthenia-gravis-cidp-aan-2026-clinical-data 2026-06-10T05:51:59.694Z monthly 0.5 https://novapharmanews.com/us/news/nuvalent-zidesamtinib-ros1-lung-cancer-aacr-2026 2026-06-10T05:52:08.980Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-verapamil-extended-release-hypertension-2024 2026-06-10T05:52:10.840Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-imgn-901-breakthrough-therapy-aml-2026 2026-06-10T05:52:00.996Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-revitan-gene-therapy-sma-type-3-2026 2026-06-10T05:52:03.087Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-mito-x-accelerated-approval-2024 2026-06-10T05:52:05.542Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-xylocor-refractory-angina-2026 2026-06-10T05:52:08.254Z monthly 0.5 https://novapharmanews.com/apac/news/atara-biotherapeutics-class-action-lawsuit-atra-stockholders-losses 2026-06-10T05:52:09.197Z monthly 0.5 https://novapharmanews.com/eu/news/ema-approves-hanmi-hmpl-523-alzheimer-herbal-medicine 2026-06-10T05:52:11.195Z monthly 0.5 https://novapharmanews.com/eu/news/gene-therapy-market-growth-crispr-aav-technologies-2034 2026-06-10T05:52:13.194Z monthly 0.5 https://novapharmanews.com/eu/news/healthcare-cold-chain-logistics-market-growth-2034-biopharmaceuticals-asia-pacific 2026-06-10T05:52:15.200Z monthly 0.5 https://novapharmanews.com/eu/news/aim-immunotech-ampligen-phase-3-pancreatic-cancer-trial-orphan-drug 2026-06-10T05:52:17.199Z monthly 0.5 https://novapharmanews.com/eu/news/ab-science-masitinib-als-phase-3-trial-insurance-25-million 2026-06-10T05:52:19.200Z monthly 0.5 https://novapharmanews.com/eu/news/meiragTx-acquires-botaretigene-sparoparvovec-gene-therapy-xlrp-johnson-johnson 2026-06-10T05:52:21.204Z monthly 0.5 https://novapharmanews.com/eu/news/beamion-zongertinib-fda-approval-her2-mutant-nsclc-lung-1-study 2026-06-10T05:52:25.432Z monthly 0.5 https://novapharmanews.com/eu/news/tri-611-fda-fast-track-alk-positive-nsclc-eisai-taletrectinib 2026-06-10T05:52:25.211Z monthly 0.5 https://novapharmanews.com/us/news/maia-biotechnology-phase-2-nsclc-telomere-treatment-trial-us-site 2026-06-10T05:52:36.447Z monthly 0.5 https://novapharmanews.com/us/news/dr-falk-pharma-renexxion-naronapride-phase-2b-gastroparesis-ddw-2026 2026-06-10T05:52:49.270Z monthly 0.5 https://novapharmanews.com/us/news/lilly-foundayo-orforglipron-achieve-4-trial-results-mortality-reduction 2026-06-10T05:52:31.215Z monthly 0.5 https://novapharmanews.com/us/news/aicuris-pritelivir-fda-priority-review-herpes-treatment 2026-06-10T07:58:25.494Z monthly 0.5 https://novapharmanews.com/us/news/medera-aav-serca2a-fda-fast-track-duchenne-cardiomyopathy 2026-06-10T05:52:35.212Z monthly 0.5 https://novapharmanews.com/us/news/boehringer-ingelheim-zongertinib-her2-mutant-lung-cancer-nejm-study 2026-06-10T05:52:37.284Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-mindbalance-digital-therapeutic-2026 2026-06-10T07:50:21.459Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-cancervax-adjuvant-melanoma-2026 2026-06-10T05:52:42.400Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-painblock-patch-chronic-pain-2024 2026-06-10T05:52:43.207Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-renalprotect-expanded-use-dkd-2024 2026-06-10T05:52:45.219Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-lungrx-inhaled-therapy-pulmonary-hypertension-2026 2026-06-10T05:52:47.224Z monthly 0.5 https://novapharmanews.com/apac/news/sanyou-ai-stal-2-antibody-discovery-14-days-drug-development 2026-06-10T05:52:49.223Z monthly 0.5 https://novapharmanews.com/apac/news/gene-expression-analysis-market-593-billion-2031-drug-discovery 2026-06-10T05:52:51.229Z monthly 0.5 https://novapharmanews.com/apac/news/perceptive-discovery-mh3d-alpha-sight-radiopharmaceutical-imaging 2026-06-10T05:53:02.652Z monthly 0.5 https://novapharmanews.com/apac/news/pg-health-apac-pharmacist-guidelines-peripheral-neuropathy-management 2026-06-10T05:52:55.214Z monthly 0.5 https://novapharmanews.com/apac/news/tga-assessed-listed-medicines-framework-update-australia 2026-06-10T05:52:57.237Z monthly 0.5 https://novapharmanews.com/apac/news/corcept-therapeutics-relacorilant-fda-rejection-investor-lawsuit-2025 2026-06-10T05:52:59.274Z monthly 0.5 https://novapharmanews.com/apac/news/florida-cancer-specialists-medically-integrated-oncology-care-2024 2026-06-10T05:53:01.251Z monthly 0.5 https://novapharmanews.com/eu/news/traws-pharma-tivoxavir-marboxil-influenza-trial-ratutrelvir-covid-results-2025 2026-06-10T05:53:03.269Z monthly 0.5 https://novapharmanews.com/eu/news/tme-pharma-nox-a12-triple-therapy-brain-cancer-gloria-trial-nature-communications 2026-06-10T05:53:05.266Z monthly 0.5 https://novapharmanews.com/eu/news/additional-risk-minimization-measures-armms-training-course-patient-safety 2026-06-10T05:53:07.267Z monthly 0.5 https://novapharmanews.com/eu/news/healthcare-logistics-market-growth-159-billion-2030-biopharmaceutical-cold-chain 2026-06-10T05:53:21.851Z monthly 0.5 https://novapharmanews.com/eu/news/medical-device-software-compliance-training-eu-mdr-ivdr-fda-june-2026 2026-06-10T05:53:11.265Z monthly 0.5 https://novapharmanews.com/eu/news/onward-medical-40-million-capital-increase-eqt-life-sciences 2026-06-10T05:53:17.293Z monthly 0.5 https://novapharmanews.com/eu/news/sahpra-african-medicines-agency-regulatory-harmonization-course-may-2026 2026-06-10T05:53:21.536Z monthly 0.5 https://novapharmanews.com/eu/news/bavarian-nordic-vimkunya-chikungunya-vaccine-swiss-approval-swissmedic 2026-06-10T05:53:17.267Z monthly 0.5 https://novapharmanews.com/eu/news/seragon-srn-901-longevity-drug-lifespan-extension-preclinical-study 2026-06-10T05:53:19.273Z monthly 0.5 https://novapharmanews.com/us/news/fda-food-additive-contact-substance-regulatory-updates-2026 2026-06-10T05:53:21.263Z monthly 0.5 https://novapharmanews.com/us/news/recognition-health-alzheimers-blood-test-clinical-trial-2026 2026-06-10T05:53:23.323Z monthly 0.5 https://novapharmanews.com/us/news/mabwell-maiweijian-denosumab-nmpa-acceptance-cancer-bone-metastases 2026-06-10T05:53:25.320Z monthly 0.5 https://novapharmanews.com/us/news/sedogen-diazoxide-patent-prader-willi-syndrome-behavioral-symptoms 2026-06-10T05:53:27.510Z monthly 0.5 https://novapharmanews.com/us/news/mabwell-lilrb4-cd3-bispecific-antibody-6mw5311-nmpa-ind-approval-leukemia 2026-06-10T05:53:30.676Z monthly 0.5 https://novapharmanews.com/us/news/mabwell-maiweijian-denosumab-nmpa-acceptance-cancer-bone-treatment 2026-06-10T05:53:31.350Z monthly 0.5 https://novapharmanews.com/us/news/thinktrends-ai-federal-health-agency-adverse-event-monitoring-system 2026-06-10T05:53:33.335Z monthly 0.5 https://novapharmanews.com/us/news/fullscript-journeys-digital-health-platform-launch-2024 2026-06-10T05:53:35.329Z monthly 0.5 https://novapharmanews.com/us/news/nexalin-technology-fda-alzheimers-strategy-meetings-china-us 2026-06-10T05:53:49.272Z monthly 0.5 https://novapharmanews.com/us/news/immunitybio-ibrx-fda-warning-letter-class-action-lawsuit-ankt 2026-06-10T05:53:39.339Z monthly 0.5 https://novapharmanews.com/us/news/fda-warning-letters-pharmaceutical-compliance-drug-safety-2024 2026-06-10T05:53:41.333Z monthly 0.5 https://novapharmanews.com/us/news/gsk-depemokimab-european-chinese-approval-ultra-long-acting-biologic 2026-06-10T05:53:43.356Z monthly 0.5 https://novapharmanews.com/us/news/elion-therapeutics-turletricin-phase-2-trial-invasive-mold-infections 2026-06-10T05:53:45.339Z monthly 0.5 https://novapharmanews.com/us/news/glaukos-epioxa-permanent-j-code-j2789-cms-approval 2026-06-10T06:19:31.553Z monthly 0.5 https://novapharmanews.com/us/news/nkarta-fda-approval-outpatient-nkx019-dosing-autoimmune-disease 2026-06-10T05:53:49.340Z monthly 0.5 https://novapharmanews.com/apac/news/phantom-neuro-phantom-x-first-human-trial-approval-australia 2026-06-10T05:53:51.345Z monthly 0.5 https://novapharmanews.com/eu/news/boehringer-ingelheim-zai-lab-dll3-targeting-combination-therapy-small-cell-lung-cancer-trial 2026-06-10T05:53:53.359Z monthly 0.5 https://novapharmanews.com/eu/news/imvt-1402-myasthenia-gravis-treatment-pipeline-2026 2026-06-10T05:53:55.341Z monthly 0.5 https://novapharmanews.com/us/news/dogwood-therapeutics-sp16-fda-ind-approval-chemotherapy-pain 2026-06-10T05:53:57.349Z monthly 0.5 https://novapharmanews.com/us/news/pds-biotech-pds01adc-78-percent-response-rate-colorectal-cancer-phase-2 2026-06-10T05:53:59.349Z monthly 0.5 https://novapharmanews.com/us/news/neffy-epinephrine-nasal-spray-approved-canada-needle-free-anaphylaxis-treatment 2026-06-10T05:54:01.352Z monthly 0.5 https://novapharmanews.com/us/news/cala-fda-clearance-kiq-plus-wearable-device-essential-tremor-parkinsons 2026-06-10T08:15:33.596Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-rapiblyk-landiolol-pediatric-svt-aop-health 2026-06-10T05:54:05.355Z monthly 0.5 https://novapharmanews.com/us/news/asco-2026-gi-innovation-gi-101a-phase-1-data-preview 2026-06-10T05:54:07.379Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-sleepwell-chronic-insomnia-2026 2026-06-10T05:54:09.359Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-nanopharm-metastatic-breast-cancer-2024 2026-06-10T05:54:11.359Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-fluguard-novel-influenza-vaccine-2026 2026-06-10T05:54:22.838Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-cardiodetect-ai-diagnostic-arrhythmia-2026 2026-06-10T06:15:52.242Z monthly 0.5 https://novapharmanews.com/apac/news/phrontline-biopharma-tj106-her2-adc-preclinical-data-aacr-2026 2026-06-10T05:54:24.077Z monthly 0.5 https://novapharmanews.com/apac/news/xellsmart-xs411-parkinsons-cell-therapy-phase-ii-trial-2026 2026-06-10T05:54:21.046Z monthly 0.5 https://novapharmanews.com/apac/news/peer-ai-regulatory-platform-predictive-intelligence-life-sciences 2026-06-10T05:54:32.401Z monthly 0.5 https://novapharmanews.com/apac/news/wuxi-biologics-iso-13485-certification-drug-device-combination-products 2026-06-10T05:54:31.848Z monthly 0.5 https://novapharmanews.com/apac/news/atelerix-jh-health-partnership-cell-preservation-middle-east 2026-06-10T05:54:31.861Z monthly 0.5 https://novapharmanews.com/apac/news/chitosan-market-growth-kitozyme-primex-pharmaceutical-biopolymer-2036 2026-06-10T05:54:27.520Z monthly 0.5 https://novapharmanews.com/apac/news/telix-tlx101-tx-phase-3-glioblastoma-trial-first-patient 2026-06-10T05:54:29.519Z monthly 0.5 https://novapharmanews.com/apac/news/nmn-500mg-energy-support-tga-approval-australia 2026-06-10T05:54:31.502Z monthly 0.5 https://novapharmanews.com/eu/news/drug-development-services-market-31-billion-2026-pharma-rd-investments 2026-06-10T05:54:33.514Z monthly 0.5 https://novapharmanews.com/eu/news/medicenna-bizaxofusp-brain-cancer-trials-2026-investor-conference 2026-06-10T05:54:35.717Z monthly 0.5 https://novapharmanews.com/eu/news/vitestro-autonomous-robotic-phlebotomy-device-clinical-trial-results 2026-06-10T05:54:37.518Z monthly 0.5 https://novapharmanews.com/eu/news/grace-therapeutics-gtx-104-phase-3-strive-on-trial-aan-2026 2026-06-10T05:54:43.200Z monthly 0.5 https://novapharmanews.com/eu/news/mena-medical-device-regulatory-training-course-may-2026 2026-06-10T05:54:41.517Z monthly 0.5 https://novapharmanews.com/eu/news/cmo-cdmo-market-growth-biologics-manufacturing-2035 2026-06-10T05:54:43.522Z monthly 0.5 https://novapharmanews.com/eu/news/clinical-trial-monitoring-gcp-compliance-course-2026 2026-06-10T05:54:45.810Z monthly 0.5 https://novapharmanews.com/eu/news/gcp-inspections-training-course-ich-e6-r3-eu-ctr-compliance-july-2026 2026-06-10T05:54:47.812Z monthly 0.5 https://novapharmanews.com/eu/news/vabysmo-market-report-2026-roche-eye-drug-growth-forecast 2026-06-10T05:54:49.810Z monthly 0.5 https://novapharmanews.com/eu/news/glyconex-gnx1021-pmda-approval-phase-1-trial-gastrointestinal-cancers 2026-06-10T08:00:30.826Z monthly 0.5 https://novapharmanews.com/us/news/psoriasis-clinical-trial-pipeline-90-companies-2026 2026-06-10T05:54:53.811Z monthly 0.5 https://novapharmanews.com/us/news/meiragTx-aav-haqp1-gene-therapy-xerostomia-3-year-data-april-2026 2026-06-10T05:54:55.799Z monthly 0.5 https://novapharmanews.com/us/news/corbus-pharmaceuticals-crb-913-obesity-drug-canyon-1-trial-enrollment-complete 2026-06-10T05:54:57.825Z monthly 0.5 https://novapharmanews.com/us/news/actuate-therapeutics-elraglusib-pancreatic-cancer-survival-nature-medicine 2026-06-10T05:54:59.817Z monthly 0.5 https://novapharmanews.com/us/news/dupont-amberchrom-xt-sl-chromatography-resins-biopharmaceutical-manufacturing 2026-06-10T05:55:01.906Z monthly 0.5 https://novapharmanews.com/us/news/vasa-therapeutics-lilly-tunelab-ai-camkii-inhibitor-partnership 2026-06-10T05:55:03.810Z monthly 0.5 https://novapharmanews.com/us/news/synusight-biotech-sst001-alpha-synuclein-pet-tracer-nmpa-approval-phase-1-trial 2026-06-10T05:55:05.811Z monthly 0.5 https://novapharmanews.com/us/news/oryon-cell-therapies-appoints-burkhard-blank-chief-medical-officer 2026-06-10T05:55:07.817Z monthly 0.5 https://novapharmanews.com/us/news/amneal-launches-albuterol-beclomethasone-respiratory-inhalers-2026 2026-06-10T05:55:20.120Z monthly 0.5 https://novapharmanews.com/us/news/bright-path-fy2027-budget-domestic-pharmaceutical-manufacturing 2026-06-10T05:55:11.817Z monthly 0.5 https://novapharmanews.com/us/news/partner-therapeutics-bizengri-fda-application-cholangiocarcinoma-nrg1-fusion 2026-06-10T05:55:13.824Z monthly 0.5 https://novapharmanews.com/us/news/clearmind-medicine-cmnd-100-alcohol-use-disorder-trial-results 2026-06-10T05:55:15.818Z monthly 0.5 https://novapharmanews.com/us/news/praxis-precision-medicines-fda-accepts-ulixacaltamide-hcl-essential-tremor-nda 2026-06-10T07:22:40.028Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-filspari-sparsentan-fsgs-first-treatment-rare-kidney-disease 2026-06-10T05:55:19.823Z monthly 0.5 https://novapharmanews.com/us/news/apotex-fda-approval-generic-infuvite-adult-injection-exclusivity 2026-06-10T05:55:21.843Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-orphan-drug-rarecure-ert-2026 2026-06-10T05:55:23.816Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-migraease-new-migraine-drug-2024 2026-06-10T05:55:31.210Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-expanded-indication-elahere-2024 2026-06-10T05:55:27.824Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-cardioshield-hfpef-2026 2026-06-10T05:55:29.827Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-vitacorp-antibiotic-priority-review-2024 2026-06-10T05:55:32.829Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-neurovance-xr-pediatric-adhd-2026 2026-06-10T05:55:33.837Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-lumagen-gene-therapy-2024 2026-06-10T05:55:46.130Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-biosimilar-insulin-lispro-biosolve-2026 2026-06-10T06:26:05.427Z monthly 0.5 https://novapharmanews.com/us/news/fda-accelerated-approval-oncocure-trk-inhibitor-2024 2026-06-10T05:55:39.833Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-cart-t20-car-t-therapy-mantle-cell-lymphoma-2026 2026-06-10T05:55:41.842Z monthly 0.5 https://novapharmanews.com/eu/news/ema-implement-ai-system-drug-safety-2024 2026-06-10T05:55:43.834Z monthly 0.5 https://novapharmanews.com/eu/news/european-commission-launches-blockchain-pilot-pharmaceutical-supply-chain-2024 2026-06-10T05:55:51.318Z monthly 0.5 https://novapharmanews.com/apac/news/nmepa-priority-review-ai-diagnostic-early-cancer-2024 2026-06-10T05:55:47.841Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-approval-ai-platform-personalized-medicine-oncology-2024 2026-06-10T05:55:49.844Z monthly 0.5 https://novapharmanews.com/us/news/fda-launches-blockchain-pilot-program-pharmaceutical-supply-chain-2024 2026-06-10T05:55:51.838Z monthly 0.5 https://novapharmanews.com/us/news/fda-implement-ai-powered-expedited-drug-review-2027 2026-06-10T05:55:53.849Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-renoprotect-diabetic-kidney-disease-therapy-2024 2026-06-10T05:55:55.860Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-airflow-inhalable-severe-asthma-2026 2026-06-10T05:55:57.840Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-osteobuild-bone-building-agent-severe-osteoporosis-2026 2026-06-10T06:19:40.707Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-arterioflow-peripheral-artery-disease-2026 2026-06-10T05:56:01.871Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-cholesterolrx-high-cholesterol-2024 2026-06-10T05:56:03.857Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-opti-sight-glaucoma-2026 2026-06-10T05:56:05.845Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-microbalance-crohns-disease-2026 2026-06-10T05:56:07.879Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-somnirestore-chronic-insomnia-2026 2026-06-10T05:56:09.847Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-neurobloc-non-opioid-pain-reliever-2026 2026-06-10T07:07:38.600Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-lysoclear-lysosomal-storage-disorders-2026 2026-06-10T05:56:13.874Z monthly 0.5 https://novapharmanews.com/eu/news/ema-conditional-approval-car-t-relapsed-b-cell-lymphoma-2024 2026-06-10T05:56:15.942Z monthly 0.5 https://novapharmanews.com/us/news/fda-breakthrough-therapy-targtex-tx202-glioblastoma-2024 2026-06-10T05:56:17.851Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-bria-cell-bria-imt-car-t-therapy-advanced-breast-cancer-2024 2026-06-10T05:56:24.321Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-zepzelca-lurbinectedin-cancer-treatment 2026-06-10T05:56:21.857Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-amgen-tarlatamab-imdylltra-small-cell-lung-cancer 2026-06-10T05:56:23.851Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-adstiladrin-gene-therapy-bladder-cancer 2026-06-10T05:56:25.857Z monthly 0.5 https://novapharmanews.com/eu/news/ema-recommends-imdylltra-tarlatamab-small-cell-lung-cancer-approval 2026-06-10T07:21:13.167Z monthly 0.5 https://novapharmanews.com/eu/news/ema-virtual-control-groups-reduce-animal-testing-drug-development 2026-06-10T05:56:29.861Z monthly 0.5 https://novapharmanews.com/us/news/fda-manufacturing-precheck-pilot-program-streamline-oversight 2026-06-10T05:56:31.869Z monthly 0.5 https://novapharmanews.com/us/news/real-world-evidence-transforms-drug-development-fda-regulatory-framework 2026-06-10T05:56:41.853Z monthly 0.5 https://novapharmanews.com/us/news/fda-untitled-letters-pharmaceutical-marketing-violations-database 2026-06-10T05:56:35.867Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-higher-dose-wegovy-7-2mg-weight-loss-priority-review 2026-06-10T06:38:32.814Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-avlayah-hunter-syndrome-neurologic-treatment 2026-06-10T05:56:39.874Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-kresladi-first-gene-therapy-lad-i-leukocyte-adhesion-deficiency 2026-06-10T05:56:41.876Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-foundayo-orforglipron-priority-voucher-program 2026-06-10T05:56:43.885Z monthly 0.5 https://novapharmanews.com/eu/news/ema-analysis-ai-pharma-rd-investment-2024 2026-06-10T05:56:46.001Z monthly 0.5 https://novapharmanews.com/eu/news/ema-accelerated-assessment-novel-mrna-vaccine-platforms-2024 2026-06-10T05:56:47.880Z monthly 0.5 https://novapharmanews.com/eu/news/ema-approval-gene-therapies-neurological-disorders-2024 2026-06-10T05:57:00.419Z monthly 0.5 https://novapharmanews.com/eu/news/ema-clinical-trials-regulation-rare-disease-2026 2026-06-10T05:57:01.690Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-dermtech-skinguard-severe-eczema-2026 2026-06-10T05:57:02.346Z monthly 0.5 https://novapharmanews.com/eu/news/ema-blockchain-pharmaceutical-supply-chain-2024 2026-06-10T05:56:55.890Z monthly 0.5 https://novapharmanews.com/eu/news/ema-gdpr-impact-pharmaceutical-data-2024 2026-06-10T05:56:57.882Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-data-integrity-requirements-guide-2024 2026-06-10T05:56:59.893Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-cognimax-alzheimers-2026 2026-06-10T05:57:01.892Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-vitarestrore-age-related-macular-degeneration-2026 2026-06-10T05:57:03.891Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-nasoclear-pediatric-rsv-2026 2026-06-10T05:57:05.890Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-revitalize-chronic-fatigue-syndrome-2026 2026-06-10T06:48:28.821Z monthly 0.5 https://novapharmanews.com/eu/news/ema-ai-powered-clinical-trial-matching-patient-recruitment-2024 2026-06-10T05:57:10.279Z monthly 0.5 https://novapharmanews.com/eu/news/ema-regulatory-outlook-digital-therapeutics-europe-2024 2026-06-10T06:36:42.094Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-ai-clinical-trial-matching-china-2024 2026-06-10T05:57:14.151Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-telemedicine-apac-opportunities-challenges-2024 2026-06-10T05:57:16.138Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-genecorrect-gene-therapy-cystic-fibrosis-2026 2026-06-10T05:57:18.153Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-myorepair-breakthrough-therapy-2026 2026-06-10T05:57:20.143Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-oncoblock-refractory-aml-2024 2026-06-10T08:36:55.345Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-xylocor-nda-advanced-melanoma-2024 2026-06-10T05:57:24.161Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-repatha-evolocumab-cardiovascular-prevention-2024 2026-06-10T05:57:26.154Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-tecentriq-atezolizumab-es-sclc-2024 2026-06-10T05:57:37.520Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-opdivo-nivolumab-advanced-rcc-2024 2026-06-10T05:57:30.154Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-keytruda-adjuvant-stage-iii-melanoma-2024 2026-06-10T05:57:32.158Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-aduhelm-alzheimers-2021 2026-06-10T05:57:40.327Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-dupixent-eosinophilic-esophagitis-2024 2026-06-10T05:57:36.167Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-johnson-johnson-stelara-ulcerative-colitis-2024 2026-06-10T05:57:38.165Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-imfinzi-durvalumab-stage-iii-nsclc-2024 2026-06-10T05:57:40.162Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-trikafta-cystic-fibrosis-children-2024 2026-06-10T07:17:59.451Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-mounjaro-weight-management-2024 2026-06-10T08:49:47.167Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-cosentyx-hidradenitis-suppurativa-2024 2026-06-10T08:42:06.032Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-moderna-mrna-1345-rsv-vaccine-2024 2026-06-10T05:57:48.168Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-zithromax-pediatric-cap-2026 2026-06-10T05:57:50.166Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-revivcor-etanercept-biosimilar-heart-failure-2024 2026-06-10T05:58:01.484Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-breakthrough-innovent-kras-g12c-inhibitor-2024 2026-06-10T05:57:54.166Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-accepts-shionogi-influenza-drug-sakigake-2024 2026-06-10T08:02:18.435Z monthly 0.5 https://novapharmanews.com/apac/news/cdsco-policy-changes-generics-market-growth-india-2024 2026-06-10T05:58:10.496Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-sakigake-designation-regenerative-medicine-market-access-2024 2026-06-10T07:59:58.299Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-priority-review-pathway-innovative-drug-approvals-2024 2026-06-10T05:58:02.210Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-inhalex-copd-2026 2026-06-10T06:42:19.275Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-rapiclot-tranexamic-acid-trauma-2026 2026-06-10T08:03:57.165Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-tarzenta-advanced-her2-negative-breast-cancer-2024 2026-06-10T05:58:18.856Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-ritempro-parkinsons-2026 2026-06-10T05:58:16.804Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-expedited-review-novel-melanoma-therapies-2024 2026-06-10T05:58:12.190Z monthly 0.5 https://novapharmanews.com/apac/news/tga-innovation-report-australian-biotech-solid-tumor-car-t-2024 2026-06-10T05:58:14.188Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-tevimbra-tislelizumab-escc-2024 2026-06-10T05:58:16.192Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-wainua-eplontersen-hattr-pn-2024 2026-06-10T05:58:18.203Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-sanofi-altuviiio-hemophilia-a-2024 2026-06-10T05:58:20.263Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-augtyro-repotrectinib-ros1-nsclc-2024 2026-06-10T05:58:22.205Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-litfulo-ritlecitinib-alopecia-2024 2026-06-10T05:58:24.207Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-gmp-standards-foreign-manufacturers-impact-2024 2026-06-10T05:58:26.231Z monthly 0.5 https://novapharmanews.com/eu/news/mhra-vs-ema-regulatory-pathway-strategy-2024 2026-06-10T05:58:28.213Z monthly 0.5 https://novapharmanews.com/eu/news/ema-market-analysis-orphan-drug-pricing-reimbursement-2024 2026-06-10T05:58:30.225Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-accelerated-approval-orphan-drugs-impact-future-trends-2024 2026-06-10T05:58:37.568Z monthly 0.5 https://novapharmanews.com/apac/news/ich-guidelines-biosimilar-development-apac-2024 2026-06-10T05:58:34.298Z monthly 0.5 https://novapharmanews.com/apac/news/cdsco-forecasting-biosimilar-market-growth-india-2024 2026-06-10T08:44:39.875Z monthly 0.5 https://novapharmanews.com/apac/news/tga-pmda-uptake-adalimumab-biosimilars-2024 2026-06-10T05:58:38.229Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-biosimilar-framework-trastuzumab-adoption-2024 2026-06-10T05:58:40.300Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-biosimilar-approval-pathway-analysis-2024 2026-06-10T08:43:31.092Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-repatha-pediatric-hefh-2024 2026-06-10T05:58:44.226Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-adzynma-thrombotic-thrombocytopenic-purpura-2024 2026-06-10T05:58:52.755Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-otc-naloxone-nasal-spray-opioid-overdose-2024 2026-06-10T05:58:48.233Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-sotorasib-kras-g12c-nsclc-2024 2026-06-10T06:26:38.984Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-veozah-fezolinetant-menopause-2024 2026-06-10T05:58:52.227Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-pmda-tga-pompe-disease-market-analysis-2024 2026-06-10T05:58:54.247Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-omidubicel-onlv-2026 2026-06-10T05:58:56.240Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-updated-covid19-vaccines-fall-2024 2026-06-10T05:58:58.233Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-bosulif-pediatric-cml-2024 2026-06-10T05:59:00.241Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-ztalmy-ganaxolone-cdkl5-deficiency-2024 2026-06-10T06:38:14.209Z monthly 0.5 https://novapharmanews.com/eu/news/ema-impact-eu-pharmaceutical-strategy-api-manufacturing-2024 2026-06-10T05:59:04.239Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-opdivo-nivolumab-gastric-cancer-2024 2026-06-10T05:59:15.596Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-breyanzi-car-t-mantle-cell-lymphoma-2024 2026-06-10T08:16:43.913Z monthly 0.5 https://novapharmanews.com/us/news/fda-accelerated-approval-mirvetuximab-soravtansine-elahere-2026 2026-06-10T07:57:09.723Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-elarek-osteoporosis-prevention-2026 2026-06-10T05:59:12.245Z monthly 0.5 https://novapharmanews.com/eu/news/ema-legislation-reform-market-access-innovation-2024 2026-06-10T08:33:06.090Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-approval-bevacizumab-biosimilar-china-2024 2026-06-10T05:59:16.255Z monthly 0.5 https://novapharmanews.com/eu/news/ema-marketing-authorization-denosumab-biosimilar-2024 2026-06-10T05:59:18.250Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-interchangeable-biosimilar-ustekinumab-2024 2026-06-10T05:59:31.233Z monthly 0.5 https://novapharmanews.com/eu/news/chmp-positive-opinion-car-t-therapy-relapsed-b-cell-lymphoma-2024 2026-06-10T05:59:26.341Z monthly 0.5 https://novapharmanews.com/eu/news/ema-legislation-reform-biopharma-innovation-2024 2026-06-10T05:59:29.196Z monthly 0.5 https://novapharmanews.com/apac/news/tga-australia-early-phase-trials-analysis-2024 2026-06-10T05:59:26.273Z monthly 0.5 https://novapharmanews.com/eu/news/ema-artificial-intelligence-clinical-trials-guidelines-2024 2026-06-10T07:34:13.171Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-anti-inflammatory-atopic-dermatitis-2024 2026-06-10T05:59:30.265Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-amgen-bispecific-antibody-colorectal-cancer-2024 2026-06-10T05:59:32.269Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-syfovre-geographic-atrophy-2023 2026-06-10T08:41:09.772Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-endeavorrx-digital-therapeutic-adhd-2024 2026-06-10T07:50:29.487Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-roche-ntrk-fusion-therapy-2024 2026-06-10T07:16:40.693Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-casgevy-gene-therapy-sickle-cell-2023 2026-06-10T06:54:04.060Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-humira-biosimilar-interchangeable-2023 2026-06-10T05:59:42.268Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-gilead-hiv-bimonthly-treatment-2024 2026-06-10T05:59:45.026Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-astrazeneca-wilson-disease-2024 2026-06-10T05:59:46.291Z monthly 0.5 https://novapharmanews.com/us/news/fda-accelerated-approval-donanemab-alzheimers-2024 2026-06-10T05:59:48.274Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-novartis-breast-cancer-treatment-2024 2026-06-10T05:59:50.280Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-lumakras-nsclc-2023 2026-06-10T05:59:52.281Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-talquetamab-multiple-myeloma-2024 2026-06-10T08:04:47.078Z monthly 0.5